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Objectives: The control of tuberculosis (TB) in South Africa has fallen short of the targets outlined by the 
World Health Organization and without improvement; TB is expected to have grave consequences for 
both the mortality and morbidity of South Africans as well as crippling financial consequences for the 
public health system. While services in the public sector are free at the point of use, little is known about 
overall access barriers and their implications for treatment adherence. This paper explores these barriers 
from the perspective of TB patients enrolled in Directly Observed Treatment, Short-Course (DOTS) in 
Mitchell's Plain, South Africa. 
Methods: Using a comprehensive framework of access, in-depth interviews were conducted with 334 TB-
patients across five facilities in Mitchell's Plain, to assess barriers across the dimensions of availability, 
af!ordability and acceptability. Summary statistics were computed and comparisons of access barriers 
between adherent and non-adherent groups, and between socioeconomic groups were explored using 
bivariate, multivariate linear and logistic regressions. 
Results: Among the respondents, 244 (73.05%) met the criteria for adherence (i.e. reported that they had 
never missed a dose of TB medication) while 90 (26.95%) met the criteria for non-adherence. Marital 
status, age, birth province, costs of self-care and costs of other providers were found to be significantly 
associated with adherence (P-values <0.05). There was no significant evidence of inequalities in access 
by socioeconomic status (all P-values > 0.05). Nonetheless, the results revealed that the poor face 
increased costs of accessing TB-services, compared to the rich, though this association was not deemed 
to be significant. 
Conclusions: Our findings indicate that non-adherence is not associated with access barriers and there is 
therefore no evidence of inequity in adherence to DOTS TB- treatment. In addition, our findings show 
that there is no significant evidence of inequalities in access to DOTS TB-services in Mitchell's Plain, by 
socioeconomic status. This study discovered that there is a need to explore the high costs of using TB-











































LIST OF ABBREVIATIONS 
World Health Organization 
Tuberculosis 
Human Immunodeficiency Virus/ Acquired Immune Deficiency Syndrome 
Medical Research Council 
Directly Observed Treatment 
Directly Observed Treatment-Short Course 
International Labour Organization 
Global Competitiveness Index 
Human Development Index 
Gross Domestic Income 
Antiretroviral Therapy 
African National Congress 
Disability-Adjusted Life Years 
Millennium Development Goals 
Infant Mortality Rate 
Adult Mortality Rate 
Public-Private Interactions 
Clinic Upgrading and Building Program 
National Tuberculosis Control Program 
Multi-Drug Resistant Tuberculosis 
Extremely Drug Resistant Tuberculosis 
. International Union Against Tuberculosis and Lung Diseases 
Low and Middle Income Countries 
Out-Of-Pocket payments 
Researching Equity in Access to Healthcare 
International Development Research Centre 
Multiple Correspondence Analysis 
Principal Component Analysis 
Primary Health Care 
Community Health Centres 












TABLE OF CONTENTS 
DECLARATION .................................•....•...........................•.......•........................•............•.....•..•..•..•...•.•.... 2 
DEDICATION ............................................................................................................................................ 3 
ACKNOWLEDGEMENTS .............................•...............................•.........................•......•...........................•. 4 
ABSTRACT ................•...............................•.........••................•.....•.......•........•.........•.................................. 5 
LIST 0 F ABBREViATIONS .......................................................................................................................... 6 
TABLE OF CONTENTS ............................................................................................................................... 7 
PART A: RESEARCH PROTOCOL .............................................................................................................. 10 
Introduction ...................................................................................................................................... 10 
Background ....................................................................................................................................... 10 
Introduction ................................................................................................................................... 10 
Equity as a Global Concern ............................................................................................................. 11 
The Global TB Landscape ............................................................................................................... 13 
The Research Context .................................................................................................................... 15 
South Africa: General Overview .................................................................................................. 15 
South African Health Indicators .................................................................................................. 18 
The South African Health Sector ................................................................................................. 21 
Background ofTB in South Africa ............................................................................................... 25 
South Africa's Response to TB .................................................................................................... 26 
Literature Review .............................................................................................................................. 27 
Introduction ................................................................................................................................... 27 
Defining Adherence ....................................................................................................................... 28 
The Debate of Directly Observed Treatment vs. Self-Supervised Treatment ................................... 31 
Factors Influencing Adherence ....................................................................................................... 33 
Acceptability .............................................................................................................................. 34 
Availability ................................................................................................................................. 36 
Affordability .. ............................................................................................................................. 38 
Demographic Characteristics & Adherence Behaviour ................................................................ 40 
Rationale & Justification .................................................................................................................... 42 











Methodology ..................................................................................................................................... 43 
Data Source ................................................................................................................................... 43 
Data Collection & Conceptual Framework ...................................................................................... 44 
Study Setting & Population ............................................................................................................ 46 
Data Analysis: Statistical Methods .................................................................................................. 48 
Univariate & Bivariate Analysis ................................................................................................... 50 
Simple Linear Regression & Logistic Regression Analysis ............................................................. 50 
Ethical Considerations ....................................................................................................................... 51 
Write Up & Dissemination ................................................................................................................. 51 
References ......................................................................................................................................... 52 
PART B: LITERATURE REViEW ................................................................................................................. 61 
Introduction ...................................................................................................................................... 61 
Equity in Health ................................................................................................................................. 61 
Equity in the South African Health Sector ........................................................................................... 63 
Equity in Health Services .................................................................................................................... 65 
Access to Health Services ................................................................................................................... 66 
Three Dimensions of Access ............................................................................................................... 70 
Acceptability of Health Services & Implications for Equitable Access .................................................. 73 
Degree of Fit between Lay and Professional Health Beliefs ............................................................. 73 
Engagement and Dialogue between Patient and Provider .............................................................. 75 
Affordability of Health Services & Implications for Equitable Access ................................................... 77 
Economic Costs of Illness: Direct & Indirect Costs ........................................................................... 77 
Ability-To-Pay & Coping Mechanisms ............................................................................................. 80 
Consequences of the Medical Poverty Trap .................................................................................... 84 
Availability of Health Services & Implications for Equitable Access ..................................................... 85 
References ......................................................................................................................................... 89 
PART C: JOURNAL MANUSCRIPT ............................................................................................................ 98 
PART D: POLICY BRIEF .......................................................................................................................... 113 











List of Figures 
Figure 1: Summary of NTCP Core Package & Activities ........................................................................... 30 
Figure 2: Map of the 8 Sub-districts of the Cape Town Metropole Health District .................................. 49 
Figure '3: The 'A' Frame ......................................................................................................................... 71 
Figure 4: Simplified Flow Chart of Key Issues Relating to the Economic Consequences of Illness ............ 82 
List of Tables 
Table 1: Summary of Data Collection Tools ............................................................................................ 46 
Table 2: Dimensions of Access .............................................................................................................. 72 











PART A: RESEARCH PROTOCOL 
INTRODUCTION 
Tuberculosis (TB) represents one of the most pressing global health issues and one of the greatest 
challenges to the health of South Africans (WHO 20lla). Despite the adoption of the Directly Observed 
Treatment, Short-Course (DOTS) strategy in 1996 and significant investments in TB control, the case 
detection rate remains far below the targets outlined by the WHO and without improvement, TB is 
expected to have grave consequences for both the mortality and morbidity of South Africans as well as 
crippling financial consequences for the public health system (Mukinda et al. 2012). The burden of non-
adherence to curative TB treatment has been widely acknowledged as being a key constraint to the 
global control of TB. Where non-adherence is the result of unfair, unjust, avoidable or unnecessary 
forces, equity concerns intensify its importance. TB services in the South African public sector are free 
at the point of use, however, little is known about overall access barriers and their implications for 
treatment adherence. This paper explores these barriers from the perspective of TB patients enrolled 
in Directly Observed Treatment, Short-Course (DOTS) in Mitchell's Plain, South Africa. The following 
chapter introduces the reader to the methodological approach to the study. It presents the research 
design, describes the study area and population, the data sources and research instruments as well as 
the methods employed in data analysis. Further, this chapter includes discussions of the requisite 




There exists widespread agreement that the health of individuals is a primary determinant of living a 
prosperous life; good health has been associated with increased enrolment and success in school, 
protection from financial vulnerability, productivity in labour, increased life security as well as growth 
and economic development of nations globally (Department for International Department 2006). As 
highlighted by Nobel Prize winner Amaryta Sen (2002, p. 660), "Health is among the most important 











reason to value" (Sen 2002; O'Donnell et al. 2(08). In recognition of the importance of good health and 
its positive gains, numerous international human rights treaties and national constitutions have 
recognized health (and access to health services) as an inalienable right - one that all individuals should 
be increasingly able to realize. Nonetheless, there exists undisputed evidence that the health of 
individuals within and across nations varies significantly as a result of socia-economic disadvantage and 
geographic location (Whitehead 1992; Mackenbach & Kunst 1997). Adequate access to health services, 
one vehicle through which individuals can improve their health, has persisted as an increasingly serious 
global concern whereby approximately 1.3 billion people, worldwide, remain unable to access health 
care as a result of largely avoidable financial, physical and cultural barriers (llO & WHO 2006; Thiede et 
al.2(07). 
Equity as a Global Concern 
Equity has endured as one of the most highly-debated concepts in the global health policy landscape 
(Mcintyre 2(07). The early twenty-first century has seen a continuation of the increasing inequalities 
which exist in health outcomes across nations, communities and geographical regions (Ong et al. 2009; 
leon & Walt 2(01). The need to address equity in health was originally provided by the relevant articles 
of the World Health Organization's Alma Ata Declaration in 1978 which promoted the need to improve 
the health profiles of those most in need through primary health care and preventative programs (Ong 
et al. 2(09). In 1986, the World Health Organization (WHO) defined equity in health as a situation in 
which "everyone should have a fair opportunity to attain their full health potential and ... that no one 
should be disadvantaged from achieving this potential, if it can be avoided" (Whitehead 1992a, p. 7) 
What seems most consistent from all literature is the notion that a health inequity exists if health 
inequalities are considered to be: (1) unfair; (2) unjust; (3) avoidable and; (4) unnecessary; and further, 
that tagging a difference in the health profile of one group as inequitable involves a moral and ethical 
judgment of the fairness of the causes of the inequalities (Whitehead 1992; Krasnik 1996; Braveman & 
Gruskin 2003). Health differentials are considered inequitable largely based on whether an individual's 
health status is as a result of circumstances out of their direct control; general consensus among 
scholars has broadly grouped health differentials determined by the following circumstances as 
inequitable: 












2. Exposure to unhealthy, stressful living and working conditions. 
3. Inadequate access to essential health and other public services. 
4. Natural selection or health-related social mobility involving the tendency for sick people 
to move down the social scale. 
(Whitehead 1992) 
The very nature of the health inequalities which exist in the world today illustrates the importance of 
equity in health as a global concern. Health differentials are pervasive and often (though not 
exclusively) affect those that are already disadvantaged the most (Ong et al. 2009). There exist weaker 
chances of survival, higher premature mortality rates, increased burdens and earlier onset of both 
chronic and communicable disease as well as increased disability among certain groups, in all regions of 
the world, across all political and social systems (Whitehead 1992; Mackenbach & Kunst 1997). Higher 
rates of mortality and morbidity are noted among poorer populations relative to their better off 
counterparts, yet despite their increased needs, these groups use health services less and frequently 
contribute a greater share of their income to accessing treatment than those who are less-
disadvantaged (O'Donnell et al. 2008). "Indeed, some non-poor households may be made poor 
precisely because of health shocks that necessitate out-of-pocket spending on health" (O'Donnell et al. 
2008, p. 1). 
What is made clear from all discussions on equity, particularly within the context of health and health 
services is the fact that it can only be achieved if there exists a fair opportunity for all to achieve health. 
This understanding reflects the central role of access; if health services are the vehicle through which 
populations and individuals can improve their health, then it undoubtedly follows that equity in health is 
dependent on the equity which exists in access to health services (Krasnik 1996; Whitehead 1992). A 
central principle for action towards achieving equity in health has therefore become targeted at 
ensuring high quality health care is accessible to all (Whitehead 1992). With this in mind, health policies 
are being focused on ways to enhance access among disadvantaged groups through: (a) resource 
allocation mechanisms and the geographical distribution of health services being based on social and 
health needs; (b) prioritizing the need to understand the experiences of access to health services by all 
social groups to explain and address reasons for poor use of essential services and; (c) examining the 











Despite the commitment to equity in health reflected by (and since) the World Health Organization's 
Alma Ata Declaration in 1978 and the growth of primary health care initiatives worldwide, health 
inequities have persisted where the poor continue to lack access to quality health services. Wealthier 
nations have been able to adopt pro-equity policies with a greater level of ease whereas progress within 
poorer nations has been hampered by the emergence and rapid growth of HIV/AIDS and other 
communicable diseases, human resource shortages as a result of globalization as well as poor 
management, stewardship and monitoring which disable health policies from being successfully 
implemented (Mcintyre, Thiede, et al. 2006; Chetty 2007; Coovadia et al. 2009). Macro-economic 
policies have also stalled health sector reforms to address health inequity particularly in low and middle 
income countries where neo-liberal reforms have imposed highly regressive health financing schemes 
on disadvantaged groups (Mackenbach & Kunst 1997; Mcintyre 2007; Gilson et al. 2007). 
Since the 1980s, health equity has moved from being considered 'ideologically unacceptable' to the top 
of the health agendas of policy makers, donors, nongovernmental organizations, governments and 
international organizations across the globe (O'Donnell et al. 2008). The pursuit of equity in health and 
health service access remains an overarching goal for health systems particularly in recent years with 
the emergence of interest in universal health coverage and the need to provide broad-based, context-
specific primary health care (Ong et al. 2009). Hope lies in the potential of strategically designed and 
effectively managed health systems that are able to deal with health inequity by addressing the specific 
circumstances of marginalized populations and the physical, financial and cultural barriers they face in 
accessing health care (Gilson et al. 2007). Equitable health systems have the capacity to "generate 
wider benefits: a sense of life security, well-being, social cohesion and confident expectation of care in 
times of illness" (Gilson et al. 2007, p. 14). 
The Global T8 Landscape 
Tuberculosis (TB) represents one of the most pressing global health issues and since 1993, has been 
considered a public health emergency (WHO 2011a). TB is spread between individuals by airborne 
droplet particles containing mycobacterium tuberculosis bacilli. This can occur when an individual with 
tuberculosis coughs or sneezes, expelling particles containing mycobacterium tuberculosis bacilli which 
are then inhaled by another individual and passed into the lungs where replication occurs. According to 
the WHO (2011), TB is a worldwide pandemic whereby low and middle income countries carry 90% of 











Asian countries (WHO 2010b; WHO 20lla; Lawn & Zumla 2011). The past two decades have seen an 
escalation in TB morbidity whereby prevalence estimates in 1993 of 7-8 million cases have grown to 8.5-
9.2 million cases in 2010- more than at any other time in history (WHO 20lla). TB is accountable for the 
most deaths from an infectious disease worldwide, after HIV/AIDS, with estimates reaching 1.2-1.5 
million deaths in 2010 (WHO 20lla). Incidence rates of TB have declined marginally at a rate of almost 
1% per year since 2002; however, the absolute burden continues to increase worldwide (Lawn & Zumla 
2011; WHO 20lla). According to the WHO (2011), there continues to be a cloud of ambiguity 
surrounding estimates of TB prevalence and incidence due to poor surveillance systems which fail to 
capture all TB cases (WHO 20lla). There are a significant number of individuals who do not seek 
treatment, are not diagnosed or whose diagnoses go unreported to the appropriate authorities and as 
such, estimates may be even greater than reflected in most published reports (WHO 20lla). 
Since the acceptance of TB as a worldwide emergency in 1993, the Directly Observed Treatment, Short -
Course (DOTS) strategy has been the main mechanism by which the WHO's Stop TB Campaign and the 
Global Plan to Stop TB aim to guide national TB policy to reach the Millennium Development Goal of 
"reduc[ingJ, by 2015, the prevalence of and deaths due to TB by 50% relative to 1990 and revers[ingJ the 
trend in incidence" (WHO 2010b, paragraph 1). Treatment of active tuberculosis is done with a 
standardized range of anti TB drugs, which must be monitored in order to ensure that individuals take 
and complete their course of medication. The DOTS strategy is based on five key covenants: (1) a 
sustained government commitment to prioritize TB control; (2) the diagnosis of TB through sputum 
microscopy; (3) standardized and supervised treatment in a supportive environment; (4) uninterrupted 
drug supply and; (5) regular monitoring of patients and health systems (Western Cape Department of 
Health 2004; Raviglione & Uplekar 2006). In 2006, these guidelines were reassessed to address 
emerging challenges involved in TB control and a provocative target was set to eliminate TB as a public 
health problem by 2050 (Lawn & Zumla 2011; WHO 20lla). TB treatment remains one of the most cost-
effective treatment regimens for disease and when administered appropriately is able to cure patients 
and prevent transmission (Lonnroth et al. 2010). Furthermore, evidence has shown that timely 
treatment has the capacity to produce economic benefits which can amount to ten times the 
investment (Lonnroth et al. 2010) 
The successes of the DOTS strategy cannot go unnoticed. Between 1995 and 2010, 55 million TB 











lives (WHO, 2011; Glaziou et ai, 2011). Nonetheless, current forecasts of TB incidence, and its marginal 
decline of 1% per year, have suggested that the target of halving TB prevalence by 2015 and eliminating 
TB as a public health crisis by 2050, will not be met (Lawn & Zumla 2011; WHO 2011a). The case 
detection rate (CDR) for TB ("an approximate indication of the proportion of all incident TB cases that 
are actually diagnosed, reported, and started on treatment" (WHO 2011a, p. 29)) has stabilized at 6QO", 
falling far below the 70% target outlined by the Millennium Development Goals (WHO 2011a; Lawn & 
Zumla 2011). Furthermore, incidence projections have illustrated that "even if the Global Plan to Stop 
TB were successfully implemented, incidence would only decrease at around 6% yearly, meaning that 
worldwide incidence rates in 2050 would remain l00-times higher than the elimination target" (Lawn & 
Zumla 2011, p. 68). 
The challenges of controlling the TB pandemic can broadly be summarized into six categories: (1) the 
HIV-associated TB epidemic; (2) the escalating problem of drug-resistant TB; (3) weak health systems 
which fail to address the key socia-economic factors which determine general population health; (4) a 
lack of resources; (5) a failure of TB preventative interventions to have been implemented at scale and; 
(6) long treatment delays (Lonnroth et al. 2010; Lawn & Zumla 2011). 
The Research Context 
Health care access and delivery is undoubtedly a global concern, however, central to any analysis and 
appreciation of health provisioning is an understanding of the unique environment in which health 
services are sought. The following discussions provide the reader with the context in which access to TB 
services and the mechanisms of ensuring such access are being studied. In particular, a summary of the 
organization of the South African health sector is provided as well as the primary health challenges 
currently being faced by the country. This will lay the foundation for crystallizing the research problem 
later on in the chapter. 
South Africa: General Overview 
Since the democratization of South Africa in 1994, the government has made Significant progress in 
reversing the effects of the apartheid legacy which was characterized by severe inequality, health and 
development policy which was disproportionately focused on ensuring the survival of the white 











(Mcintyre, Thiede, et al. 2006; Chetty 2007; Coovadia et al. 2009). Today, South Africa is home to 
approximately 50.59 million people and represents a multiracial democracy comprised of a 79.5% black 
African majority, and minority groups of a 9.0% White population, 9.00h Coloured population and a 2.5% 
Indian population (Coovadia et al. 2009; StatsSA 2011)", It has been estimated that 61% of South 
Africans reside in urban areas and 39% live in rural areas (World Bank 2011). 
With regards to development, South Africa has seen modest, positive economic growth since the first 
democratic elections in 1994 with annual growth rates falling between 2% and over 5% over the past 
decade (Coovadia et al. 2009). In 2011, South Africa's Gross Domestic Income (GOI) Per Capita in pppt 
terms was estimated at US$ 10,278 (Adelzadeh & UNOP 2003) and the nation has earned a Global 
Competitive Index* (GCI) score of 4.34 placing it in the 50th position of 142 countries which confirms its 
place among the most emerging competitive economies (World Economic Forum 2011). However, 
despite its positive economic performance, South Africa is still ranked in the company of the poorest 
nations in the world by its Human Development Index§ (HOI) scor  - a summary composite index that 
measures a country's average achievements in three basic aspects of human development: life 
expectancy, education, and a decent standard of living (by GOI per capita (PPP US$)) (UNOP 2011). The 
HOI for South Africa was 0.61 in 2011, falling from 0.72 in 1990 and plaCing it in 123rd place of 187 
countries (Adelzadeh & UNOP 2003; UNOP 2011). This measure indicates that despite reasonable 
economic growth, and a concerted effort b  the South African government, the living standards and 
experiences of societal life for the majority of South Africans has worsened over the past two decades 
(Adelzadeh & UNOP 2003). 
The terms allocated to racial groups are consistent with those used in the national census and do not accept 
racial attributes of any kind. 
t GDI per capita in PPP terms (constant 2005 international $): Aggregate income of an economy generated by its 
production and its ownership of factors of production, less the incomes paid for the use of factors of production 
owned by the rest of the world, converted to international dollars using purchasing power parity (PPP) rates, 
divided by midyear population (UNDP 2011) 
* Global Competitiveness Index measures the set of institutions, policies, and factors that set the sustainable 
current and medium-term levels of economic prosperity; this measure indicates the level of prosperity that can be 
earned by an economy (World Economic Forum 2011) 
§ The Human Development Index is a composite measure of human development which includes life expectancy, 











According to the World Health Organization, approximately 26.2% of South Africans live in absolute 
poverty", representing an estimated 13.3 million people (WHO 2011b). Recent estimates have 
suggested that 37% of the South African population is unemployed (Coovadia et al. 2009). In 1994, the 
newly elected government was committed to reversing the wealth disparities which were produced by 
years of racial discrimination; government policy became focused on improving access to basic social 
services by improved funding to these sectors particularly through a national system of social grants 
(Coovadia et al. 2009). Currently this system successfully serves approximately 12.4 million beneficiaries 
through disability, pension and child support grants (Coovadia et al. 2009). However, wealth disparities 
have persisted and worsened since 1994; the Gini-coefficient, a measure of income inequality (in a 
range from zero to 1, with zero referring to total equality), rose from 0.56 in 1995 to 0.78 in 2005 -one 
of the highest in the world (Coovadia et al. 2009). The average annual income among the poorest 
groups is R4,314 (about US$516) compared with an average annual income of R405,646 (about 
US$48,462) among the wealthiest groups (Coovadia et al. 2009). 
Over the past two decades, the nature of the unequal income distribution has changed. As many of the 
rural poor migrate to the urban areas in search of improved employment prospects, the population of 
urban poor has risen by 4.7 million between 1993 and 2008 (May 2010). As such, South Africa has seen 
a rise in urban poverty and this has been reflected by an increase in urban income inequality and a 
reduction in rural income inequality (Adelzadeh & UNOP 2003). Racially, "there is a rising polarization of 
income within all racial groups ... however, the deterioration of income equality is more severe among 
African, Coloured and Indian households than among White households" (Adelzadeh & UNOP 2003, p. 
xvi). Inter-race comparisons of HOls in South Africa have also showed that despite a slight improvement 
from 1990, the HOI for the black African population in South Africa has continued to fall far below the 
HOI for the White population (Adelzadeh & UNOP 2003). 
What is seemingly clear is that the gains in the national economy have failed to translate to the 
prosperity of the South African population. After 18 years, South Africa is still struggling with the 
"legacy of apartheid and the challenges of transforming institutions and promoting equity in 
development" (Coovadia et al. 2009, p. 817) . 











South African Health Indicators 
Despite its economic position as a middle-income country, the health of South Africans is worse than 
many of the poorest populations in the world particularly due to the effect of the concomitant 
epidemics currently being faced by the country (Coovadia et al. 2009). "Poverty related illnesses such as 
infectious diseases, maternal death, and malnutrition, remain widespread, and there is a growing 
burden of non-communicable diseases [furthermore;] HIV/ AIDS accounts for 31% of the total disability-
adjusted life years {DALYs)tt of the South African population, with violence and injuries constituting a 
further cause of premature deaths and disability" (Coovadia et al. 2009, p. 817). 
South African health indicators illustrate the poor progress that has been made towards the 
achievement of the health-related Millennium Development Goals. Life expectancy in 2009 for males 
was 54 years and 55 years for females, having substantially decreased from 1990 when life expectancy 
was estimated to be 59 years for males and 68 years for females (WHO 2011b). Of particular concern, 
the Adult Mortality Rates (which provide the probability of dying between age 15 and 60 years) have 
increased by just over 52% for males and around 150% for females between 1990 and 2009 (WHO 
2011b). The Infant Mortality Rate (lMR) in 2009 was 43/1000 live births showing a modest decrease 
from the 1990 IMR of 48/1000 live births however, 62 children per 1000 still die before their fifth 
birthday- a rate that has not improved since 1990 (WHO 2011b). In fact, the under five mortality rate for 
South Africa in the year 2000 had actually increased to 77 children per 1000; South Africa representing 
only one of twelve countries who saw child mortality increase since the Millennium Development Goals 
were established (WHO 2011b; Coovadia et al. 2009). 
One of the greatest challenges to South African health has been the burden of communicable disease, 
particularly the concurrent HIV/AIDS and TB epidemics (Abdool-Karim et al. 2009). With only 0.7% of 
the world's population, South Africa carries approximately 17% of the global burden of HIV/AIDS, "and 
one of the world's worst tuberculosis epidemics, compounded by riSing drug resistance and HIV co-
infection" (Abdool-Karim et al. 2009, p. 921). In 2011, the prevalence of HIV/AIDS was 10.6%, 
representing just over 5.36 million people living with the disease, while the prevalence rate of TB 
tt The disability-adjusted life year (DALY) is a measure of overall disease burden, expressed as the number of years 











reached 795 per 100 000 people - a rate that has nearly doubled over the past decade (Health Systems 
Trust 2012). With the development of drug resistant strains of TB, it has become increasingly evident 
that the South African health system cannot cope (Abdool-Karim et al. 2009). After a substantial period 
of denial and a lack of political interest which saw the unnecessary death of thousands of South Africans, 
the country has finally begun to see some successes in the control of both HIV/AIDS and TB whereby 
there has been a marked improvement in access to condoms as well as an expansion of tuberculosis 
control programs, and a modest scale-up of free antiretroviral therapy (ART) - the standard means of 
reducing morbidity and mortality among those infected with HIV/AIDS (Abdool-Karim et al. 2009; 
Coovadia et al. 2009). 
Nonetheless, efforts to combat the co-epidemics of HIV/AIDS and TB have been hampered by failures in 
the implementation of policies and an inability to successfully integrate HIV/AIDS and TB services with 
each other and with the wider primary health care system (Abdool-Karim et al. 2009). Furthermore, the 
progression of disease has created a need for increasingly complex and expensive interventions which 
are persistently inaccessible to those who require them the most (Abdool-Karim et al. 2009). HIV/AIDS 
and TB continue to cause devastating mortality among South Africans. Although the full scale of 
HIV/AIDS-related mortality has been difficult to assess due to misclassification, to date, over 2.6 million 
South Africans have died due to HIV/AIDS, predominantly children under five and young adults (Harrison 
2009). It is assumed that a considerable amount of deaths classified to be caused by non-communicable 
disease have in fact been HIV/AIDS-related and as such, the mortality rates are expected to be 
significantly higher than reflected in most published reports (Harrison 2009). According to the WHO 
(2011), cause-specific mortality rates have shown that HIV/AIDS kills 627 (511-775) per 100,000 people 
while TB causes death for 52 (29-85) per 100,000 HIV-negative people, in South Africa (WHO 2011b). 
Chronic non-communicable diseases are also a major contributor to the burden of disease in South 
Africa and evidence has suggested that after communicable disease, the prevention of chronic 
conditions should be prioritized within the national health agenda (Puoane et al. 2008). Chronic non 
communicable diseases encompass cardiovascular diseases, diabetes, certain cancers as well as chronic 
respiratory diseases (WHO 2011b). These conditions are steadily growing, affecting all population 
groups (WHO 2011b). Of the primary conditions which contribute to mortality in South Africa, four of 
the ten diseases belong to this category causing a loss of approximately 65 000 lives per year through: 











disease (3.2% of total deaths) and; (4) diabetes mellitus (2.6% of total deaths) (Norman et at. 2007; 
Puoane et at. 2008). 
Current methods to control non-communicable diseases in South Africa have not been particularly 
effective. Programs which aim to educate the population about the associated risk factors and the 
importance of early diagnosis have not been strategically implemented which has rendered key target 
populations without access to these campaigns, particularly in rural areas where infrastructure is poor 
(Puoane et al. 2008). In addition, the practice of routine screening and annual physical health 
examinations has not been adopted by both health workers and the population at large (Puoane et at. 
2008). The impact of chronic non-communicable disease extends to the individuals facing disease, their 
households as well as the health system. These diseases tend to affect individuals when they are in their 
most economically productive years which reduce their households earning capacity through a 
diminished ability to engage in productive labour (Puoane et at. 2008). Further, chronic disease 
treatment places a heavy burden on the already strained health system particularly due to the longevity 
of treatment and the associated financial investment (Puoane et al. 2008) 
Despite the fact that deaths relating to injury and violence do not feature among the Millennium 
Development Goals, South Africa carries a substantial health burden related to these causes which 
creates an enormous demand for medical care and rehabilitation services (WHO 2011b). Within the 
country, approximately 3.5 million people will seek health services for both intentional and 
unintentional, non-fatal injuries annually, of which 50% are predicted to be due to interpersonal 
violence (Harrison 2009). When combined, violence and traffic injuries account for 75% of death and 
injury from external causes and represent 6.5% and 3.0% of the total disability-adjusted life years of the 
South African population, respectively (Harrison 2009; Coovadia et at. 2009). Despite a decline in the 
homicide rate over the past two decades, rates of sexual assault and rape, as well as death rates from 
traffic injuries continue to escalate (Harrison 2009). 
The constitution of South Africa requires that the government work towards the progressive realization 
of the right to health however, eighteen years after the democratization of the country, massive health 
inequities continue to exist (Coovadia et at. 2009). The burden of illness, injury and mortality 
disproportionately falls upon certain groups, who often "live, work and travel in unsafe environments; 











20). Disease has a wide array of risk factors however, those that are of primary interest to policy makers 
are those which are modifiable including "individual and community influences, living and working 
conditions and socia-cultural factors" (Puoane et al. 2008, p. 75). Racially, prevalence of HIV among 
Indian South Africans, falls between 0.6% and 1.9% whereas the prevalence of HIV among Black South 
Africans has been found to be 13.3%; "in 2002, infant mortality [was] 7 per 1000 in the white population 
and 67 per 1000 in the black population, [further,] life expectancy for white adult women was 50% 
longer than it was for black women" (Coovadia et al. 2009, p. 824). Inequities across provinces are also 
evident: in 2000, the provincial mortality rate for children under 5 years in the Western Cape Province 
was 46 per 1000 live births compared to a substantially higher rate of 116 per 1000 live births in the 
KwaZulu-Natal province (Coovadia et al. 2009). Even intra-provincial infant mortality rates show a high 
degree of health inequity whereby there exists a threefold difference in infant mortality between 
middle-class communities and squatter communities (Coovadia et al. 2009). 
The marked differences in the rates of disease and mortality in South Africa can be seen between races, 
socia-economic groups, provinces and gender which reflect differences in access to basic household 
living conditions and other determinants of health (Coovadia et al. 2009). South Africa's apartheid past 
continues to influence inequities in its health, se~ices, and resources (Harris et al. 2011). Even with a 
host of policies directed at ensuring water, housing, electricity, sanitation and health care is provided to 
all, these services have become highly unreliable and insufficient through poor implementation and 
management (Coovadia et al. 2009). 
The South African Health Sector 
Though food, employment, education and housing- the conditions by which people live- will strongly 
affect health and must be prioritized by the state; access to health services are a critical component of 
addressing the ways in which individuals live and die (WHO 2010a). The agenda for post-Apartheid 
South Africa's health policy was born out of a need to address the highly fragmented health system 
which existed through colonialism and apartheid. By 1994, this system had been weakened by 
disempowerment, discrimination and underdevelopment whereby budgets were overspent, human and 
financial resources poorly distributed and large inequalities in infrastructure were evident between 











Since then, the South African health sector has experienced significant restructuring. The fourteen 
health administrations of the pre-1994 state were consolidated into one national and nine provincial 
health departments (Coovadia et al. 2009). The National Department of Health provides a framework 
for health policy while provincial health departments are responsible for developing their own 
respective policy within the confines of the national framework (Coovadia et al. 2009). Focus was 
shifted toward primary health care delivery through the demarcation of health districts as an integrated, 
comprehensive approach to servicing the health needs of the country, particularly for those that were 
disadvantaged (Coovadia et al. 2009). The broad framework for planning and implementing this 
program was initially provided by the relevant articles of the 1995 African National Congress (ANC) 
National Health Plan, the 1996 National Drug Program, the 1997 White Paper for the Transformation of 
the Health System in South Africa and more recently by the 2004 National Health Act. 
The Public Sector 
The public health system is led by the National Department of Health which is responsible for overall 
health policy and co-ordination and is largely financed by general taxation. Implementation and delivery 
of health services is through the nine provinces and 53 health districts which are divided into 284 
municipalities (local government authorities). The provinces provide mainly curative hospital services 
through tertiary and regional hospitals; district and municipal government provide primary health care 
and preventative and promotive health services through district level hospitals and nurse-driven 
services at community health centres (Coovadia et al. 2009). ApprOXimately 84% of the total population 
of South Africa, an estimated 42.50 million people, is reliant on the public sector for health services 
(Retchin et al. 1997; South African Department of Health 2002). Nonetheless, only 30% of South African 
health care facilities belong to this sector (Retchin et al. 1997; South African Department of Health 
2002). 
Since 1996, primary health care has been free for all South African citizens marking a significant step 
towards making health care accessible to all (Harrison 2009). Furthermore, clinic infrastructure has 
been significantly expanded through the Clinic Upgrading and Building Program (CUBP) (1994) and the 
Hospital Rehabilitation and Reconstruction Program (1998) (Harrison 2009). These initiatives have seen 
the establishment of eleven district and regional hospitals, three academic complexes, 1345 new clinics 











and marginalized communities (Coovadia et al. 2009; Harrison 2009); "the proportion of Africans who 
reported travelling fifteen minutes or less from home to health services increased from just over a third 
(36.3%) to above half (54%) between 1995 and 1998" (Harrison 2009, p. 16). Furthermore, the past 
decade has seen improvements in the parity of district health expenditure; between 2001 and 2008, 
"the ratio between the district with the highest and lowest public per capita spending dropped from 9.3 
to 3.3 - a considerable improvement in the equitable allocation of public resources" (Harrison 2009, p. 
16). 
Despite these successes, key challenges remain. With the projected growth in both the incidence rates 
and complexities of both communicable and non-communicable disease, there is a corresponding need 
for a rational, comprehensive approach to the simultaneous prevention and treatment of these 
conditions which will require greater parity in resource allocation as well as co-ordination between all 
levels of the public health sector (Harrison 2009). A considerable body of research has also highlighted 
the inefficiencies which exist in the South African public health sector as a result of poor quality of care 
and low health worker morale which necessitate monitoring and quality improvement initiatives 
through education and training (Harrison 2009). A related concern is the persistent health worker 
shortages faced by the public sector, more pronounced in rural areas despite rural skills allowances and 
community health service which is mandatory for the majority of health workers after the completion of 
their studies (Harrison 2009). Further, poor implementation has repeatedly been cited as a principal 
reason why the gains of the effectively designed, evidence-based and internationally-praised South 
African health policies have not been translated to the population, which demands improved planning 
and management of policy implementation as well as harmonious leadership across provinces (Coovadia 
et al. 2009) 
The Private Sector 
The private sector services the health care needs of 16% of South Africans, an approximated 8.10 million 
people, through 70% of the health care resources which exist in the country (Retchin et al. 1997; South 
African Department of Health 2002). Primarily composed of general practitioners, medical specialists 
and private hospitals, the private sector is predominantly funded by voluntary medical schemes 











(encompassing 29.7% of total private expenditure on health) (WHO 2011b). Since 1998, the proportion 
of South Africans belonging to a medical scheme has remained fairly constant at around 14% of the 
population; so too have the contributions made by these members (Harrison 2009; Health Systems Trust 
2012). Nonetheless, there has been a significant decline in the benefits paid by most medical schemes, 
which has lead to higher out-of-pocket expenses for members seeking treatment in the private sector 
(Harrison 2oo9). Another notable trend in medical aid membership has seen many members opt for 
lower risk schemes; between 2007 and 2009, a 19% increase in membership to low-risk medical aid 
schemes was observed and a corresponding 27% decline in membership to high-risk medical schemes 
(Harrison 2009). The private sector is not anticipated to grow considerably unless the incomes of the 
general population grow (Harrison 2oo9). As an alternative mechanism for growth, the private sector 
has become involved in service delivery within the public sector through PubliC-Private Interactions 
(PPls) (Harrison 2oo9); these interactions have notably included "contracts with both profit and non-
profit providers supporting the delivery of tuberculosis, psychiatric and secondary level hospital care for 
public patients" (Wadee et al. 2004, p. 7). 
Private care in South Africa has been criticized for being unequally distributed and responsible for the 
maldistribution of health workers in the country; approximately 70% of private hospitals exist in three of 
the nine provinces with 38% located in the Gauteng Province (Johannesburg and Pretoria) alone and; 
approximately 60% of all South African doctors and 80% of all dentists and pharmacists are employed by 
the private sector which serves only a small fraction of the population (Coovadia et al. 2009; Retchin et 
al. 1997). 
Health Funds 
According to the WHO, health expenditure in South Africa constitutes 8.2% of the nations' GOP, a value 
which has modestly increased over the past decade (WHO 2011b). Between 2005 and 2006, general 
taxation accounted for approximately 40% of total health care funds, medical aid contributions 
contributed 45% and out-of-pocket payments contributed 14% of total health care funds (Health 
Economics Unit 2009). Despite the progressivity of South African health care financing, whereby "the 
richest 20% of the population contribut[eJ about three times the proportion of personal income than 











disproportionately when compared to the public sector which has a significant impact on the benefits of 
health services which are available to the users of each respective sector (Harrison 2009). 
Between 2008 and 2009, expenditure per person was about 5.4 times higher than public sector 
expenditure per person (Health Systems Trust 2012). In totality, general government expenditure on 
health was 39.7% of the total expenditure on health whereas general private expenditure on health 
represented 60.3% of total expenditure on health (WHO 2011b). Evidently, there is a substantial 
difference in resource availability between public and private sectors particularly significant when one 
considers that the public sector has a far smaller resource base to serve a population approximately four 
times the size of the population served by the private sector. As made evident by the health indicators 
discussed earlier, the burden of disease is much higher among the marginalized and poor who are 
largely dependent on the public system for health care; when the resources available to the public 
health sector is considered, it can be said that the distribution of benefit from health services in unfairly 
distorted toward wealthier groups and is inequitable (Harrison 2009). As a result, South Africa is now on 
a trajectory toward a National Health Insurance scheme to allow cross-subsidization between the rich 
and poor as a means of reversing these trends and promoting equity in health service delivery (Harrison 
2009). 
Background of TB in South Africa 
South Africa currently has the third-highest TB burden in the world with TB notification rates increasing 
fivefold over the last twenty years (Wood et al. 2011). In 2008, TB incidence was an estimated 940 cases 
per 100 000 people (Mukinda et al. 2012). Despite the adoption of the DOTS strategy in 1996 and 
significant investments in TB control, the case detection rate remains less than 60% with treatment 
success rates in 2008 at 76%, falling short of the WHO targets of 70% and 85%, respectively (Mukinda et 
al. 2012). The TB notification rates for a single health district in South Africa (Cape Town Metropolitan) 
represent double the number of TB cases reported in the United States of America (Wood et al. 2011). 
A serious contributor to the burden of TB in South Africa has been the emergence of multi-drug resistant 
(MDR) strains of the mycobacterium tuberculosis bacilli, the organism which causes TB (Fourie 2011). 
Those that become infected with MDR are subject to extended, complex and extremely expensive 
treatment regimens which have poor success rates and often fatal outcomes (Fourie 2011). It has been 











2011). Furthermore, the impact of the HIV/AIDS epidemic has been considerable; HIV/AIDS infected 
individuals possess weakened immune systems and are therefore highly at risk to acquire TB. In 2007, 
approximately 40% of all notified TB cases in South Africa were tested for HIV/AIDS infection and 73% 
were estimated to be positive (Wood et al. 2011). Over the next five years the epidemiological profile of 
TB in South Africa is likely to show increasing rates of infection, more pronounced in the provinces of 
KwaZulu-Natal, Mpumalanga and Gauteng, which have the fastest-growing HIV infection rates in the 
country (Fourie 2011). 
The TB burden faced by the country is largely a product of the failures and injustices which took place in 
the country's past. Until 1995 which saw the establishment of the National Tuberculosis Register, 
national cure rates were unknown and control efforts were unable to challenge poor performance 
(Fourie 2011). Estimates by the Medical Research Council's (MRC) National Tuberculosis Program have 
indicated that if control efforts do not improve, an anticipated 3.5 million new cases of TB will develop 
with approximately 90,000 deaths over the next decade (Fourie 2011). 
South Africo's Response to TB 
The National Tuberculosis Control Program (NTCP) is the South African plan for TB control and was 
revised in 1995 based on the WHO's Directly Observed Treatment, Short -Course (DOTS) strategy which 
necessitates: (1) a sustained government commitment to prioritize TB control; (2) the diagnosis of TB 
through sputum microscopy; (3) standardized and supervised treatment in a supportive environment; 
(4) uninterrupted drug supply and; (5) regular monitoring of patients and health systems (South African 
Department of Health 2004). This program replaced the non-standardized short-course chemotherapy 
which had been available for several years. Since then, recommendations by the WHO's Stop TB 
Campaign and the Global Plan to Stop TB have modernized TB control within South Africa through: new 
and improved TB drugs (with shorter periods of treatment); superior TB diagnostic tools; improved TB 
registration mechanisms and; clear performance targets. "The recommended treatment regimen for 
newly diagnosed, drug-susceptible TB consists of a 2-month intensive phase of isoniazid, rifampicin, 
pyrazinamide and, optionally, ethambutol, followed by a 4-month continuation phase of isoniazid and 
rifampicin, administered daily" (Van den Boogaard et al. 2011, p. 693). The most recent objectives of 
the NTCP (for the period 2007-2011) are: 











2. To address TB and HIV, MDR and XDR-TB; 
3. To contribute to health systems strengthening; 
4. To work collaboratively with all care providers; 
5. To empower people with TB as well as communities; 
6. To coordinate and implement TB research 
7. To strengthen infection control 
(South African Department of Health 2007) 
The NTCP core package and essential activities are outlined in Figure 1. The NTCP involves all levels of 
health governance: the national level - through the co-ordination, facilitation and evaluation of TB 
services for the whole country; the provincial level - through the implementation and budgetary 
activities of TB service delivery and; the district level for the management of primary health care 
(Western Cape Department of Health 2004). 
LITERATURE REVIEW 
Introduction 
TB treatment remains one of the most cost-effective treatment regimens for disease and when 
administered appropriately is able to cure patients and prevent transmission (Lonnroth et al. 2010). 
Despite the long-standing existence of effective TB treatment and its delivery through the WHO's 
Directly Observed Treatment, ~hort -Course (DOTS) strategy, TB has yet to be controlled globally and has 
persisted as a serious epidemic within South Africa where the incidence of the disease is currently 
estimated to be 940 cases per 100,000 people (Mukinda et al. 2012). The dangerous interaction 
between HIV/AIDS and TB, the escalating problem of drug-resistant TB and the social determinants of 
the disease have contributed to the gravity of this situation. 
According to the WHO (2003), poor adherence to anti-tuberculosis medication is among the most 
significant barriers to its global control (WHO 2003). This is particularly due to the fact that TB is a 
communicable disease and as a result, poor adherence to treatment has implications at both the 
individual and community levels through morbidity, mortality and drug resistance (WHO 2003). The 











to anti-tuberculosis therapy within South Africa and other comparable settings. Specifically, the 
objective is the gain insight into the ways in which the availability, affordability and acceptability of TB 
treatment can shape adherence and to understand the consequences of non-adherence to treatment. 
Defining Adherence 
There have been a range of ways in which adherence has been defined in the research and policy 
landscape. By accepting that the existence of efficacious treatment alone does not guarantee positive 
health outcomes and that poor administration and continuation of treatment threatens its 
effectiveness, it becomes particularly important to understand (and address) the factors which govern 
how an individual consumes and continues therapy for health conditions over a period of time (Vol mink 
& Garner 2007). This is especially crucial for chronic, communicable disease where reduced treatment 
effectiveness has implications for the individual and the communities to which they belong through 
increased and prolonged infectiousness, drug resistance, relapse and death (Volmink & Garner 2007). 
Over the past two decades, there has been a paradigm shift which has seen increased emphasis on the 
empowerment and autonomy ofthe patient in the patient-provider interaction. As a result, patients are 
no longer seen as "passive, acquiescent recipient[s] of expert advice" (WHO 2003, p. 3). Patients have 
become active collaborators in the treatment process (WHO 2003). Adherence, therefore, is not solely 
concerned with taking prescribed medication or following medical direction (i.e.: medication 
adherence), though these are important dimensions of the concept. Treatment adherence broadly 
encompasses the extent to which all therapeutic behaviours which have the capacity to improve the 
health outcomes of an individual correspond with the recommendations of the provider (WHO 2003). In 
much of the literature which examines adherence, patient-related factors are blamed for poor 
adherence and there is a propensity for researchers to neglect the role of the provider and the wider 
health environment (WHO, 2003). The WHO (2003) asserts that the quality of the treatment 
relationship is an important determinant of adherence, effective when: (1) an atmosphere is created in 
which alternative therapeutic means are explored; (2) the regimen is negotiated; (3) adherence is 
discussed and; (4) follow-up is planned (WHO 2003). As aptly summarized by Annik Rouillon (former 
Executive Director of the International Union Against Tuberculosis and Lung Diseases (IUATLD)): "To 
default is the natural reaction of normal, sensible people: a person who continues to swallow drugs or 
have injections with complete regularity in the absence of encouragement and help from others is the 
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3. Deviation from the prescribed treatment in another way, including brief treatment 
interruptions and under- or overdosing 
(Farmer 1999; Van den Boogaard et al. 2011, p. 694) 
Currently, however, there exists no empirical definition for non-adherence which delineates the point at 
which a patient is said to be non-adherent. Strategies which have aimed to do so have been 
complicated by the fact that standard TB treatment guidelines allow a certain level of flexibility with 
regards to intermittent dosing i.e. whether treatment is administered daily or weekly (Munro et al. 
2007; WHO 2003). Further, although "premature termination of treatment increases the risk of 
treatment failure and relapse, the exact relationship between this risk increment and the duration of 
treatment until termination is unknown"(Van den Boogaard et al. 2011, p. 693). 
The Debate 0/ Directly Observed Treatment vs. Self-Supervised Treatment 
Since the acceptance of TB as a worldwide emergency in 1993, the Directly Observed Treatment, Short -
Course (DOTS) strategy has been the main mechanism by which the WHO's Stop TB Campaign and the 
Global Plan to Stop TB aims to guide national TB policy to reach the Millennium Development Goal of 
"reduc[ing], by 2015, the prevalence of and deaths due to TB by 50% relative to 1990 and revers[ing] the 
trend in incidence" (WHO 2010a, paragraph 1; Lawn & Zumla 2011, p. 64). The DOTS strategy is based 
on five key covenants which have been discussed earlier. One of the most important aspects of the 
DOTS strategy is that treatment is supervised whereby an appointed person (health worker, community 
volunteer or trained family member) directly observes the patient swallowing their anti-tuberculosis 
medications over approximately six to eight months - the average duration of treatment for drug-
susceptible TB (Volmink & Garner 2007). DOT was first adopted in the 1960s in certain areas of India 
and Hong Kong and since then has been widely implemented in most countries with national 
tuberculosis treatment programs (Volmink & Garner 2007). 
A number of studies have argued that the DOTS strategy is essential and is the most effective way of 
preventing relapse and the development of drug resistance; patients are able to be closely supervised 
and are coerced into adherence through peer pressure and other social influences (Volmink & Garner 
2007). However there are also a number of claims that the DOTS strategy is no more beneficial than 
self-supervised treatment; these critics also assert that directly observing treatment can actually 
promote non-adherent behaviour by reverting to the former view of patients as passive recipients of 











associated with DOT are that it moves away from adherence models of communication and cooperation 
between patient and provider... [and] may make adherence worse if it is rigidly applied in an 
authoritarian setting or where people are expected to travel considerable distances to have their 
treatment supervised" (Volmink & Garner 2007, p. 3). Furthermore, where caseloads are particularly 
high, the resources required to sustain the DOTS strategy as a national TB treatment program are 
substantial (Vol mink & Garner 2007). 
DOTS programs vary widely across the world as the framework provided by the WHO is sufficiently 
broad to allow for individualized interpretations; as yet, "the essential components for DOT strategy 
success have not been systematically established through randomized trials" (Moonan et al. 2011, p. 6). 
This has made it increasingly difficult to compare studies (Moonan et al. 2011). Moonan et al (2011) 
describe two different approaches to the implementation ofthe DOTS strategy; although both adhere to 
the guidelines put forth by the WHO, the outcomes of each program are significantly different (Moonan 
et al. 2011). In the first case, the authors describe a program which serves a poor population using a 
"maximally restrictive" (Moonan et al. 2011, p. 6) interpretation of DOTS whereby patients are 
mandated to visit a facility five times weekly for approximately twelve weeks and three times weekly 
thereafter until cured (Moonan et al. 2011). In the second case, the authors describe a program which 
has used an alternative interpretation of DOTS whereby medications are delivered to the homes of 
patients for a period of two months and thereafter, patients are self-supervised until cured (Moonan et 
al. 2011). In the former case, over 40% of patients did not complete their treatment whereas in the 
latter, the program achieved cure rates of over 85% (Moonan et al. 2011). 
In 2007, Volmink and Garner (2007) conducted a Cochrane Review to compare DOT with self-supervised 
treatment for clinically active TB (Volmink & Garner 2007). According to their findings, in both clinic-
based DOT and community-based DOT (i.e. by a family member or community volunteer) treatment 
adherence and outcomes are similar to those of self-supervised treatment (Volmink & Garner 2007). 
Volmink and Garner (2007) suggest that the benefits that have been linked (through observational 
studies) to the DOT strategy are more likely the result of the cumulative effect of a range of 
interventions aimed at improving adherence (Volmink & Garner 2007). In a similar vein, Udwadia and 
Pinto (2007) suggest that the success of the DOTS strategy can be attributed to the major investments in 
infrastructure that is required for the program to be administered, rather than the fact that treatment is 











In 2009, Volmink and Garner (2007) updated their findings through an analysis and review of 
randomized and quasi-randomized trials that had not been previously available. Nonetheless, their 
conclusion remained the same; as yet, there is no assurance that the use of DOT in low and middle 
income countries improves cure rates or completion of treatment when compared to self-supervised 
treatment (Volmink & Garner 2007). A cluster-randomized trial in South Africa found that support and 
motivation by a health worker was more effective at ensuring treatment adherence than DOT-based 
services (Clarke et al. 2005; Volmink & Garner 2007). The authors urge governments to refocus 
resources away from DOT strategies to interventions which have been proven to improve adherence 
such as patient support, motivation and incentives until more is known about the situations in which 
DOT will be most effective (Volmink & Garner 2007). 
The DOTS strategy is currently Hin the process of shifting from being a rigid model involving observation 
of drug swallowing to one that includes an array of incentives and enablers for supporting the patient" 
(Volmink & Garner 2007, p. 7; Macq et al. 2003). Given that those affected by TB are generally poor and 
face a number of barriers to treatment adherence, it has been suggested that programs which target a 
reduction in social and health system barriers may be far more effective in improving adherence and 
cure rates (Volmink & Garner 2007). Rates of n n-adherence to treatment are required to fall below 
10% in order to achieve treatment success of 85%, one of the health-related indicators of the 
Millennium Development Goals (Western Cape Department of Health 2002) 
Factors Influencing Adherence 
What is consistent from the majority of literature which examines adherence to TB treatment is the fact 
that adherence cannot be predicted or controlled by a single factor. Likewise, non-adherence is a 
"complex, dynamiC phenomenon with a wide range of interacting factors impacting treatment-taking 
behaviour" (Munro et al. 2007, p. 1243). Adherence barriers take effect against an array of facilitating 
factors, and the final decision about treatment adherence depends on which factors predominate 
(Gebremariam et al. 2010). Therefore, efforts which aim to improve adherence, treatment outcomes 
and more widely, to control the global TB burden, require a better understanding of the specific barriers 
to and facilitators of adherence to TB treatment, and of patient experiences oftaking treatment (Munro 
et al. 2007). In the context of TB, adherence to and the success of treatment are hinged on assured daily 











specific barriers and facilitating factors have been categorized based on the three dimensions of access: 
acceptability, affordability and availability, as outlined by the most recent contributions to the study of 
access (Mcintyre et al. 2009; Thiede et al. 2007) 
Acceptability 
There are a number of documented ways in which the acceptability of TB treatment affects patient 
adherence. These include: knowledge about TB and belief in the efficacy of the medication; cultural 
belief systems; the nature of relationships between the health provider, social networks and the patient 
and; regimen complexity (WHO 2003). 
In a systematic review conducted by Munro et al (2007), the authors sought to understand the factors 
which were considered to be important determinants of TB medication adherence by reviewing a 
number of qualitative studies (Munro et al. 2007). The authors reported that the nature of the 
interaction between the patient and the provider was a significant influence on adherence to TB 
treatment (Munro et al. 2007). Poor follow-up and maltreatment by providers resulted in non-
adherence especially where patients were reprimanded for missing appointments (Munro et al. 2007). 
Qualitative findings from Khan et al (2005) also illustrate the negative attitudes by health workers to TB 
patients enrolled in a DOTS program in Pakistan whereby facility staff reported a lack of commitment to 
treatment, a high degree of cynicism and little concern for the outcomes of the patients (Khan et al. 
2005). 
Kaona et al (2004) note that discrimination on the basis of TB infection occurs within many health 
facilities and exacerbates problems with adherence to tuberculosis drug taking (Kaona et al. 2004). 
Where there is little privacy between patient and provider, patients resist collecting medication due to 
discriminatory behaviour by health care providers (Kaona et al. 2004). Correspondingly, where patient-
provider interactions were reported to be positive, patients were more adherent to treatment (Munro 
et al. 2007). In certain regions of Columbia and in Middleburg, South Africa, health workers reported 
high intrinsic motivation to treating TB and developed close relationships with patients which lead to 











Another key finding by Munro et al (2007) related to the nature of direct-observation. A number of 
studies which were reviewed by the authors reflected how patients saw direct-observation negatively 
and felt as though it indicated distrust between the provider and themselves (Munro et al. 2007). Some 
patients likened the process of direct-observation to serving a sentence within a correctional institution 
(Munro et al. 2007). This finding is consistent with those from a South African trial which compared DOT 
to self-supervised treatment whereby direct-observation was seen to have a demoralizing effect on 
patients and a resultant negative effect on adherence, particularly among those who were undergoing 
treatment for a second time (Zwarenstein et al. 1998; Volmink & Garner 2007). Udwadia and Pinto 
(2007, p. 103) further cement the effects of direct-observation on the interaction between the patient 
and provider; according to the authors, DOT is viewed by patients as being "humiliating, authoritarian 
and an invasion of privacy" (Udwadia & Pinto 2007). Approximately 45% of the patients reviewed 
refused to allow a health facility worker to observe the intake of medication, most often citing that they 
were responsible enough to do so without observation and that they did not trust public services 
(Udwadia & Pinto 2007). 
The impact of knowledge and beliefs surrounding treatment practices and efficacy of treatment is also 
well documented. A large number of patients will cease treatment when their symptoms have been 
alleviated or interrupt treatment when and if their symptoms worsen (Munro et al. 2007). The majority 
of studies reviewed by Munro et al (2007) claimed that a primary reason for this is that patients are not 
correctly informed by providers as to the nature of TB, the duration of treatment and the consequences 
of non-adherence (Munro et al. 2007). Further, many patients doubt the efficacy of the medication and 
the validity of the diagnostic tools which reflects low levels of confidence in public health services as 
well as a high degree of fear and denial surrounding the TB diagnosis (Munro et al. 2007). Khan et al 
(2005) found that the two most significant contributors to TB treatment default in Pakistan were: (1) a 
lack of belief in the efficacy of the drugs and; (2) the belief that the drugs were harmful (Khan et al. 
2005). In an ongoing study of the knowledge and perception of DOTS in Delhi, India, only 14% of 
patients were aware of DOTS, particularly pronounced among the illiterate and marginalized who form a 
large proportion of the TB population (Udwadia & Pinto 2007). Correspondingly, where patients 
understand and fear the negative consequences of non-adherence, they are more likely to choose to 











Vulnerability to ostracism and the stigma associated with TB is a considerable acceptability-related 
barrier to treatment adherence (Udwadia & Pinto 2007). A study of TB treatment adherence in the 
Eastern Cape province of South Africa revealed that the majority of individuals (90%) within the lay-
community believe that irresponsible individuals are to blame for the TB epidemic (Cramm et al. 2010). 
The same focus group discussions revealed a widespread belief that those who acquire TB through 
drinking and smoking are deserving of the fatal consequences of the disease and that TB patients are 
less respected within their communities; these findings are indicative of a high level of susceptibility to 
stigma for TB patients, particularly within this setting (Cramm et al. 2010). 
Munro et al (2007) also document the influence of stigma. According to their review, TB patients will 
often hide their diagnosis and harbour feelings of guilt and shame because of the disease (Munro et al. 
2007). TB patients have been seen to evade treatment because of fear of disclosing their TB-status to 
their employers, often rendering them unable to purchase medications or take time off work to attend 
health facilities (Munro et al. 2007). In Ethiopia, patients reported being pointed at and excluded from 
social events when their TB status became known in their communities (Gebremariam et al. 2010). The 
fear of stigma from community members has meant that many refuse to seek treatment at facilities 
within their respective communities and will either avoid treatment altogether or face high costs to 
travel to distant clinics to avoid being identified (Gebremariam et al. 2010; Macq et al. 2003) 
Availability 
The organization and structure of TB services have the capacity to influence adherence to TB treatment 
in a variety of ways. Shargie and lindtjorn (2007) conducted a cohort study to determine the extent and 
predictors of non-adherence to TB treatment in southern Ethiopia (Shargie & lindtjorn 2007). Their 
findings indicate that the majority of factors which contribute to treatment default were concerned with 
physical access to health facilities, particularly in rural settings (Shargie & lindtjorn 2007). SpeCifically, 
the authors note that the longer the distance between the patient's home and the treatment centre, the 
more likely patients were to forgo daily-DOTS visits; 50% of patients who lived beyond a two hour 
walking distance of the facility defaulted on their treatment (Shargie & lindtjorn 2007). In addition, 
where patients were reliant on public transport, they were also more likely to fail to complete their 
treatment regimen (Shargie & lindtjorn 2007). These findings are consistent with the results of the 











whereby long distances and a lack of available transport were regularly cited as the primary reasons for 
default in the majority of the literature reviewed (Munro et al. 2007). 
The burden of travelling considerable distances to facilities is exacerbated by the fact that TB patients 
are typically subject to severe, debilitating symptoms which often renders them too frail and weak to 
travel alone. Gebremariam et al (2010) note that many patients express that this burden extends 
beyond themselves whereby family members are required to accompany them to the facilities and it is 
often easier to skip visits altogether (Gebremariam et al. 2010). Similarly, Sagbakken et al (2008) found 
that patients walked on average two hours to reach the facility where they were receiving their 
treatment, often describing the journey as extremely arduous, frequently vomiting and fainting while 
travelling (Sagbakken et al. 2008). These patients were forced to wait for several hours before being 
seen by a health worker due to poor management systems which requested all TB patients arrive at the 
clinic during the same period of time (Sagbakken et al. 2008). In the same way, findings from the 
systematic review conducted by Munro et al (2007) found that long waiting times, queues and 
inconvenient appointment times (or opening hours) lead to high levels of treatment default (Munro et 
al.2oo7). 
In efforts to decentralize treatment and reduce the physical barriers to treatment adherence, many 
national governments have provided systems which facilitate the delivery of medications to the homes 
of patients by appointed community members or community health workers (Macq et al. 2003). In 
practice, these systems have been seen to present their own range of barriers. In Pakistan, rather than 
delivering medications to the patient's homes, many appointed community members force patients to 
travel to their own private residences to collect their medications (Khan et al. 2005). Furthermore, 
patients expressed that they would prefer to opt out of this arrangement out of fear of being identified 
as a TB patient by their respective communities (Khan et al. 2005). 
The WHO (2003) has stated that the availability of expertise also affects adherence to treatment; DOTS 
programs are often facilitated by ambulatory health care units which are organized to effectively 
accommodate acute illnesses rather than chronic illnesses that require long-term care (WHO 2003). As 
a result, within these settings, the staff have been seen to lack the expertise to develop long-term illness 
management plans and will place little importance on patient follow-up (WHO 2003). All health 











daily supervision is a demanding task for most patients, especially for those who are HIV positive and are 
required to attend clinics for ART in addition to TB treatment (Gebremariam et al. 2010). Many health 
workers likened the process of DOT to patient punishment and conceded that the DOT strategy is too 
rigid, not flexible to the daily schedules and priorities of the patients they treat (Gebremariam et al. 
2010). 
Affordabifitv 
Given that national TB treatment programs are largely free at the point of service, affordability-related 
factors which influence adherence are most often related to: (1) the direct costs of transportation; (2) 
extraordinary dietary requirements as a result of the illness and/or treatment related side-effects and; 
(3) the indirect costs of productive time losses incurred while travelling and receiving daily DOT. 
In 2008, Sagbakken et al (2008) explored the barriers and enabling factors to TB treatment in Ethiopia, 
concluding that the economic burden of treatment is a key determinant of treatment adherence 
through a dynamic process of interaction between individuals, their households, family members, social 
networks and employers (Sagbakken et al. 2008). Through a series of in-depth interviews and focus 
group discussions, the authors note that employment-related factors significantly restrict an individual's 
ability to remain in treatment, particularly among those referred to as 'daily labourers' (defined as an 
individual who is not employed but convenes with other individuals to compete to be hired for the day) 
(Sagbakken et al. 2008). 
Gebremariam et al (2010) also discovered that DOT was particularly challenging for those patients who 
had irregular jobs (Gebremariam et al. 2010). Many individuals in the private sector lost employment 
upon diagnosis due to the time-consuming nature of the treatment available to them as well as an 
inability to continue working because of severe symptoms of illness, and daily labourers were no longer 
able to compete with their healthier counterparts (Sagbakken et al. 2008). These effects also resonated 
among family-members who accompanied individuals to treatment facilities (Sagbakken et al. 2008). An 
important consideration is the fact that time costs represent different burdens to each gender whereby 
work-related time costs represent more of a barrier to men and time costs relating to family 











Factors which relate to the cost of transport are associated with significant barriers to adherence; many 
individuals discontinued treatment as they were unable to afford transportation and were not strong 
enough to walk to treatment facilities which were usually a considerable distance away (Sagbakken et al. 
2008). This finding is consistent with those of Gebremariam et al (2010) who noted patients having to 
sell off their belongings (such as jewellery and articles of clothing) in order to afford transportation costs 
to TB treatment facilities. Where facilities are a considerable distance away, patients often face 
additional travel costs for provisions during travel such as lodging and food, the enormity of which can 
determine whether or not a patient will adhere to treatment (Macq et al. 2003). 
Sagbakken et al (2008) found that the majority of respondents prioritize their employment and income, 
interrupting or ceasing their treatment regimens, to ensure that they are able provide food to their 
respective households (Sagbakken et al. 2008). It is estimated that an adult suffering from TB loses 
approximately three to four months of productivity and the household income experiences a reduction 
of about 30-40% (Udwadia & Pinto 2007). For those that maintained their visits to health facilities, 
many became impoverished and unable to afford basic foods due to the loss of income, rendering them 
chronically hungry with little motivation to continue treatment (Sagbakken et al. 2008). In a cross-
sectional study conducted in Zambia, 11.4% of non-adherent patients cited a lack of food at home as the 
primary reason for defaulting on treatment while 16.4% of these patients cited a loss of will to live, 
reflecting feelings of hopelessness that may result from impoverishment (Kaona et al. 2004) 
What is clear is that indirect and direct costs are very easily and often exacerbated by availability and 
acceptability barriers. In light of the burden of TB among the poor, the economic factors which influence 
adherence require particular attention. The role of social networks and community is often a primary 
determinant of a household's ability to cope with direct costs of treatment, Iipatients with limited access 
to financial or practical help from relatives or friends experience that the total costs of attending 
treatment exceed[s] their available resources" (Sagbakken et al. 2008, p. 4). Despite TB's association 
with a high degree of stigma and fear, Sagbakken et al (20OS) found that during times of crisis, many 
individuals relied on reciprocal arrangements between households, where encouragement and shared 
resources, which compensated for lost income, was an important determinant of accessing and 
adhering to treatment (Sagbakken et al. 2008). Social support has also been deemed crucial to the 
treatment process in other settings; through accompanying patients who are facing debilitating 











social capital of an individual is a strong determinant of adherence to TB treatment regimes 
(Gebremariam et al. 2010; Munro et al. 2007). 
Nonetheless, Sagbakken et al (2008) note that with time, levels of financial and practical support from 
community members diminished due to "social and financial exhaustion" (Sagbakken et al. 2008, p. 8) 
which was a huge concern considering the longevity of illness associated with TB, often leading to 
treatment termination and social exclusion (Sagbakken et al. 2008). It is also important to note that 
reliance on the community and family members to cope with the direct and indirect costs of attending 
daily-DOT visits and .adhering to the TB treatment regimen is dependent on the existence of such social 
capital. For some, these options do not exist and the very serious consequences include untreated 
morbidity and premature death. 
Demographic Characteristics & Adherence Behaviour 
The previous discussions suggest that an interplay of factors is involved in determining whether or not a 
patient will adhere to the TB treatment course. Although the majority of the aforementioned factors are 
liable to improvement through intervention, there are a number of largely un-modifiable, patient-level 
characteristics which also have the capacity to create an unfavourable environment for ensuring 
adherence to treatment (WHO 2003). Although there are, as yet, no specific traits which are able to 
describe the 'typical' non-adherent patient; several traits have been associated with treatment 
adherence including ethnicity, gender, literacy (or education) and age (WHO 2003). Although these 
associations do not allow for a pragmatic or logical means of resolving them, they are extremely 
important in drawing conclusions about the equity of health service access (WHO 2003). 
In 2006, Bam et al (2006) conducted a cross-sectional analysis on factors affecting patient adherence to 
DOTS in an urban region of Nepal (Bam et al. 2006). The authors established a two-fold increase in non-
adherence in patients over the age of 54 years (Bam et al. 2006). They further found significant 
differences in non-adherence between those that were single, married and widowed or divorced, where 
the likelihood of default increased in a corresponding order (Bam et al. 2006). The findings of Bam et al 
(2006) are supported by those of Shargie and Lindtjorn (2007). Through a univariate analysis, being over 
the age of twenty-five was determined to be significantly associated with treatment non-completion 
(Shargie & Lindtjorn 2(07). Other demographic factors also deemed to be significantly associated with 











more prevalent among rural respondents and; educational level, whereby literacy was associated with 
increased levels of adherence compared to the illiterate respondents (Shargie & Lindtjorn 2007). 
Gender has also been seen to determine individual responses to treatment choices (Munro et al. 2007). 
Within this context, gender refers to: (1) the physiological variations between males and females and; 
(2) the expectations and roles that are associated with each sex, governed by the social, economic and 
cultural context (Diwan & Thorson 1999). With regards to TB treatment behaviours, there are two 
perspectives on the effect of gender on adherence. 
On the one hand, researchers have described the effects of stigma on adherence behaviours in women, 
whereby women often face higher levels of social exclusion if their TB status becomes known, when 
compared to men (Connolly & Nunn 1996). For example, in India, TB-associated stigma in women has 
been seen to cause divorce; while male TB patients expect and receive care from their wives, married 
women seldom receive support from their husbands and family members (Connolly & Nunn 1996). For 
single women, disclosure of their TB status often lead to an inability to marry, particularly where 
marriage arrangements are largely a product of community participation (Connolly & Nunn 1996). 
These influences lead to many women avoiding treatment and hiding their symptoms, or receiving care 
only until symptoms have dissipated (Connolly & Nunn 1996). In a similar vein, Udwadia and Pinto 
(2007) describe that women face harassment from family members, fear of being unable to find a 
spouse and dismissal from work which collectively represent the largest impediments to adhering to 
DOTS in India, among women (Udwadia & Pinto 2007). 
A second perspective asserts that women are in fact more adherent to TB treatment and more likely to 
seek treatment when compared to men (Khan et al. 2005). Khan et al (2005) demonstrate that women 
in Pakistan have achieved substantially higher cure rates ofTB where the cure rates are 71% and 50% for 
women and men, respectively (Khan et al. 2005). The authors believe that women are more likely to 
adhere to treatment because they possess a sense of a responsibility to their household and children 
(Khan et al. 2005). Rather than observing pressure and harassment from family members as a barrier, 
Khan et al (2005) show that these forces can actually facilitate adherence to the TB treatment regimen 











It is important to consider that approximately 70% of the world's poorest people are female (Diwan & 
Thorson 1999). In addition to disproportionate poverty levels, women typically receive inferior social 
status within their communities, lower levels of education and face the largest barriers to seeking health 
care (Diwan & Thorson 1999; Connolly & Nunn 1996). Too often, TB policy assumes that adherence 
rates are the product of a patient's willingness to adhere (Munro et al. 2oo7). However, even where 
patients are willing, structural factors such as gender discrimination prevent them from doing so (Munro 
et al. 2007). As urged by the WHO (2003), interventions which are aimed at improving adherence must 
strategically address the wider context of the health care system (Munro et al. 2007; WHO 2003). 
RATIONALE & JUSTIFICATION 
Tuberculosis (TB) represents one of the most pressing global health issues and one of the greatest 
challenges to the health of South Africans (WHO 20lla). Despite the adoption of the DOTS strategy in 
1996 and significant investments in TB control, the case detection rate remains far below the targets 
outlined by the WHO (Mukinda et al. 2012). The effects of the disease are particularly pronounced 
among the 13.3 million South Africans living in poverty (WHO 2011b). It is widely documented that 
these groups face higher rates of mortality and morbidity relative to their better off counterparts, yet 
despite their increased needs, use health services less (O'Donnell et al. 2oo8). With this in mind, health 
initiatives and policies are being focused on ways to enhance access among disadvantaged groups by 
prioritizing the need to understand their individual experiences of accessing health services (Whitehead 
1992). In this way, poor use of essential services can be explained and addressed whereby quality of 
care and cultural factors which influence access can also be examined (Whitehead 1992). 
This approach is particularly vital in the context ofT8 where the success of current treatment protocol is 
hinged on daily access to health care for a prolonged treatment period. The burden of non-adherence 
to curative TB treatment has been widely acknowledged as being a key constraint to the global control 
of TB. Where non-adherence is the result of unfair, unjust, avoidable or unnecessary forces, equity 
concerns intensify its importance. There are two primary obstacles to finding effective solutions: (1) 
there exists a cloud of ambiguity surrounding the mechanisms in which different levels of non-
adherence impacts treatment outcomes and; (2) there is no "comprehensive and holistic understanding 











al. 2011). It therefore follows that evidence-based research is needed to demonstrate in quantitative 
terms the nature of the interaction between the facilitating forces and barriers of adherence so that 
national governments are equipped to tailor the provision of treatment and health promotive 
interventions to ensure patients are able to complete their treatment. 
OBJECTIVES 
1. Describe the socio- demographic characteristics of adherent and non-adherent DOTS patients. 
2. Explore the relationship between the availability, affordability and acceptability of DOTS services 
and patient adherence. 




This study will be based on data derived from Phase 1 of the Researching Equity in Access to Health Care 
(REACH) project, a five-year study of health system access in South Africa which commenced in 2007. 
The author of this thesis had no role in the study design and data collection of the REACH project. 
Funding for the study has been provided by a Teasdale-Corti Team Grant, administered by the Canadian 
International Development Research Centre (IDRC). REACH assesses equity in access to health services 
through an in-depth investigation into the use of three health interventions (or, 'tracers'): TB treatment 
services, maternal health services and antiretroviral therapy (ART) across four health sUb-districts in 
South Africa: Bushbuckridge (Mpumalanga), Mitchell's Plain (Western Cape), Soweto Region 0 of the 
City of Johannesburg (Gauteng) and Hlabisa (KwaZulu-Natal) (Schneider et al. 2009). Phase 1 of the 
REACH study specifically sought to examine health service users to determine whether they reflect the 
population in need by socio-economic and demographic variables. A second feature of Phase 1 
examines access to the three tracer health services, defined as the 'degree of fit' between service users 
and service providers in the availability, affordability and acceptability of services (Schneider et al. 2009). 
In totality, REACH endeavours to: 
1. Map inequities in utilization and access nationally; 











3. Integrate research, capacity strengthening and knowledge translation, through a variety 
of methodologies to strengthen the capacity to respond to health inequities in the 
health sector more widely. 
(Schneider et al. 2009) 
This study focuses on the Mitchell's Plain sub-district data set (N= 999) and specifically draws on 
individuals using TB treatment services (n=334). Mitchell's Plain represents an urban sub-district in the 
Western Cape province of South Africa. The data set was collected between 2008 and 2009 by the 
REACH research team, an experienced multi-disciplinary team of health economic, systems, policy and 
social science researchers. Mitchell's Plain has been included in this study primarily based on: (a) its 
geographic location, which enables comparisons to be made between and among the other urban 
(Soweto Region D, Gauteng) and rural sites (Bushbuckridge, Mpumalanga; Hlabisa, KwaZulu-Natal); (b) 
the number of facilities offering tracer services; (c) the province to which it belongs, to allow for 
comparisons between different provincial governance structures; (d) consultations with district health 
managers and local health authorities who have broad knowledge and experience with sub-districts 
facing access challenges and; (e) the availability of recent and reliable household and census data 
pertaining to the socioeconomic status of those with TB and HIV within the district (Schneider et al. 
2009). 
In Mitchell's Plain, multiple facilities offer TB services and each varies considerably in size and capacity. 
To ensure that individuals visiting larger facilities had the same probability of getting into the sample as 
those visiting smaller sites for treatment, a probability proportional to size method was used to choose 
the five facilities (Crossroads I, Lentegeur, Mzamomhle, Phumlani and Weltevreden) which were 
included in the study. This method necessitated the use of existing data on the total number of users in 
each facility at the time of the data collection; further, this method allows some facilities to be sampled 
twice so the sample size within facilities varied slightly across the five facilities. Such a sampling 
approach allows for results to be generalizable to TB service users within the sub- district. Within 
facilities, systematic random sampling methods were used to choose respondents. 











The REACH project fieldwork involved two key elements: interviewer-administered, in-depth, exit 
interviews on access-barrier to tracer services as well as sOcia-demographic data and; record reviews of 
patient records. The two primary data collection tools used to derive this data included: 
1. Patient Exit Interview Questionnaire - Tracer TB (Appendix A) 
2. Record Review of Tuberculosis Services (Appendix B) 
A total of 334 patients, made up of 47% males and 53% female, were interviewed across all five facilities 
in Mitchell's Plain. Subjects were included if they had been receiving TB treatment for at least two 
months, were over the age of eighteen and were deemed to be sufficiently well to participate, by facility 
staff. 
The data collection approach was guided by a comprehensive conceptual framework of access whereby 
access is assessed in terms of the degree o/fit between the needs of the population and the availability, 
affordability and acceptability of the health system response (Thiede et al. 2007; Mcintyre et al. 2(09). 
Under this conceptual framework, the availability (physical access factors), affordability (financial access 
factors) and acceptability (cultural access factors) of health services, can be empirically investigated to 
understand the experience of accessing services and the ensuing barriers which may exist in doing so. 
Furthermore, this framework can assist in developing health policy strategies that can address the 
barriers (Thiede et al. 2007; Mcintyre et al. 2(09). Each of these access dimensions can be represented 
by a number of clear and measurable variables which formed the basis of the questionnaire design and 
data collection of the REACH study. 
In-depth interviews were administered by trained fieldworkers using a structured exit interview 
questionnaire (see Appendix A) in the language of each subject's choice. Patients were asked about the 
affordability, acceptability and availability of TB services and questions covered specific factors 
underlying these three themes. A summary of principal areas of questioning through the exit interview 
is provided in Table 1. The availability variables included the travel time for the patient to reach the TB-
treatment facility, the time spent within the facility, whether patients were required to travel on foot 
and how often they were required to visit the facility to fetch their TB medications. Affordability 
variables incorporated coping mechanisms by asking whether or not the patient was required to borrow 
money in order to meet the costs of treatment and also included information on health care 
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The Mit(m.II', Plain ,ub-district belong, to tile Cape Town Mdropolitiln health district, located in tile 
W~5t~ rn Cap" Provinc~ in the south-west region of So, th Afric. Tile Western Cape i, hom~ to 
approximat~ ly 4,7 million p"opl~ - 10% of the South AfriCiln population, and i$ composed of. 5Z% 
Colour~ d majority," 24'JO White pOpulation and a Z4% Black African population (Cummin, ZooZ; Barron 
& H~a l t h Sy,tem, Trust ZOO6), The province repr~,ents the tich ~st of the ni.-... South Afri(an provinc~, 
ond apPfOximately JO'AO IR3.7 billion) ofth ~ provincial budget ha, bpen allocated to health care which 
has translated to a per capita expenditur~ on Prim.ry H ~alth C.re of R306 per person, the highest in 











The Cape Town Metropolitan health district serves a concentrated geographic area which holds 
approximately 72% of the Western Cape population, an estimated 3.4 million people (Western Cape 
Department of Health 2oo7a). Approximately 73% of the population in the Cape Town Metropole is 
reliant on public health services where the remaining 27%, largely white, population is serviced by the 
private sector (MDHS Planning Task Team 2004; Cummins 2002). The Cape Town Metropolitan health 
district is divided into eight health sub-districts: Northern Panorama, Central, Southern, Klipfontein, 
Mitchell's Plain, Tygerberg, Khayelitsha and Helderberg which are illustrated in Figure 2. 
This study focuses on the Mitchell's Plain sub district which, based on Censes projections from 2001, 
holds a population of an estimated 460,686 people - 14% of the total population of the Cape Town 
Metropolitan health district (MDHS Planning Task Team 2004). The population of Mitchell's Plain is 
largely poor whereby 30% of households fell below the poverty line in 2003 and 41% lived in informal 
dwellings (MDHS Planning Task Team 2004). "Many households hav[e] no stable income and little social 
capital... [and] poverty results in the collapse of family life, escalating violence, substance abuse and an 
inability to escape the poverty trap" (MDHS Planning Task Team 2004, p. 12). This area of the Cape 
Metropole is notorious for high crime rates where homicide represents the leading cause of premature 
death, producing approximately 22% of all deaths in the sub-district in 2001 (MDHS Planning Task Team 
2004). 
Mitchell's Plain represents one of the provincial sub-districts with a relatively low HIV/AIDS prevalence 
rate, recorded to be 12.9% in 2004; HIV/AIDS was responsible for 15% of deaths in 2001 (Draper et al. 
2007; MDHS Planning Task Team 2004; Shaikh et al. 2006). Overall HIV/AIDS prevalence in the Western 
Cape is below national averages (Draper et al. 2007; Shaikh et at. 2006). Tuberculosis rates in the 
Western Cape however are among the highest in the country; between 1997 and 2003, the Cape Town 
TB Control Report showed an increase of 66% in reported cases over the seven years, reflecting a 
growing population, migration, improved case detection and increased burden of disease, mainly in 
regions where HIV/AIDS is most prevalent (Draper et al. 2007; MDHS Planning Task Team 2004). 
Currently, the Western Cape's incidence rate of TB is 909 cases per 100 000 (Western Cape Department 
of Health 2011). 34% of the registered Provincial TB caseload is managed by twenty two high-burden 
facilities in the Cape Metropole district alone, two of which (Mzamomhle and Phumlani) exist in the 











Primary Health Care (PHC) facility-based services (including TB services) are rendered through 
community health centres (CHCs) and local government clinics (Western Cape Department of Health 
2011). These facilities serve as the entry points to the public health system and also act as referral units 
for those who need other levels of care (Western Cape Department of Health 2011). Services are 
provided primarily by clinical nurse practitioners (CNPs) who are supported by medical officers (Western 
Cape Department of Health 2011). There are fifteen clinics in the Mitchell's Plain sub-district which 
individually serve approximately 30,737 people (Western Cape Department of Health 2007a). In 
addition, there exist four CHCs which each serve a population of approximately 115,264 people 
(Western Cape Department of Health 2007a). The current population to facility ratio of 1:30,737 is 
substantially behind the national target of 1:10,000 (MDHS Planning Task Team 2004). 
Data Analysis: Statistical Methods 
For the purpose of this analYSiS, the exit interview content will be divided into three analytical domains, 
defined by the investigators as availability, affordability and acceptability. The availability domain will 
include physical access attributes including travel time to visit the facility, time taken to see the 
physician and/or nurse and mode of travel. The affordability domain will include financial access 
attributes such as total monthly expenditure on health care disaggregated by type of provider, total 
monthly expenditure as a percentage of household expenditure and how patients coped with health 
care costs. The acceptability domain will include cultural access attributes which will include variables 
related to stigma, respect as well as structural factors such as facility cleanliness. 
Record review data will primarily be used for descriptive purposes; to identify patients who are not 
being treated for pulmonary TB (Le. those being treated for extra-pulmonary TB) and; to distinguish the 
patient's prescribed drug regimen. 
There have been a range of ways in which adherence has been defined in the research and policy 
context. As yet there exists no empirical definition for non-adherence which delineates the point at 
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This study will involve the use of a secondary dataset which has already been coded and redacted to 
remove sensitive and confidential information and as a result no specific individual or household can be 
identified and the privacy of the participants has been upheld. Approval for the original study, of which 
this analysis is a SUbcomponent, was granted by Ethics committees at the University of Cape Town (see 
Appendix C), University of Witwatersrand and the University of KwaZulu-Natal and further permission to 
conduct research was granted by both provincial and local health authorities in South Africa. 
WRITE UP & DISSEMINATION 
As per the requirements of the Masters in Public Health (Health Economics specialization) program, 
outlined by the University of Cape Town; the research findings will be presented as a manuscript of a 
research article for submission to a suitable peer reviewed journal. In addition, a policy brief will be 
composed to provide a comprehensive and persuasive argument justifying the policy recommendations 
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PART B: LITERATURE REVIEW 
INTRODUCTION 
The following chapter presents a comprehensive review of literature which has been guided by the 
themes and objectives being explored in this study. Its purpose is to provide a rich theoretical and 
conceptual base of the ways in which the availability, affordability and acceptability of health services 
can impact equitable access to treatment; to examine the diverse methodologies which have been used 
to explore access and equity in health care provision particularly within low and middle income 
countries and; to provide an analysis of key empirical findings. The chapter first explores the concept of 
equity; the range of ways it has been defined, its importance in the context of health and health services 
and the interpretation of equity in the South African policy landscape. The chapter then provides a 
review of a number of different conceptual approaches to the relationship between access and equity. 
The final section of the chapter is guided by the conceptual framework of access put forth by Thiede et 
al (2007) and Mcintyre et al (2009). This framework structures the discussion of a number of 
publications which have explored the barriers being faced in accessing health services across the 
dimensions of acceptability, affordability and availability. Published studies have been sourced from a 
variety of credible online databases which are widely used in public health research (including PubMed 
Ovid, Medline Ovid, Ebscohost and Google Scholar). An array of grey literature including technical 
reports and documents has also been integrated into the review, primarily sourced directly from the 
releasing government agency or organization (for example, the World Health Organization and the 
World Bank). 
EQUITY IN HEALTH 
Despite the widespread recognition of the importance of equity as a goal for health systems (with 
respect to health service delivery and financing) and the vast literature available on the subject, there 
has been little consensus on the definition of the term. There exists undisputed evidence that the 
health of individuals within and across nations varies significantly as a result of socio-economic 
disadvantage and geographic location (Whitehead 1992; Mackenbach & Kunst 1997). These variations 
are made particularly evident through the existence of weaker chances of survival, higher premature 
mortality rates, increased burdens and earlier onset of both chronic and communicable disease as well 











1997). Furthermore, evidence has revealed that individuals of lower socia-economic status use less 
health services, despite their needs, and spend a greater proportion of their income on seeking 
treatment which often forces them into poverty, a phenomenon known as the 'medical poverty trap' 
(Whitehead et a!. 2001; Sauerborn et a!. 1996; Asenso-Okyere & Dzator 1997). 
Since the World Health Organization's Alma-Ata Declaration (1978) which promoted the need to 
improve the health profiles of those most in need through primary health care and preventative 
programs and the recognition that "fairness and social justice are valued by most societies" (Ong et a!. 
2009, p. 2), equity has been a central goal for global public health policy and practice. In 1986, the 
World Health Organization (WHO) expanded their views and defined equity in health as a situation in 
which Neveryone should have a fair opportunity to attain their full health potential and ... that no one 
should be disadvantaged from achieving this potential, if it can be avoided" (Whitehead 1992, p. 7; WHO 
1986). This definition was further supported by Whitehead (1992) as she called attention to the 
important role that health services provide with respect to their abilities to improve health (Whitehead 
1992; Krasnik 1996). In a similar light, Braveman & Gruskin (2003, p. 254) have defined equity in health 
as the "absence of systematic disparities in health (or in the major social determinants of health) 
between social groups who have different levels of underlying social 
advantage/disadvantage"(Braveman & Gruskin 2003). 
What seems most consistent from all literature is the notion that a health inequity exists if health 
inequalities are considered to be: (1) unfair; (2) unjust; (3) avoidable and; (4) unnecessary; and further, 
that tagging a difference in the health profile of one group as inequitable involves a moral and ethical 
judgment of the fairness of the causes of the inequalities (Whitehead 1992; Braveman & Gruskin 2003; 
Krasnik 1996). 
As Braveman and Gruskin (2003, p. 254) highlight, "because social justice and fairness can be 
interpreted differently by different people in different settings, a definition [of equity in health] is 
needed that can be operationalised based on measurable criteria" (Braveman & Gruskin 2003). Despite 
the fact that equity and equality are two independent characteristics, equality is central in 
operationalizing equity (Braveman & Gruskin 2003). Absolute inequalities in the distribution of wealth 
and health across a population will affect human capital investments, which will therefore affect the 











inequalities are a result of limited access to health services and unfair resource distribution processes as 
opposed to individual preferences, then they are indeed inequities (Braveman & Gruskin 2003; A. Sen 
1973). 
EQUITY IN THE SOUTH AFRICAN HEALTH SECTOR 
Since the democratization of South Africa in 1994, the government has made significant progress in 
reversing the effects of the apartheid legacy which was characterized by severe inequality, health and 
development policy which was disproportionately focused on ensuring the survival of the white 
population's rule, as well as a fragmented, highly segregated and largely privatized health sector 
(Mcintyre, Thiede, et al. 2006; Chetty 2007; Coovadia et al. 2009). The newly elected government, the 
African National Congress (ANC), immediately established their commitment to equity and social justice 
through the ANC National Health Plan and the White Paper for the Transformation of the National 
Health System for South Africa, which provided direction as to how the health sector would be 
transformed and later served as the foundation of the National Health Act, adopted in 2003 (Chetty 
2007). The National Health Act (2003, preamble) explicitly focuses on the need to address "the socio-
economic injustices, imbalances and inequities of health services of the past; the need to heal divisions 
of the past and to establish a society based on democratic values, social justice and fundamental human 
rights ... " (Department of Health 2003, preamble; Chetty 2007, p. 4). 
An abundance of structures and health policy initiatives have been formulated since 1994, however the 
South African health policy landscape can be broadly seen as targeted at three key areas: 
Equity in health service delivery and financing 
Redistributing public sector health care resources between and within provinces 
Increasing primary health care utilization levels for currently disadvantaged groups 
Addressing the public/private mix - facilitate making resources currently located in the private 
sector accessible to a broader section of the population, and/or redistributing resources 
from the private to the public sector 
Improving access to primary health care services 
Policies and programs targeting vulnerable groups and diseases of poverty 











Despite the newly adopted South African constitution which emphasized the "progressive realization of 
the right to health" (Coovadia et al. 2009, p. 824) and the strong commitment to transformation and 
equity of the health sector in and since 1994, health inequities have endured, exacerbated by failures of 
leadership, stewardship and management, the inability to provide a financing system that emphasizes 
income-related cross-subsidization across the health system as well as human resource limitations 
(Coovadia et al. 2009; Mcintyre 2007). 
South Africa represents a tiny percentage of countries whose life expectancy and childhood mortality 
rates have worsened since the Millennium Development Goals were established, further, "HIV and 
Tuberculosis epidemics, ... morbidity and mortality .. .from violence and injury, chronic diseases, mental 
health disorders, ... maternal [and] neonatal mortality" are among the notable reasons why South Africa 
has fallen short of health and health care expectations set at the time of liberation (Chopra et al. 2009, 
p. 1023). This trend can be seen most evidently by extreme differences in the prevalence and incidence 
of disease and rates of mortality between South Africa's race groups: prevalence of HIV/AIDS among 
Indian South Africans, for example, falls between 0.6% and 1.9% whereas the prevalence of HIV/AIDS 
among Black South Africans has been found to be 13.3%; "in 2002, infant mortality [was] 7 per 1000 in 
the white population and 67 per 1000 in the black population, [further,] life expectancy for white adult 
women was SOOA; longer than it was for black women (Coovadia et al. 2009, p. 824). 
Several reasons have been cited as to why the deep-seated commitment to equity in health and health 
services has not translated into positive gains for the South African population. The arrangement of 
public sector funding has seen a loss of power by the national government in affecting resource 
allocation decisions to the public health sector; funding has become largely dependent on "provincial 
priorities ... [the] health sector is often forced to compete with other social demands such as education, 
housing and social development" (Chetty 2007, p. 31). In addition, inequities between the private and 
public sector continue to grow (Mcintyre et al. 2008; Chetty 2007). Furthermore, the shortage of health 
workers and the emergence and rapid growth of HIV and Tuberculosis have limited the capacity for the 
South African health sector to respond effectively where poor management, stewardship and 
monitoring disable health policies aimed at responding to such trends, to be successfully implemented 











EQUITY IN HEALTH SERVICES 
Health services are the means by which populations and individuals are granted the opportunity to 
achieve their full health potential and therefore serve a critical role in improving the health of both 
individuals and populations alike (Krasnik 1996; Whitehead 1992). As described by Aday and Andersen 
(1981), there are many influential forces that playa role in the health status of an individual; engaging in 
multiple-risk behaviours, genetic predispositions to ill-health, for example, are among these forces 
which cannot be controlled by the state (Aday & Andersen 1981). As a result, it is the responsibility of 
policy-makers and governments to create health systems which ensure that all people have the right to 
access health services to ensure they are granted their right to health (Aday & Andersen 1981). 
As with many of the beliefs surrounding equity and its place in health and health services, there is no 
consensus among scholars as to the exact definition of 'equitable health services' or 'equity in health 
care'. Mooney (1983) summarizes two dominant views as: (a) equity in health services as occurring 
when a health system is resourced equally among all geographical areas (based on size of population) 
and; (b) equity in health services as only being attained when there is equality in the health profile of all 
individuals; when all individuals within a population have the same health status (Whitehead 1992; 
Mooney 1983). These positions have been criticized particularly because the former does not take into 
account the diverse needs for services among the different groups within their respective populations 
while the latter involves complex measures for 'health status' which are likely to be constructed 
differently across populations, leading to imprecision (Whitehead 1992; Makinen et al. 2000). Further, 
in practice, directing health policy at equalizing the health status of a population can mean that the 
distribution of health resources would in some cases be neither cost-effective nor efficient, since it can 
be quite costly to improve the health status of very sick people (Makinen et al. 2000). 
Aday et al (1980) first proposed that "an equitable distribution of health care services is one in which 
illness is the major determinant of the allocation of resources (Krasnik 1996, p. 3; Aday, Andersen & 
Fleming 1980). In a later publication, they described equitable access to health services as a situation in 
which "services are distributed on the basis of people's need for them ... [and] inequit[able access] is 
[identified when] services are distributed on the basis of demographic variables, such as race, family 
income, or place of residence, rather than need" (Aday & Andersen 1981, p. 6). Whitehead (1992, p. 8) 











1. Equal access to available care for equal need 
2. Equal utilization for equal need 
3. Equal quality of care for all 
(Whitehead 1992) 
Since then, utilization and access, two interrelated indicators have dominated health system equity 
research and policy. As defined by Mooney (1983, p. 179), "the difference between equity by access 
and by utilization lies in separating supply and demand (or need) issues ... equality of access is about 
equal opportunity ... whether or not the opportunity is exercised" (Mooney 1983). Of the two 
indicators, utilization, being more empirical in nature, has tended to be the focus of the majority of 
literature available on heath service equity (Mooney 2009). This has hindered the usefulness of many 
of these studies, particularly in the research to policy context where recommendations are narrowly 
focused on health service delivery methods without attention given to "understanding the incidence, 
levels and types of use ... and non-use of services ... [to understand] how (and whether) the health care 
system interacts with individuals, households and communities" (Mcintyre et al. 2009, p. 180; Mooney 
2009). In later papers, Mooney et al (1991, 1992) defend the need to approach equity in health services 
by "equaliz[ing] access ... [and] accept[ing the resultant] distribution of utilization and health" (Wagstaff 
& van Doorslaer 2000, p. 12; Mooney et al. 1991; Mooneyet al. 1992). 
What is made consistently clear from all discussions on equity, particularly within the context of health 
and health services is the fact that it can only be achieved if there exists a fair opportunity for all to 
achieve health. This understanding reflects the central role of access; if health services are the means 
by which populations and individuals are granted the opportunity to achieve their full health potential 
then it undoubtedly follows that equity in health is dependent on the equity which exists in access to 
health services (Krasnik 1996; Whitehead 1992). Therefore, fundamental to any discussion of equity 
requires a deeper understanding of the concept of access. 
ACCESS TO HEALTH SERVICES 
Despite a considerable body of research dedicated to conceptualizing access to health services, there 











term, particularly when being operationalized to evaluate health systems in low- and middle-income 
countries (LMICs) (Thiede et al. 2007; Oliver & Mossialos 2004; Gulliford 2009; Aday & Andersen 1974). 
As explained by Thiede et al (2007, p. 105), " .. .if the access concept is not well understood, 
comprehensive evidence on what should be done to promote equitable health systems cannot be 
gathered", especially in the research-ta-policy context (Thiede et al. 2007). Furthermore, the 
inconsistency of notions of 'equitable access' render policy-makers worldwide "without a reference 
point against which to judge the consistency of their healthcare policies" (Oliver & Mossialos 2004, p. 
655), which has, in some cases, seen health policies aimed at improving access indirectly worsen the 
inequitability of health service access (Oliver & Mossialos 2004). The early 21st century has seen a 
growing acceptance of the important role of individual autonomy and the need to balance traditional 
notions of 'top-down' and 'bottom-up' health policy formulation and implementation (Gulliford 2009). 
This awareness has given rise to an evolution in the ways in which access and equity have been 
conventionally defined (Gulliford 2009). 
Traditionally, there have been four schools of thought with respect to access to health services, each 
differentiated from the other by placing varying levels of importance (or in some cases, unimportance) 
on those issues concerned with supply and those concerned with demand (or need). When access is 
seen as the consequence of supply-side dimensions alone, studies often narrowly focus on accessibility 
to health services with respect to their location and density; this type of approach often sees access in 
terms of 'spatial accessibility' and has been criticized for being highly simplified in nature (Mcintyre et at. 
2009). Even where a health facility is identified as providing a particular service within an area for which 
there is a need, many individuals may be unaware of their availability and efficacy and thus there is no 
guarantee that those in need have the opportunity to use these services (Mcintyre et at. 2009; Goddard 
& Smith 2001). 
A second approach to health service access is dominated by studies which place greater importance on 
demand-side considerations. In these cases, affordability of services is seen as the sole proxy of access 
(Mcintyre et at. 2009). Those that follow this approach tend to look at the prices of the services 
themselves and the individual's ability to pay for these services based on their insurance coverage, 
income and/or eligibility for government-funded services (Penchansky & Thomas 1981). Critiques of 
this view emphasize that the impact of the price of services can jeopardize access for some while access 











unchanged (Gulliford et al. 2002). In this way, "the impact depends on the magnitude of the costs and 
on the user's willingness and ability to pay; equal costs do not necessarily give equal access" (Gulliford et 
al. 2002, p. 187) 
A third approach and one of the most widely referenced views of access to health care in the past 
decade has seen access being expressed in terms of use of services (Donabedian 1972; Andersen 1995; 
Mcintyre et al. 2009; Ricketts & Goldsmith 2005; Penchansky & Thomas 1981). Aptly summarized by 
Donabedian (1972), many who have inherited this view believe "the proof of access is use of service, not 
simply the presence of a facility" (Gulliford et al. 2002, p. 187; Donabedian 1972). Service use i s 
analysed both in terms of actual use of services (absolute terms) and in terms of the differential use of 
health services across groups and individuals with diverse needs (relative terms) (Mcintyre et al. 2009). 
As pioneers of this approach, Andersen, Aday and Newman (1974; 1980; 1981; 1995) devised a 
framework which has been highly influential in health-policy formulation (Aday & Andersen 1974; Aday 
& Andersen 1981; Andersen 1995; Ricketts & Goldsmith 2005; Aday, Andersen, Fleming 1980). Despite 
the evolution of their framework over time, their approach essentially associates use of services with 
different classes of access; these classes include potential, realized, effective and efficient access 
(Andersen 1995; Mcintyre et al. 2009; Ricketts & Goldsmith 2005). Where access to a particular service 
is deemed the same across individuals and groups, and where absolute and/or relative measures of 
utilization are seen to be different, the framework uses "predisposing [components] (generally 
characteristics of individuals), enabling [components] (system or structural characteristics)" (Ricketts & 
Goldsmith 2005, p. 274) as well as biological need to explain these differences (Penchansky & Thomas 
1981; Andersen 1995; Mcintyre et al. 2009). 
Despite extensive explanations of the differences between classes of access as defined by Andersen 
(1995), confusion exists around the distinctness of each class (Andersen 1995; Gulliford et al. 2002). 
Nonetheless, it is important to mention that this framework introduces the notion of potential access 
(which allows for realized access) to health services as being completely dependent on enabling factors 
which are concerned with the structure and processes of health systems (Andersen 1995). As a result, 
"early users of this access concept attempted to create global indicators of access that focused on 
process[es]; ... the travel time to care; ability to get an appointment in a reasonable time; and in office 












Undoubtedly, this framework has been the basis of the majority of academic efforts concerned with 
understanding and measuring access to health services and its implications for equity, over the past 
decade. As a result, the value of the contributions of Andersen, Aday and Newman (1974; 1981; 1995) 
cannot be ignored (Aday & Andersen 1974; Aday & Andersen 1981; Andersen 1995). likewise, their 
limitations cannot go unnoticed. As explained by Mcintyre et al (2009, p. 182), this method sees "an 
individual who did not use services, or used services differently from others with the same needs [as 
having] different access to care" (Mcintyre et al. 2009). This cannot hold true where it is impossible to 
assume that all individuals share the same "beliefs, values, and attitudes towards illness and health 
care" (Mcintyre et al. 2009, p. 182-183). Another limitation of this method is its inability to thoroughly 
consider equity in access to health services (Daniels 1982). Their method does not show how process 
factors (such as waiting time or fees associated with treatment) can represent a greater burden to some, 
particularly where utilization rates are constant (Daniels 1982). Further, those that seek to use this 
method to evaluate access to health services are required to poss ss data related to the use and non-
use of services, typically only available through household surveys. 
An alternative means of looking at the access concept was developed by Penchansky (1981) in response 
to a need to "define and measure ... phenomena [beyond the ability to use, willingness to use or actual 
heath service use] which significantly influence the use of health care services ... to obtain desired 
intermediate or final outcomes" for health system strengthening (Penchansky & Thomas 1981, p. 127-
128). In an attempt to fill this void, Penchansky (1981, p. 128-129) described the heart of the concept of 
health service access as the degree of fit between traits of the health system and characteristics and 
expectations of the individuals it serves based on five measurable criteria: 
1. Availability (volume of physicians and other health care services); 
2. Accessibility (spatial relationship between the providers and users of care); 
3. Accommodation (content and organization of the health system and the ease with which 
people can use care); 
4. Affordability (both the financial ability-to-pay and the users perception of value); 
5. Acceptability (the attitudes of users toward the providers, and vice versa). 











As explained by Mcintyre et al (2009, p. 181), Penchansky's contributions were particularly significant as 
they revealed access as a "communicative interaction" (Mcintyre et al. 2009) between the health care 
system and the individuals it serves (Mcintyre et al. 2009). In this way, it becomes clear that "what 
constitutes compatibility between one individual and the system (e.g., the availability of female 
physicians) may represent incompatibility for another" (Mcintyre et al. 2009, p. 181). 
What can be seen from the majority of theoretical literature on the concept of access is the fact that the 
concept itself is constructed of a wide array of dimensions, many of which are closely interrelated, 
presenting both at the supply and demand side of health service access. 
THREE DIMENSIONS OF ACCESS 
The most recent contributions to the study of access, particularly in its application to low and middle 
income countries has been developed by Thiede et al (2007) and further described by Mcintyre et al 
(2009) (Thiede et al. 2007; Mcintyre et al. 2009). Their framework first explores the importance of 
understanding access as a unique experience; the empowerment of individuals to use and benefit from 
health services (Mcintyre et al. 2009). By viewing access as empowerment, a balance is created 
between the role of health system financing and delivery and between the ways in which individuals 
gain from the interaction with their health system (Thiede et al. 2007; Mcintyre et al. 2009). Thus, they 
state that in order for health services to be equitably accessible to all individuals, it is the responsibility 
of policy-makers to go further than ensuring they are available or present within a given community; 
their responsibility extends to ensure that efforts are made to empower individuals to choose to use 
services if and when they are needed (Thiede et al. 2007; Mcintyre et al. 2009). By this definition, access 
is not equivalent to use; "empowerment offers individuals the opportunity to realize their preferred 
choices, which may encompass non-use as well as use of health services ... [therefore] ifthe potential to 
use a service exists, then access is present even when an individual makes the choice not to use care" 
(Gulliford 2009, p. 224). 
As mentioned, traditional schools of thought regarding access can be differentiated from one another as 
they place varying levels of importance (or in some cases, unimportance) on those issues concerned 
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In practice, the dimensions of acceptability, affordability and availability are most often captured by 
several fundamental variables which are summarized in Table 2 and further clarified in the following 
sections. 
ACCEPTABILITY OF HEALTH SERVICES & IMPLICATIONS FOR EQUITABLE ACCESS 
Of the three dimensions, acceptability has received the least attention with regards to both empirical 
and conceptual literature however, systematic differences in health care utilization can be seen to be 
closely associated with acceptability barriers among high-, middle- and low-income countries alike which 
is indicative of its importance, particularly with regards to discussions on health care equity policy 
(Gilson 2007; Mcintyre et al. 2009). Acceptability refers to the ways in which individuals and 
communities seeking care perceive health service provision (Thiede et al. 2007). This dimension is 
affected by culture, language, ethnicity and gender which collectively shape the attitudes of patients 
and providers within the health service delivery environment and tend to be among the primary 
determinants of the sensitivity of a given health system to the beliefs and expectations of those it serves 
(and vice versa) (Mcintyre et al. 2009; Thiede et al. 2007). As summarized by Mcintyre et ai, 2009: 
"acceptability is concerned with the fit between provider and patient attitudes towards and 
expectations of each other" (Mcintyre et al. 2009, p. 187). Gilson (2007, p. 124) further adds to this 
definition by describing acceptability as the "social and cultural distance between health care systems 
and their users" (Gilson 2007) which is hinged on the level of trust which exists within the relationship 
between the providers and the patient. In the context of access, these factors are of most value in the 
ways in which they influence an individual's ability or freedom to receive care (Mcintyre et al. 2009). 
To understand acceptability, we can systematically analyze its influence on an individual's ability or 
freedom to use health care by examining two key elements as defined by Gilson (2007): (a) the fit 
between lay and professional health beliefs and; (b) patient-provider engagement and dialogue. 
Degree of Fit between Lay and Professional Health Beliefs 
Lay health beliefs encompass the ways in which individuals within a given community understand their 
symptoms, disease and the effectiveness of treatment alternatives (Gilson, 2007). This also includes 
how patients rate the technical competence of health providers and pharmaceutical interventions 











biomedical model of medicine which, at its core, views disease in terms of pathology, biochemistry and 
physiology. This has created a situation where the social determinants of disease (and health) are often 
neglected causing a pervasive difference in the health beliefs of health care providers and the 
individuals they serve (Gilson 2007). Such a situation has lead to a general mistrust in health care 
among many lay-populations which has a well-documented effect on how and if individuals seek 
allopathic treatment (Gilson 2007). 
In a study of the acceptability of an HIV vaccine among young adults in South Africa, Sayles et al (2010) 
used a series of focus group discussions to determine key motivational factors and barriers to the 
potential uptake of the intervention (Sayles et al. 2010). Their findings illustrate the negative effect that 
disparities in health beliefs can have on an individual's treatment seeking behaviour. The authors 
findings reveal a mistrust in both the government and the scientific community as all participants 
believed that "the risks and toxicities associated with an HIV vaccine would not be fully disclosed [to 
them)" (Sayles et al. 2010, p. 198) and further believed that health providers would paint a false picture 
of the efficacy of the vaccine (Sayles et al. 2010). Another key finding demonstrates a general mistrust 
in western medicine relative to traditional African medicine (Sayles et al. 2010). Five of the six focus 
group discussions that were conducted revealed that individuals would be reluctant to receive the HIV 
vaccine because it was not aligned with their traditional beliefs of healing (Sayles et al. 2010). 
Furthermore, 80% of the participants believed that they were not personally vulnerable to HIV, which is 
of particular concern as perceived vulnerability is often observed as a key determinant of preventative 
action (Sayles et al. 2010). 
In another study, Munro et al (2007) conducted a systematic review of qualitative research on patient 
adherence to TB treatment (Munro et al. 2007). Their findings showed that individuals refused to 
believe and accept that they had TB due to their doubts over the validity of the diagnostic methods and 
confidence in the medical system (Munro et al. 2007). In many instances, this denial resulted in poor 
treatment adherence whereby treatment was ceased once symptoms had disappeared (Munro et al. 
2007). Further, Munro et al (2007) illustrate that in many cases, TB treatment was not initiated at all 
particularly due to false beliefs regarding the negative side effects of treatment as well as the inefficacy 
of treatment alternatives (Munro et al. 2007). In much the same way, Chuma et al (2010, p. 10) 











(Chuma et al. 2010) and their perception of the effectiveness of government-issued drugs were among 
the most prominent barriers of access to malaria treatment in Kenya (Chuma et al. 2010). 
Engagement and Dialogue between Patient and Provider 
The nature of the interaction between the patient and the provider has the potential to dissuade 
individuals from seeking health services particularly through provider attitudes towards patients, 
discrimination as well as issues of confidentiality which have a seemingly large effect on the level of 
trust shared between patient and provider (Gilson 2007). The relationship between provider and 
patient inherently involves a complex power dynamic whereby "providers [are able to] exercise their 
power through their communication practices" (Gilson 2007, p. 130) and their commitment to 
maintaining confidentiality and refraining from making assumptions about particular groups and 
individuals which may result in differential treatment of certain individuals and groups (Gilson 2007). A 
qualitative study of clinical care for HIV patients in rural Zimbabwe uncovered how control over patient 
movements in health facility spaces reinforces power inequalities between patients and health workers 
(Campbell et al. 2011). Patients were exposed to erratic demands by facility staff to form lines or 
assemble in a particular manner which they found to be extremely disempowering (Campbell et al. 
2011). Furthermore, providers may subconsciously treat those that they believe to be 'blamed' for their 
illness more harshly than others (Mcintyre et al. 2009). Bakeera et al (2009) found that service 
acceptability was primarily determined by health worker attitudes (Bakeera et al. 2009). Participants 
observed health providers treating pregnant women who appeared to be older in an inhumane manner 
simply due to their age; participants further added that these practices brought about ttfear and 
scepticism in using the service" (Bakeera et al. 2009, p. 6). 
Much of the literature on acceptability makes reference to the effect of this interaction. In a 2004 
discussion paper by the World Bank on barriers to health service access, differences in the social status 
between a health provider and the patient was deemed a significant determinant of utilization of health 
services (Ensor & Cooper 2004). The authors explain that many patients often feel inferior to their 
health providers and convey a perceived lack of ability to communicate with their providers effectively 
in a wide array of contexts (Ensor & Cooper 2004). In Malawi, O'Gorman et al (2010) illustrated how the 
negative and threatening attitudes of health workers was a key barrier to access of Nevirapine, a 
method of prevention of mother to child transmission (PMTCT) of HIV/AIOS (O'Gorman et al. 2010). 











providers were harsh and threatening, creating a widespread belief that they had no respect for the 
patients (O'Gorman et al. 2010). The following transcript from an interview with an Antenatal 
participant aptly summarizes their sentiments: 
"[The health workers] shout, insult women even when the time has come for the 
women to deliver. They even leave you to deliver on your own while they are shouting 
bad words at you. There are times when you try to call them for help, they do not 
come .. .it can be when the mother delivered at home, she can have fear to go to the 
hospital Uor nevirapine syrup], because most of us fear to be shouted at by doctors 
because of delivering at home" 
(O'Gorman et al. 2010, p. 4) 
In the case of TB, adherence to treatment has also been shown to be affected by the nature of the 
interaction between the patient and the provider. Providers were seen to harshly reprimand patients 
who had missed scheduled appointments; patients were threatened and humiliated by enraged facility 
staff, the combinatiOn of which resulted in non-adherence to TB treatment (Munro et al. 2007; 
Sagbakken et al. 2008). 
Demand-side factors also play an important role in the interaction between patient and provider. 
Individual characteristics of the patients themselves may make them more willing to disclose 
information, having more confidence in providers which share their ethnicity, language or gender 
(Mcintyre et ai, 2009; Gilson et ai, 2007). A key demand-side factor which presents itself in much of the 
literature in is stigma. As described by Gebremariam et al (2010, p. 6), "fear of stigma lead[s] 
to ... patients not disclosing their illnesses [to providers] but also [leads to] TB treatment in their 
catchments [becoming] difficult .. .for fear of being identified by neighbours" (Gebremariam et al. 2010). 
Similarly, in a study of access barriers to health care for the chronically ill in South Africa, Goudge et al 
(2009) found that over a third of respondents with a chronic illness were unable to report their diagnosis 
which the authors owe to a lack of effort on behalf of facility staff to ensure that the patients 
understand and absorb the information they provide, as well as the fact that the stigma attached to 
their diagnosis does not harbour clear communication between patient and provider (Goudge et al. 
2009). 
The benefits of productive interactions between the patient and provider extend beyond the fact that 
patients are enabled and empowered to seek and adhere to treatment. Where patients understand 











able to make a well-defended case for financial assistance and furthermore are able to serve as a 
resource to their communities and to the health system, potentially empowering others to seek 
treatment (Goudge et al. 2009). 
AFFORDABIUTY OF HEALTH SERVICES & IMPUCATIONS FOR EQUITABLE ACCESS 
The affordability of health services has been the most frequently discussed dimension of access in light 
of the debilitating costs of illness, particularly for populations existing within low and middle income 
countries (LMICs) (Mcintyre, Thiede, et al. 2006; Thiede et al. 2007). The concept of affordability 
broadly describes an individual's financial access to health services by exploring the relationship 
between the package of costs of seeking care (borne by the individual and their household) and their 
ability-to-pay for these services, reflected most often by their socio-economic status (Thiede et al. 
2007). The concept further encompasses the impact of these costs on the livelihood of the individual 
seeking care and their household (Mcintyre et al. 2009). In recent years, the notion of financial risk 
protection has been at the forefront of the global health policy agenda in response to an abundance of 
literature which reflects the dynamic, multifaceted ways in which the affordability of health care has 
exacerbated inequity in health and access to health care among populations globally (Mcintyre, Thiede, 
et al. 2006; Thiede et al. 2007). 
Economic Costs 0/ /IIness: Direct & Indirect Costs 
The economic cost of illness encompasses both direct and indirect costs (Mcintyre et al. 2009; Thiede et 
al. 2007). Direct, out-of-pocket, costs refer to the financial costs of care, typically inclusive of: official 
consultation fees (or, if insured, co-payments); unofficial consultation fees, also referred to as 'under-
the-counter fees; fees attached to diagnostic tests, scans or procedures; fees for prescription and non-
prescription medications; fees associated with hospitalization (e.g. pre-admission deposits, ward fees, 
theatre fees) and; other items which necessitate direct payment such as transportation, extraordinary 
dietary requirements as a result of treatment or while seeking care and child-care costs (Mcintyre et al. 
2009; Thiede et al. 2007). 
Indirect costs typically measure productive time losses such as lost income while travelling and 
receiving care, for the patient and those accompanying them (Mcintyre et al. 2009; Thiede et al. 2007; 
Mcintyre, Thiede, et al. 2006). Methodological issues with calculating the economic cost of illness and 











more difficult to calculate where "differences arise according to whether total productivity loss is 
estimated as the number of days off work due to illness only or whether the years of productive life lost 
due to premature death are also included" (Mcintyre, Thiede, et al. 2006, p. 860). Further challenges 
may arise through the different ways these measures are transformed into monetary values, whether 
average wage rates or actual income losses are applied to productive time losses and further and how 
studies quantify time losses for those who are not employed in the formal sector (Mcintyre, Thiede, et 
al. 2006). The following discussions reflect the considerable burden that indirect costs can represent 
and the central role they serve in an individual's ability to access treatment (Mcintyre, Thiede, et al. 
2006). 
While illness occurs in individuals, its costs do not fall on ill individuals alone thus it is important to 
include the household as a unit of analysis for treatment seeking behaviour, given that the "large 
majority of time and financial costs of illness [are] borne by healthy household members" (Sauerborn et 
al. 1996, p. 291). There has been significant attention paid to the costs of illness at a household level 
which has been triggered by the "growing empirical evidence that user fees at public facilities, and a 
growing reliance on private for-profit providers for whose services there are frequently direct payments, 
constitute a major financial burden on households" (Mcintyre, Thiede, et al. 2006, p. 858). 
Approaches for estimating direct and indirect costs of illness vary widely by health condition as well as 
the nature and availability of data (Bloom et ai, 2011; (Mcintyre, Thiede, et al. 2006)). Though national 
household surveys are often the source of data, comparisons of costs of illness across countries can 
sometimes be limited due to the fact that surveys differ by sample size, recall period, geographical area 
and statistical power (Makinen et al. 2000). In the sphere of public health and health economics, two 
key indicators have been consistently used to describe the economic cost of illness: (1) Health care 
expenditure as a proportion of household income (direct cost burden) and; (2) Production and income 
loss caused by illness as a proportion of 'normal' income (indirect cost burden) (Russell 2005). The 
former considers the opportunity cost of making health care payments and the related consequences 
for households while the latter considers indirect income losses (Russell 2005). 
In 1993, Leighton & Foster (1993) found that the total annual health costs of malaria in Kenya could 
range between 4% and 9% of annual household income while in Nigeria these costs could range 
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already impoverished settings (Russell 2004). Russell (2004) explains how indirect costs of TB generally 
impose higher cost burdens (relative to many other diseases) because of the lengthy duration of illness 
associated with the disease, delays associated with receiving a concrete diagnosis as well as its 
dominance among individuals who are economically active (Russell 2004). The author further suggests 
that the impoverishing effect of these costs on households is a common reason why many avoid 
treatment; in Tanzania, 90% of the annual household income is dedicated to treating TB, likely forcing 
households to exhaust resources allocated to their basic needs in order to ensure their ill family member 
is tended to (to be further discussed in the following sections) (Russell 2004). The magnitude of indirect 
costs has also been highlighted by a number of other studies, many of which have found indirect costs 
to far exceed direct costs (Koopmanschap & Rutten 1994; Mcintyre, Thiede, et al. 2006). Indirect cost 
estimates for some low and middle-income countries are 2 to 3.6 times greater than direct costs 
(Asenso-Okyere & Dzator 1997; Attanayake et al. 2000; Ettling & Shepard 1991; Sauerborn et al. 1996; 
Mcintyre, Thiede, et al. 2006). 
Studies on the economic cost of illness have also pointed policy-makers toward the importance of 
reducing the cost of drugs available to treat illness. Medications have been seen to represent over 6()o~ 
of total direct costs for treatment of malaria and lymphatic filariasis in Ghana and India, respectively and 
over 30% of direct costs across all illnesses in Sri Lanka (Asenso-Okyere & Dzator 1997; Babu et al. 2002; 
Russell 2001; Mcintyre, Thiede, et al. 2006). Furthermore, transport as well as the need to provide 
accommodations and nutritious food for patients and their caregivers during travel to a health care 
facility can significant intensify costs to the household, particularly in rural settings where health care 
providers may be situated a substantial distance away (Attanayake et al. 2000; Nahar & Costello 1998; 
Babu et al. 2002; Mcintyre, Thiede, et al. 2006). TB treatment, for example, requires the intake of 
nutritious foods that can also place huge costs on the household and though these costs are often not 
included in estimations of treatment costs, they represent a noteworthy expense for poor households; 
"foods that are not usually part of patients' diets (meat, eggs, vegetables, oranges) can account for up to 
44% of a patients' or households' income" (Russell 2004, p. 149). The burden of food and 
accommodations, and transport for ill-family members and their caregivers has, in other studies, been 
approximated to represent 20% of direct costs in some contexts (Attanayake et al. 2000; Nahar & 
Costello 1998; Babu et al. 2002; Mcintyre, Thiede, et al. 2006). 











Morbidity and mortality are often measured in order to estimate the burden of disease in populations, 
however, ill-health imposes a range of consequences on the welfare of the individual and household 
(WHO Department of Health Systems Financing 2009). "'Health shocks' or the unexpected increases in 
health expenditure, reduced functional capacity and lost income or productivity are often a primary risk 
factor for impoverishment" (WHO Department of Health Systems Financing 2009, p. 8); households risk 
worsening health by adapting their use of healthcare to evade costs they cannot face, or employing 
financial strategies which compromise their livelihoods (Goudge et al. 2007). It has been widely 
accepted that where the total economic costs of illness represents loo" or more of a household's 
income (as in the majority of cases described above), households are at risk of impoverishment; a lesser 
proportion is likely to be catastrophic for poorer households (Ranson 2002; Prescott 1999; Mcintyre, 
Thiede, et al. 2006). As a result, ability-to-pay is the second key component of the concept of 
affordability and relates to the ways in which individuals and households manage and respond to the 
economic costs of illness. 
While households in different countries and contexts are likely to respond differently to 'health shocks' 
(as defined by the WHO (2009)), Mcintyre et al (2006) have established a Simplified flow-chart of the key 
issues relating to the economic consequences of illness (depicted in Figure 4)(WHO Department of 
Health Systems Financing 2009; Leive & Xu 2008; Mcintyre, Thiede, et al. 2006). While this framework is 
extremely useful in guiding those who seek to understand the experiences of households, it is important 
to recognize that those who are too poor to access and use health services are not captured. Formal 
health insurance and credit programs are rare in many low and middle income countries, as a result, 
households will exhaust their savings, "sell assets, borrow money from friends and family or take out a 
loan using collateral" (Leive & Xu 2008, p. 849) to cope with medical bills (Leive & Xu 2008). If illness 
occurs in a head of household or a member who is depended on for income, households may be forced 
to make decisions regarding labour allocation to make up for lost income or productivity (Leive & Xu 
2008). Ability-to-pay is a combined measure of several factors including: how individuals benefit from 
public funding (national insurance schemes, disability grants); the value and schedule of income within 
the household (and the resultant capacity of a household to make payments for health care); the ease at 
which additional sources of funding can be mobilized which is dependent on the amount and nature of 
household assets (and the ease at which they can be converted for cash) as well as confidence in 
community members to provide financial assistance (through gifts and loans) and; a household's 
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has the capacity to repay borrowed assets; (c) there exists sufficient social capital (Leive & Xu 2008). 
Another key finding reflected that households were at least 10% more likely to borrow and sell their 
assets if the level of inpatient spending was greater; this was consistent for eleven of the fifteen 
countries where the "effect was greatest in the Congo, Ethiopia and Ghana [as] households in the 
highest category of inpatient spending were 38%, 39% and 40016, more likely to cope by selling assets and 
borrowing" (Leive & Xu 2008, p. 851). 
In 2008, Sagbakken et al (2008) explored the barriers and enabling factors to TB treatment in Ethiopia, 
concluding that the economic burden of treatment is a key determinant of treatment adherence 
through a dynamic process of interaction between individuals, their households, family members, social 
networks and employers (Sagbakken et al. 2008). Through a series of in-depth interviews and focus 
group discussions, the authors note that employment-related factors Significantly restrict an individual's 
ability to remain in treatment, particularly among those referred to as 'daily labourers' (defined as an 
individual who is not employed but convenes with other individuals to compete to be hired for the day) 
(Sagbakken et al. 2008). Many individuals in the private sector lost employment upon diagnosis due to 
the time-consuming nature of the treatment available to them as well an inability to continue working 
because of severe symptoms of illness, and daily labourers were no longer able to compete with their 
healthier counterparts (Sagbakken et al. 2008). These effects also resonated among family-members 
who accompanied individuals to treatment facilities (Sagbakken et al. 2008). Transport represented a 
significant barrier to access; many individuals discontinued treatment as they were unable to afford 
transportation (and/or provisions during travel) and were not strong enough to walk to treatment 
facilities which were usually a considerable distance away (Sagbakken et al. 2008). Sagbakken et al 
(2008) found that the majority of respondents prioritize their employment and income, interrupting or 
ceasing their treatment regimens, to ensure that they are able provide food to their respective 
households (Sagbakken et al. 2008). Their vulnerability is reflected by an Ethiopian health worker: "they 
rather live for a while, with money and their jobs, to eat and then die" (Sagbakken et al. 2008, p. 5). 
The role of social networks and community is often a primary determinant of a household's ability to 
cope with out of pocket payments, "patients with limited access to financial or practical help from 
relatives or friends experience that the total costs of attending treatment exceed[s] their available 
resources" (Sagbakken et al. 2008, p. 4). Despite TB's association with a high degree of stigma and fear, 











arrangements between Ethiopian households, where encouragement and shared resources, which 
compensated for lost income, was an important determinant of accessing and adhering to treatment 
(Sagbakken et al. 2008). Nonetheless, the authors note that with time, levels of financial and practical 
support from community members diminished due to Nfinancial and social exhaustion" (Sagbakken et al. 
2008, p. 8) which was a huge concern considering the longevity of illness associated with TB, often 
leading to treatment termination and social exclusion (Sagbakken et al. 2008). 
Consequences 0/ the Medical Poverty Trap 
As indicated in the preceding discussions, there is a substantial body of evidence illustrating the 
debilitating economic costs of illness. Though these costs may vary in type and intensity by socio-
economic status, even those who are among the middle-income quintiles of their respective populations 
can be pushed into poverty when confronted with medical expenses, particularly when combined with 
loss of income and labour productivity (Mcintyre, Thiede, et al. 2006). The incorporation of user-fees for 
public services over the past two decades coupled with an increasing trend for households to seek 
private services in response to quality weaknesses in the public sector has created considerable 
problems for the already frail health-systems in low and middle-income countries, particularly with 
regards to equity and coverage implications (Whitehead et al. 2001; Russell 2004). These problems have 
"deter[red] use of public health services, [particularly by those that are stricken by poverty,] so services 
are often ineffective in reaching the poor and generate less benefit for the poor than the rich ... 
impos[ing] regressive cost burdens, with [low-income] households spending a higher proportion of their 
income on health care than better-off households" (Russell 2004, p. 147). The enormity and extent of 
this situa~ion has been defined as 'the medical poverty trap' (Whitehead et al. 2001). 
Untreated illness is perhaps the most dangerous and grave consequence of the medical poverty trap 
whereby individuals are unable to treat their illness purely because they do not have the financial ability 
to do so. This phenomenon has been empirically examined, and imposes devastating costs to both 
society and individuals, particularly because of its prevalence among the poor (Whitehead et al. 2001). 
In both the Caribbean and in rural India, of those who reported poor health, up to 20% and 17%, 
respectively, did not seek health care due to an inability to meet hospital, treatment and transport costs 
(Theodore 1999; Iyer & Sen 2000; Whitehead et al. 2001). Further, in China, a nation with stable 
economic growth that has been celebrated for its rural health network, 35-40% of rural respondents to 











of doing so; 60% of those who were evaluated by a medical doctor and prescribed hospitalization did 
not do so for fear of the associated financial burden (Fu 1999; Whitehead et al. 2001). 
The very nature of 'health shocks'-that the increases in health expenditure are unexpected and where 
the total expenditure needed to treat the illness is not known until after these costs have been incurred, 
forces households into the medical poverty trap, of which long-term impoverishment is another serious 
consequence (Whitehead et al. 2001; WHO Department of Health Systems Financing 2009; Leive & Xu 
2008). The sale of assets, such as livestock or land imposes a "vicious cycle of increased economic 
vulnerability" (Mcintyre, Thiede, et al. 2006, p. 862) as households relent on vital resources to their 
household's livelihood (Mcintyre, Thiede, et al. 2006). Coping mechanisms, as outlined in previous 
sections, often come at a dire cost; households face lifelong debt repayment, exacerbated by exorbitant 
interest rates (underwritten by private lenders who seek to capitalize on the vulnerability of these 
groups) and a reduction of the consumption of essential, basic goods such as food and education to 
meet health care costs (Whitehead et al. 2001). 
A key point is that ability-to-pay and payment are not one in the same; in a number of settings health 
care costs are highly regressive (Segall et al. 2000; Whitehead et al. 2001). As explained by Mcintyre 
(2007, p. 5), "individuals should contribute to health care funding according to their ability to pay and 
should benefit from health services according to their need for care" (Mcintyre 2007). The goal for 
countries now must be to develop health systems which circumvent regressive mechanisms by creating 
systems which protect households by including "cross-subsidies from the rich to the poor and from the 
healthy to the ill" (Mcintyre 2007, p. 32). 
AVAILABIUTY OF HEALTH SERVICES & IMPUCATIONS FOR EQUITABLE ACCESS 
The final dimension of access explores the role of physical access to health services, or availability. This 
dimension is concerned with whether or not the appropriate package of health services exist in the 
geographic areas that they are needed, when they are needed, in a way that ensures they are an 
appropriate distance from the communities they serve (based on the travel resources available to the 
community) (Mcintyre et al. 2009; Thiede et al. 2007). When considering availability, it is useful to 
observe the degree of fit between health system factors such as: the physical location of facilities, the 











and whether they are mobile or 'in-house') and; household factors such as: the health needs of the 
community, the demographics of the population, transport options as well as the appropriateness of 
opening hours (Mcintyre et al. 2009; Thiede et al. 2007). 
In 2009, Goudge et al (2009) combined results of a household survey with qualitative methods to 
understand availability barriers to health care for the chronically ill in Mpumalanga, South Africa 
(Goudge et al. 2009). This area is recognized as predominantly rural, with poor sanitation and road 
infrastructure, little access to electricity and high unemployment rates; the findings of this study are 
therefore useful in gaining insight into the barriers of access for low-income communities. The authors 
identify availability as a central factor affecting access across three key areas: (a) insufficient and 
ineffective clinical services; (b) interrupted drug supplies and; (c) inadequate transport options (Goudge 
et al. 2009). Respondents described a number of nursing professionals at their community health clinics 
who displayed insufficient knowledge to treat certain conditions as well as a lack of equipment including 
key diagnostic tools such as blood pressure cuffs, and blood glucose measurement devices (Goudge et 
al. 2009). Patients were forced to repeatedly, personally finance travel to distant district hospitals 
where these devices were available at higher consultation fees; "for highly vulnerable households, 
repeat visits generated cost burdens amounting to 30-50% of monthly income" (Goudge et al. 2009, p. 
11). Attending the hospital was only an option f r those who could afford the taxi fare, as ambulatory 
services at community health clinics were "not available to take [individuals] to hospital or return [them] 
back to the clinic after [their] inpatient stay" (Goudge et al. 2009, p. 12). Though ambulances were 
physically present, drivers were reportedly unavailable or the vehicles were not deemed roadworthy 
(Goudge et al. 2009). In several instances, patients reported having to cease TB treatment and became 
critically ill (Goudge et al. 2009). Furthermore, staff shortages, the lack of continuity of care by the same 
physician, due to high turnover in rural community clinics and a "lack of a system for reimburSing nurses 
for tracing patients" (Goudge et al. 2009, p. 12) lead to approximately 66% of identified TB cases 
resulting in mortality and only "four of the eleven [identified] chronic cases in vulnerable households, 
and 5 out of 8 [identified] chronic illnesses in secure households being treated regularly" (Goudge et al. 
2009, p. 10). 
The majority of respondents also explained their frustration over a lack of medication at public clinics 
who most often reacted by self-treating their illnesses, visiting retail pharmacies and obtaining 











many low and middle income countries whereby drugs are sold without prescriptions by unqualified 
individuals at retail pharmacies who will often overprescribe medication, motivated by financial 
incentives, which leads to irrational drug use and drug resistance (Whitehead et al. 2001). Furthermore, 
these practices, born out of frustration and a lack of options for ill individuals and their households, 
often significantly contribute to the inequity of the medical poverty trap (Whitehead et al. 2001). 
Expenditure for medicines outside of health facilities are exorbitant, particularly when individuals are 
resistant to first or second line disease treatment options and are forced to obtain the pricier third line 
options (Whitehead et al. 2001). These retail outlets usually operate during weekends when public 
health facilities are closed and are generally a closer proximity to rural households than community 
clinics and hospitals, both factors of which were deemed to contribute to treatment seeking in the retail 
sector by Smith et al (2011) in a study of access to malaria treatment in rural Kenya (Smith et al. 2011). 
In a similar vein, Chuma et al (2010) illustrated the effect of physical distance from health facilities on 
treatment seeking behaviour in rural Kenya (Chuma et al. 2010). According to their findings, 
approximately 33% of respondents who engaged in self-treatment for malaria through a visit to a retail 
pharmacy reported that they would have opted to visit a public health facility if it had been closer 
(Mbagaya et al. 2005; Chuma et al. 2010). Similarly, in another district, 74% of respondents reported 
that they visited a public health facility to receive malaria treatment simply because it was close to 
where they resided (Munguti 1998; Chuma et al. 2010). 
Chuma et al (2010) also communicate drug-related supply-side barriers to access which further 
substantiate the findings of Goudge et al (2009) and Smith et al (2011) (Chuma et al. 2010; Goudge et al. 
2009; Smith et al. 2011). Public facilities in rural Kenya were regularly confronted with drug shortages 
due to failures in central-level drug deliveries and poor drug need-assessments which failed to respond 
to the seasonal fluctuations of malaria incidence (Chuma et al. 2009; Chuma et al. 2010). As in the 
aforementioned cases, individuals defaulted to self-treatment, purchasing drugs from retail vendors 
without prescriptions where quality was not controlled and dosage information not provided (Chuma et 
al. 2010). Chuma et al (2010) however, note how poor quality of care within public facilities also served 
a critical role in access to malaria treatment where health workers demonstrated poor and 












Rural health facilities have become accustom to sporadic drug supplies which has created fear among 
health workers of 'stock-outs' (Chuma et al. 2010). As a result, health workers have been seen to 
disregard national malaria prescription guidelines whereby health workers make personal judgments 
over who they believe is deserving enough to receive treatment (Wasunna et al. 2008; Chuma et al. 
2010). Furthermore, many health workers simply do not received adequate training of malaria drug 
prescribing practices, considered to be the result of staff shortages at rural facilities and a resultant lack 
of supervision (Wasunna et al. 2008; Chuma et al. 2010). According to a study of prescribing practices of 
anti-malarial medications in Kenya, of all children who had displayed malarial symptoms (as defined by 
national guidelines), only 26% were prescribed amodiaquine (the nationally recommended anti-malarial 
drug) and 23% of children were recorded to have left health facilities with no treatment or prescription 
for treatment which illustrates the potentially lethal effects of poor quality of care (Wasunna et al. 2008; 
Chuma et al. 2010). 
As highlighted in the preceding discussions, the world's poor and marginalized groups are undeniably 
suffering higher rates of illness, disease and mortality. While not exclusively, one of the largest, most 
Significant and most avoidable contributors to these health distributions are the inequitable barriers 
which exist in accessing health services. It is clear that certain populations are being culturally, 
physically and financially prohibited from accessing the services they need to treat their illnesses and 
reverse current trends. A pro-poor, equit -based approach requires that health-care services pay 
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Objectives: The control of tuberculosis (TB) in South Africa has fallen short of the targets 
outlined by the World Health Organization and without improvement, TB is expected to have 
grave consequences for both the mortality and morbidity of South Africans as well as crippling 
financial consequences for the public health system. While services in the public sector are free 
at the point of use, little is known about overall access barriers and their implications for 
treatment adherence. This paper explores these barriers from the perspective of TB patients 
enrolled in Directly Observed Treatment, Short-Course (DOTS) in Mitchell's Plain, South 
Africa. 
Methods: Using a comprehensive framework ofaccess, interviews were conducted with 334 TB 
patients to assess barriers across the dimensions of availability, aft"ordability and acceptability. 
Summary statistics were computed and comparisons of access barriers between adherent and 
non-adherent groups, and between socioeconomic groups were explored using bivariate, 
multivariate linear and logistic regressions. 
Results: Among the respondents, 244 (73.05%) met the criteria for adherence (i.e. reported that 
they had never missed a dose of TB medication) while 90 (26.95%) met the criteria for non-
adherence. Marital status, age, birth province, costs of self-care and costs of other providers 
were found to be significantly associated with adherence (P-values <0.05). There was no 
significant evidence of inequalities in access by socioeconomic status (all P-values > 0.05). 
Conclusions: Our findings indicate that non-adherence is not associated with access barriers and 
there is therefore no evidence of inequity in adherence to DOTS TB- treatment. In addition, our 
findings show that there is no significant evidence of inequalities in access to DOTS TB-
services in Mitchell's Plain, by socioeconomic status. This study discovered that there is a need 
to explore the high costs of using TB-services, specifically high transport costs which are 
associated with the frequency of clinic visits. 
Tuberculosis (TB) represents one of the most pressing global 
health issues and since 1993, has been considered a public health 
emergency [1]. According to the World Health Organization 
(WHO) (2011), TB is a worldwide pandemic whereby low and 
middle income countries (LMICs) carry 90% of the worldwide 
burden; Africa assumes 26% of cases of TB, while 59% of all 
new cases are emerging from Asian countries (WHO 201Ob; 
WHO 20lla; Lawn & Zumla 2011). The past two decades have 
seen an escalation in TB morbidity; prevalence estimates in 1993 
of7-8 million cases have grown to 8.5-9.2 million cases in 2010 
- more than at any other time in history [1]. TB is accountable 
for the most deaths from an infectious disease worldwide, after 
HIV/AlDS, with estimates reaching 1.2-1.5 million deaths in 
2010 [1]. Incidence rates of TB have declined marginally at a 
rate of almost 1 % per year since 2002; however, the absolute 
burden continues to increase worldwide [1], [3]. 
cases per 100 000 people [5].A serious contributor to the burden 
of TB in South Africa has been the emergence of multi-drug 
resistant (MDR) strains of the mycobacterium tuberculosis 
bacilli, the organism which causes TB [6]. Those that become 
infected with MDR are subject to extended, complex and 
extremely expensive treatment regimens which have poor success 
rates and often fatal outcomes [6]. It has been estimated that 
treatment for MDR costs 100 times the cost of treating drug-
susceptible TB [6]. Furthermore, the impact of the HIV/AIDS 
epidemic has been considerable; the weakened immune systems 
of HIV/AIDS infected individuals puts them at a greater risk of 
acquiring TB. In 2007, approximately 40% of all notified TB 
cases in South Africa were tested for HIV/AIDS and 73% were 
estimated to be positive [4]. Over the next five years the 
epidemiological profile of TB in South Africa is likely to show 
increasing rates of infection, more pronounced in the provinces 
of KwaZulu-Natal, Mpumalanga and Gauteng, which have the 
fastest-growing HIV infection rates in the country [6]. 
South Africa currently has the third-highest TB burden in the 
world with TB notification rates increasing fivefold over the last 
twenty years [4]. In 2008, TB incidence was an estimated 940 











Availability Affordability Acceptability 
Total Expenditure (Direct & Indirect) on Health 
Care including: 
Perceptions of Staff Attitudes, Facility 
CIean1iness, Length of Queues, and Community 
Judgment (as a proxy for Stigma), Confidentiality 
and Privacy. 
Mode & Cost of Transport Expenditure to reach facility 
Expenditure on self-care 
Expenditure on other providers 
Lost wages as a result of facility visit 
Travel Time to Facility Healthcare Costs as a Proportion of Household 
Expenditure 
Provider expectations of Patient 
Waiting Time at Facility Ability to Borrow Money to Pay for Healthcare 
Expenses 
Perceptions of The Effectiveness of Treatment 
Availability of Government' Disability' Grants Receipt of Government 'Disability' Grants 
Table 1. Dimensions of Access 
In 1995, the South African government revised the National 
Tuberculosis Control Program (NTCP) based on the WHO's 
Directly Observed Treatment, Short -Course (DOTS) guidelines 
which necessitate: (1) a sustained government commitment to 
prioritize TB control; (2) the diagnosis of TB through sputum 
microscopy; (3) standardized and supervised treatment in a 
supportive environment; (4) uninterrupted drug supply and; (5) 
regular monitoring of patients and health systems [9]. Treatment 
of active tuberculosis is done with a standardized range of anti-
TB drugs, which must be monitored and administered daily by 
public health facilities or community health workers, over a 
period of approximately six months, in order to ensure that 
individuals take and complete their course of medication [10]. 
Adoption of the DOTS strategy in South Africa in 1996, and 
significant investments in TB control have helped the country 
achieve 100% population coverage (defmed as the proportion of 
population living in administrative areas with access to DOTS 
services) of DOTS TB-treatment, free at the point of use, and 
allowed for the adoption of new and improved TB drugs (with 
shorter periods of treatment); superior TB diagnostic tools; 
improved TB registration mechanisms; and clear performance 
targets. While these are considerable achievements, the case 
detection rate remains less than 60% with treatment success rates 
in 2008 at 76%, falling short of the WHO targets of 70% and 
85%, respectively [5]. Estimates by the South African Medical 
Research Council have indicated that if control efforts do not 
improve, an anticipated 3.5 million new cases ofTB will develop 
with approximately 90,000 deaths over the next decade [6]. 
Since the democratization of South Africa in 1994, the 
government has established its cotnmitment to equity in health 
service delivery and fmancing by directing health policies and 
programs to vulnerable groups and diseases of poverty [11], [12]. 
Broadly, health policy has been centered on improving access to 
health care services, yet, despite a considerable body of research 
dedicated to conceptualizing access, there has long-existed a 
cloud of ambiguity surrounding a universally-acceptable, 
empirical defmition of the term, particularly when being 
operationalized to evaluate health systems in LMICs [7], [13-
15]. As explained by Thiede et al (2007), " .. .if the access 
concept is not well understood, comprehensive evidence on what 
should be done to promote equitable health systems cannot be 
gathered"[7]. 
In earlier literature, 'access' was primarily viewed in terms of 
two factors - money fees at the point of use and distance 
travelled to use health care services [16]. Others have defined 
access as use of services; both in terms of actual use (absolute 
terms) and in terms of the differential use of health services 
across groups and individuals with diverse needs (relative terms) 
[8], [17-20]. The most recent contributions to the study of 
access, particularly in its application to LMICs has explored 
access as a unique experience; the empowerment of individuals 
Adapted from: [7], [8] 
to use and benefit from health services [8]. By this defmition, 
access to health services can only be understood when 
characteristics of the individuals and characteristics of the health 
system are considered together and relative to one another as they 
are constantly engaging in a "dynamic process of interaction" 
[8]. The degree of access to a particular health service is 
therefore governed by the relative fit between the system and the 
individuals it serves across all individual and system factors 
which have the potential to affect the freedom to use health care. 
Under this conceptual framework, these individual and system 
factors can be grouped into three dimensions: availability 
(Physical access factors), affordability (fmancial access factors) 
and acceptability (cultural access factors), as a starting point for 
empirically investigating access and for developing health policy 
strategies that can address these barriers [7], [8]. 
Since the World Health Organization's Alma-Ata Declaration 
(1978) which promoted the need to improve the health profiles of 
those most in need, the WHO has defined equity in health as a 
situation in which "everyone should have a fair opportunity to 
attain their full health potential [whereby] no one should be 
disadvantaged from achieving this potential, if it can be avoided" 
[21], [22]. Equity has endured as a central goal for global public 
health policy and practice. A health inequity exists if health 
inequalities are considered to be: (I) unfair; (2) unjust; (3) 
avoidable and; (4) unnecessary; and further, that tagging a 
difference in the health profile of one group as inequitable 
involves a moral and ethical judgment of the fairness of the 
causes of the inequalities [22-24]. What is made consistently 
clear from all discussions on equity, particularly within the 
context of health and health services is the fact that it can only be 
achieved if there exists a fair opportunity for all to achieve 
health. This understanding reflects the central role of access; if 
health services are the means by which populations and 
individuals are granted the opportunity to achieve their full health 
potential then it undoubtedly follows that equity in health is 
dependent on the equity which exists in access to health services 
[22], [24]. 
The effects of the TB are particularly pronounced among the 
13.3 million South Africans living in poverty [25]. It is widely 
documented that these groups face higher rates of mortality and 
morbidity relative to their better off counterparts, yet despite their 
increased needs, use less health services [26]. In the context of 
TB, the success of treatment and ultimately the control of the 
disease are hinged on assured daily access to health care for a 
prolonged treatment period. According to the WHO (2003), 
poor adherence to anti-tuberculosis medication is among the most 
significant barriers to its global control [27]. This is particularly 
due to the fact that TB is a communicable disease and as a result, 
poor adherence to treatment has implications at both the 











morbidity, mortality and drug resistance [27]. Where non-
adherence is the result of unfair, unjust, avoidable or unnecessary 
forces which prevent access to TB medications, equity concerns 
intensify its importance. 
What is consistent from the majority of literature which 
examines adherence to TB treatment is the fact that adherence 
cannot be predicted or controlled by a single factor. Likewise, 
''non-adherence is a complex, dynamic phenomenon with a wide 
range of interacting factors impacting treatment-taking behavior" 
[28]. Adherence barriers take effect against an array of 
facilitating factors, and the fmal decision about treatment 
adherence depends on which factors predominate [29]. There are 
a number of documented ways in which the acceptability, 
affordability and availability of TB treatment affects patient 
adherence. Even where TB treatment is provided free at the 
point of use, adherence can be compromised by the direct costs 
of: transportation; extraordinary dietary requirements as a result 
of the illness and/or treatment related side-effects and; the 
indirect costs of productive time losses incurred while travelling 
and receiving daily treatment. The location of treatment facilities 
and the need for transportation has also been linked to reduced 
adherence reflecting the impact of availability-related forces. 
Furthermore, cultural factors such as the stigma attached to TB, 
the knowledge about TB and belief in the efficacy of the 
medication as well as the nature of relationships between the 
health provider, social networks and the patient also have proven 
to be critical forces in influencing treatment adherence [27]. 
Despite the importance of equitably accessible TB treatment, 
very little research exists which explores access to DOTS 
services and the barriers of TB-treatment adherence in South 
Africa making it particularly difficult for the government to tailor 
the provision of treatment and health promotive interventions in a 
way that ensures patients are able to initiate and complete their 
treatment. Furthermore; few studies have explored whether the 
factors which influence access vary according to the 
socioeconomic status of the patient. This study aims to explore 
the relationship between access to DOTS services (i.e. the 
availability, affordability and acceptability of TB-treatment) and 
patient adherence, and to examine whether service access is 
equitable. Findings from the study may provide evidence to 
assist in evaluating the success of current TB policy and may 
further assist in developing strategies and interventions which 
mitigate the barriers to both accessing and adhering to DOTS 
TB-treatment, in order to achieve the TB-related targets outlined 
by the WHO. 
Methods 
Study Design & Conceptual Framework of Access 
This study is based on data derived from Phase 1 of the 
Researching Equity in Access to Health Care (REACH) project, a 
five-year study of health system access in South Africa which 
commenced in 2007. Details regarding the survey methodology 
are available in published sources [30]. Briefly, an exit-interview 
style, interviewer administered questionnaire was used to gather 
socioeconomic and demographic data, data regarding the 
individual's dwelling characteristics, household income, an 
estimate of monthly household expenditure and household asset 
ownership, as well as data regarding key barriers to DOTS TB-
treatment accessibility, from the perspective of the patients. The 
data set was collected between 2008 and 2009 by the REACH 
research team, an experienced multi-disciplinary team of health 
economics, systems, policy and social science researchers. 
This study draws on a comprehensive conceptual framework 
of access whereby access is assessed in terms of the degree of.fit 
between the needs of the population and the availability, 
affordability and acceptability of the health system response [7], 
[8]. Each of these access dimensions can be represented by a 
number of clear and measurable variables, examples of which 
have been outlined in Table 1. A fundamental part of the 
framework is the understanding that while each dimension is 
concerned with its own set of issues: affordability being 
primarily concerned with factors related to fmancial access; 
availability being concerned primarily with those factors which 
are related to physical access; and acceptability being concerned 
with those factors related to cultural access; that the dimensions 
are interrelated and affect the interaction between the health 
system and its users [7], [8]. In this way, access to health 
services can only be achieved and understood if all dimensions 
are addressed and considered from both the health care system 
(supply-side) and individual (demand-side) perspectives [7], [8]. 
Within this study, the availability variables included the travel 
time for the patient to reach the TB-treatment facility, the time 
taken within the facility, whether patients were required to travel 
on foot and how often they were required to visit the facility to 
fetch their TB medications. Affordability variables incorporated 
coping mechanisms by asking whether or not the patient was 
required to borrow money in order to meet the costs of treatment 
and also included information on monthly health care 
expenditure including: the direct costs of seeking treatment, 
expenditure on other providers (e.g. traditional healers) and 
expenditure on self-care (e.g. special dietary requirements). 
These measures were combined and contrasted with the patient's 
reported overall monthly household expenditure to determine 
whether costs were catastrophic (in this instance defmed by 
whether the total costs of care exceeded 10% of monthly 
household expenditure). 
With regards to acceptability, respondents were asked to 
report their perceptions of staff attitudes (by reporting whether 
they felt respected by staff and whether they felt that staff 
members were too busy to answer questions), facility cleanliness, 
queues and community stigma. 
Setting & Participants 
This study focuses on individuals using TB treatment services 
(n=334) in Mitchell's Plain. Mitchell's Plain was purposively 
sampled by the REACH research team to represent a 
metropolitan, urban setting of South Africa. The Mitchell's Plain 
sub-district belongs to the Cape Town Metropolitan health 
district, located in the Western Cape Province in the south-west 
region of South Africa. Based on Censes projections from 2001, 
Mitchell's Plain holds a population of an estimated 460,686 
people - 14% of the total population of the Cape Town 
Metropolitan health district [31]. The population of Mitchell's 
Plain is largely poor whereby 30% of households fell below the 
poverty line in 2003 and 41% lived in informal dwellings [31]. 
Tuberculosis rates in the Western Cape are among the highest in 
the country; between 1997 and 2003, the Cape Town TB Control 
Report showed an increase of 66% in reported cases over the 
seven years, reflecting a growing population, migration, 
improved case detection and increased burden of disease, mainly 
in regions where HIV/AIDS is most prevalent [31], [32]. 
Currently, the Western Cape's incidence rate ofTB is 909 cases 
per 100000 [33]. 
In Mitchell's Plain, a probability proportional to size method 
was used to choose five facilities (Crossroads I, Lentegeur, 
Mzamomhle, Phurnlani and Weltevreden) out of those providing 
TB services, with a fixed cluster size, using data on the total 
number of users in each facility at the time of research. With this 
method, some facilities can be sampled twice so the sample size 
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Age was found to be significantly associated with adherence 
(P=0.017). Older age groups tended to have a higher proportion 
of adherent patients when compared to non-adherent patients. 
Consequently, the youngest age group had a higher proportion of 
non-adherent patients. 
A larger proportion of non-adherent participants were single: 
78.89% of non-adherent respondents and 55.74% of adherent 
respondents were single. Correspondingly, there was a two-fold 
increase in being married in the adherent group where 26.64% of 
respondents were married compared to 13.33% in the non-
adherent group. Marital status was seen to be significantly 
related to adherence (P=0.004). 
The majority of adherent and non-adherent respondents were 
born in the Eastern Cape province (72.73% and 56.82%, 
respectively) although there was a nearly two-fold increase in the 
proportion of participants who were born in the Western Cape 
province in the non-adherent group where 42.05% of non-
adherent participants were born in the Western Cape versus 
23.14% of adherent participants. Differences in adherence by 
province of birth were found to be statistically significant 
(P=0.002). 
The asset index indicated that 47.78% of non-adherent 
patients belonged to the poorest socioeconomic group. This 
proportion was slightly higher among adherent patients where 
50.82% of patients were among the poorest respondents. 
Nonetheless, the relationship between socioeconomic status and 
adherence was not found to be statistically significant. Other 
socioeconomic and demographic parameters including level of 
education, receipt of a disability grant, employment status and 
race were also not found to be associated with adherence. 
Access & Adherence 
Table 3 documents the results of the bivariate, unadjusted 
analysis of the association between each of the access variables 
and adherence. 
In terms of the availability of TB-services, the majority 
(67.66%) of respondents reported that they travelled on foot in 
order to reach the facility; this proportion translated to 66.80% of 
adherent patients and 70% of non-adherent patients. 92.79% of 
respondents received a form of facility based daily-DOTS TB-
treatment which required them to visit the facility on a daily basis 
to receive medication. A slightly higher percentage of non-
adherent patients were on facility daily-DOTS compared to 
adherent patients (95.56% versus 91.77%, respectively). The 
median (interquartile range) travel time to reach the facility and 
return home was slightly shorter for non-adherent patients (17.50 
(30-10) minutes versus 20 (30-10) minutes for adherent patients. 
Nonetheless, no significant association was found between any of 
the availability variables and adherence. 
In terms of affordability, the monthly expenditure on self-care 
and the monthly expenditure on other providers were both found 
to be significantly associated with adherence. Self-care 
expenditure refers to the monthly costs incurred by the patient for 
over-the-counter medications, special foods as a result or 
requirement of treatment and/or expenditure on traditional 
medications. The mean (±standard deviation) monthly 
expenditure on self-care for adherent patients was R7.51 
(±R29.50) versus R5.00 (±R22.16) for non-adherent patients (P-
value: 0.026). Expenditure on other healthcare providers includes 
costs incurred from visiting general practitioners (GPs) or 
traditional healers. The mean (±standard deviation) expenditure 
on other healthcare providers for adherent patients (R32.54 ± 
RI06.63) was nearly three times that of non-adherent patients 
(RI1.25 ± R23.13) (P-value: 0.048). 
The total expenditure on TB-treatment was catastrophic (Le. 
greater than 10% of the respondent's household expenditure) for 
33.47% of adherent patients and 28.89% of non-adherent patients 
although this association was not found to be statistically 
significant. Figure I depicts the breakdown of healthcare costs 
as a percentage of total household expenditure. According to the 
graph, the direct costs of treatment and the expenditure on self-
care represent similar proportions of overall health expenditure 
(10% and 1%, respectively) for both adherent and non-adherent 
groups. Expenditure on other providers represents 3.00% of the 
total household expenditure for adherent patients and 1.00% for 
non-adherent patients. Total healthcare costs for adherent 
patients, on average, accounts for 14.00% of total household 
expenditure and 12.00% of total household expenditure for non-
adherent patients. 
With regards to perceptions of the acceptability of TB 
services, none of the variables were found to be significantly 
associated with adherence. Distinctly, 43.54% of respondents 
reported that queues were too long. In addition, perceptions of 
respectful treatment from facility staff were seemingly more 
problematic for adherent patients whereby 21.31 % agreed that 
the staff did not treat patients with respect (compared to 15.56% 
of non-adherent patients). 
Access & Equity 
Table 4 documents the results of the bivariate, unadjusted 
analysis and the multivariate analysis of the association between 
SES and each of the access variables. The results of the 
multivariate regressions are shown as adjusted Odds Ratios or 
coefficients. Using the 'poor' respondent group as the referent, 
these results summarize differences between 'rich' and 'poor' 
respondents across each dependent access variable, after 
controlling for level of education, age, sex, province of birth and 
marital status. 
Using an asset index computed by pooling household and 
individual data of respondents, we were able to compare the 
barriers faced by respondents of different socioeconomic groups 
in accessing TB-services. The resulting index achieved two, 
equally spaced groups, indicating no problems with clumping. 
As shown in Table 4, there was no statistically significant 
evidence of inequalities in access by SES (all P-values > 0.05). 
We explored grouping the distributions into four socioeconomic 
quintiles, but as before, no significant differences were detected 
(data not shown). 
In terms of availability, poor respondents were more likely to 
report having travelled on foot whereby 71.86% of poor 
respondents travelled on foot compared to 63.47% of rich 
respondents. The travel time to reach the facility was higher for 
poor respondents whereby the median (interquartile range) travel 
time for the poor was 20.00 (30.00-10.00) minutes compared to 
15.00 (30.00-10.00) minutes for the rich. 
In terms of affordability, the rich were seen, on average, to 
spend more on other providers, self-care and on the direct costs 
of seeking treatment (Le. transport), when compared to the poor. 
Overall, total monthly expenditure on health care represented a 
more substantial burden for poorer respondents who, on average, 
spent 17.59% of their total household expenditure compared to 
the rich who spent 10.42% of their total household expenditure 
on seeking treatment. Costs were catastrophic for a larger 
proportion of the poor (34.15%) when compared to the rich 
(30.25%). Figure I depicts the breakdown of health care costs as 
a percentage of total household expenditure. According to the 
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answer their questions, compared to only 8.43% of poor 
respondents. 
Discussion 
In interpreting the results, it is important to recognize the 
limitations of this study. The study uses a comprehensive 
framework of access to describe the barriers of access (and their 
effects on adherence) by users of free DOTS TB-services in 
Mitchell's Plain, South Africa. The study was based on the 
perspectives of users interviewed in five facilities within this 
setting. This analysis was limited to the sample of users and 
therefore, we cannot explore access barriers to DOTS TB-
services which would contribute to the non-use of services. 
Second, where adherence has been evaluated, this analysis adopts 
a narrow definition of adherence, which relates only to missing 
doses of medication as reported by the patient. Correspondingly, 
given that this analysis was based on patient recall, there is the 
potential for both recall bias and social desirability bias whereby 
patients may either underreport missing doses of medication 
because they cannot recall doing so or because they believe it is 
more desirable to do so. Further, it is important to note that by 
using this definition of adherence, we are not implying that non-
adherence amounts to treatment failure nor are we ignoring the 
fact that adherence can be governed by a range of variables in 
addition to medication adherence. 
In earlier discussions, there is great emphasis on the 
importance of evaluating both health system and patient level 
forces which influence access to health services is stressed. This 
study only involves participation from patients therefore; the 
barriers to treatment access from the perspectives of health 
workers are not captured. In the absence of this data, there are a 
number of key barriers to treatment access which are not 
explored within the scope of this study. 
The distance travelled to obtain TB treatment has been 
captured by the time taken to reach the health facility. Although 
this is a common means of doing so, it is important to understand 
that for many individuals, seeking treatment is combined with 
many other daily activities such as visiting friends and relatives 
or going to market. Thus, the time travelled to reach the facility 
may have been overestimated in some cases. 
Finally, an important consideration when interpreting the 
fmdings of this study relate to those who were excluded from the 
sample of participants. The inclusion criteria mandated that only 
patients who had been receiving TB treatment for two months 
and who were deemed to be sufficiently well were able to be 
included in the sample, thus excluding those who withdrew from 
treatment, died, were lost-to-follow-up or were very ill, all of 
whom are likely to have been non-adherent. 
By the defmition of adherence employed within this study 
73.05% met the criteria for adherence while 26.95% met the 
criteria for non-adherence. A recent systematic review of 
qualitative evidence regarding the determinants ofTB medication 
adherence suggested that as many as half of all patients with TB 
will not complete treatment [28]. It may be possible that the 
level of non-adherence within this setting is in fact even lower 
than our result suggests. Although some have argued that any 
deviation or interruption in a prescribed TB-treatment regimen 
should be considered non-adherence [34], others have argued that 
because the exact effect of poor compliance with a prescribed 
TB-regimen is unknown, and that a certain degree of flexibility is 
unlikely to affect treatment outcome [27], [28], that patients 
should only be labeled as non-adherent if their level of non-
adherence affects their therapeutic outcomes. Therefore, it 
becomes evident that adherence measures can be largely affected 
by the way in which the term is defined. Nonetheless, it is 
important to consider that even if the methods of this study have 
potentially inflated the rate of non-adherence, rates of non-
adherence to treatment are required to fall below 10% in order to 
achieve treatment success of 85%, one of the health-related 
indicators of the Millennium Development Goals [35]. 
According to our fmdings, a larger proportion of younger 
patients were found to be non-adherent. These results differ from 
similar studies in Nepal (2006) and Southern Ethiopia (2007) in 
which the former found a two-fold increase in non-adherence 
among patients over the age of fifty-four years and the latter 
found a significant association between being over the age of 
twenty-five years and treatment non-completion [36], [37]. A 
possible explanation for this result could be that older 
participants have a well-established network of social and 
community support, which is often a primary determinant of a 
household's ability to cope with the requirements of treatment 
[38]. In addition, older participants may have had more exposure 
to health-promotive interventions and may have a greater level of 
knowledge regarding treatment practices, the efficacy of 
treatment and the effects of poor-adherence. Furthermore, 
younger participants may be more likely to be vulnerable to 
ostracism and stigma associated with TB. As described in a 
number of studies TB patients will often miss appointments out 
of fear of being identified as a TB patient by their communities 
[28], [39], [40]. 
Marital status was also found to be significantly associated 
with adherence whereby a higher proportion of non-adherent 
participants were single than married. These findings are 
inconsistent with a similar study in Nepal (2006) which found 
significant differences in non-adherence between those that were 
single, married and widowed or divorced, where the likelihood of 
default increased when participants were married [36]. It is 
possible that within our setting, married respondents have a 
higher degree of support from their spouses which encourages 
and/or pressures them to adhere to the treatment regimen. 
When we observed the association between the access 
variables and adherence, self-care costs and costs for other 
providers were the only variables which were found to be 
significantly associated with adherence. In both cases, adherent 
patients were seen to incur larger costs for these items. It could 
be the case that adherent patients are more likely to value their 
health and are therefore more likely to invest in over-the-counter 
medications, special foods and visits to other providers. When 
disaggregated by type, it is noteworthy that the largest proportion 
of healthcare costs are assumed by direct costs, which is largely 
composed of transport costs, consistent with other published 
studies [28], [29], [38]. For both adherent and non-adherent 
patients, direct costs represented 10% of total monthly household 
expenditure. 
Although the association with adherence was not statistically 
significant, it is important to note that total healthcare costs were 
catastrophic for 32.21 % of all respondents. Furthermore, costs 
were catastrophic for a larger proportion of poorer households 
compared to rich households, and on average, total costs 
represented a burden of 17.59% of the total household 
expenditure for poor households (Table 4). It is important to 
consider that the largest proportion of costs for TB-patients is 
assumed by the direct costs of seeking treatment, particularly 
those concerned with transportation (Figure 1). It has been 
widely accepted that where the total economic costs of illness 
represents 10% or more of a household's income, households are 
at risk of long-term impoverishment; although a lesser proportion 
is likely to be catastrophic for poorer households [41-43]. It is 
possible that many of these people will be unable to sustain these 
costs over the entire duration of treatment and may be forced to 
sacrifice vital resources to their household's livelihood such as 












Additional research is needed to explore the fmancial coping 
strategies employed by patients facing catastrophic healthcare 
costs in adhering to TB-treatment within this setting. 
Another interesting fmding reflected that more adherent 
patients felt that the staff did not treat patients with respect. 
Although this fmding was not significantly associated with 
adherence, it talks to another element of TB-treatment. A 
number of studies have argued that the DOTS strategy is 
essential and is the most effective way of preventing relapse and 
the development of drug resistance; patients are able to be closely 
supervised and are coerced into adherence through peer pressure 
and other social influences [44]. However there are also a 
number of claims that the DOTS strategy is no more beneficial 
than self-supervised treatment; these critics also assert that 
directly observing treatment reverts to the former view of patients 
as passive recipients of treatment [44]. A number of studies have 
reflected how patients see direct-observation negatively and feel 
as though it indicates distrust between the provider and 
themselves [28]. In a South African trial which compared DOT 
to self-supervised treatment, direct-observation was seen to have 
a demoralizing effect on patients [44], [45]. In another study, 
directly-observed therapy was described as "humiliating, 
authoritarian and an invasion of privacy" [40] whereby 
approximately 45.00% of the patients reviewed reported that they 
were responsible enough to do so without observation and that 
they did not trust public services [40]. It is likely that the 
majority of adherent patients within this study interact more 
frequently with facility staff. It may be that the nature of direct-
observation is the reason that many adherent patients feel a lack 
of respect from facility staff, although further study is required. 
When the association between SES and each of the access 
variables were tested, there was no statistically significant 
evidence of inequalities in access by SES (all P-values > 0.05). 
Both within South Africa and within other settings, it has been 
widely documented that the effects of TB have been particularly 
pronounced among poorer, disadvantaged groups who use health 
services less, despite their increased needs, and face increased 
barriers in accessing these services [25], [26]. As previously 
mentioned, the results reveal that the poor face increased costs of 
seeking treatment. Though these associations were not found to 
be significant, they warrant the attention of policy-makers. 
The National Health Act (2003) explicitly focuses on the need 
to address ''the socio-economic injustices, imbalances and 
inequities of health services of the past; the need to heal 
divisions of the past and to establish a society based on 
democratic values, social justice and fundamental human 
rights ... " [12], [46]. This study reflects that despite the 
shortcomings of the South African health sector, the TB-service 
in Mitchell's Plain appears to be distributed in a way that reflects 
the equity goals of the government. South Africa faces many 
challenges in successfully controlling the TB-epidemic over the 
next decade. We hope that our fmdings illustrate the potential of 
the TB-service, and the health system more widely, in reaching 
and treating all those in need. 
Conclusion 
Our fmdings indicate that non-adherence is not associated 
with access barriers and that there is no significant evidence to 
suggest that access barriers are higher for those of lower SES. 
These fmdings suggest that there is no evidence of systematic 
inequalities in access to DOTS TB-services in Mitchell's Plain. 
However, this study elicits concerns about the high costs of using 
TB-services and the impact on households of catastrophic 
payments. This warrants a need to further explore the issue of 
transport costs - the main constituent of the direct monthly cost-
which in turn is associated with the frequency of clinic visits. 
Acknowledgments 
The data presented in this paper were collected as part of the 
REACH - Researching Equity in Access to Health Care - Project 
which was carried out with support from the Global Health 
Research Initiative, a collaborative research funding partnership 
of the Canadian Institutes of Health Research, the Canadian 
International Development Agency, Health Canada, the 
International Development Research Centre and the Public 
Health Agency of Canada. The funders had no involvement in 
study design or data collection. The authors are grateful to the 
REACH research team, particularly those who contributed to the 
methods development, data collection and study 
conceptualization. The authors would further like to 
acknowledge the patients and health workers who agreed to be 
involved in this project. 
Conflicts of Interest: None 
Author Information 
Sumaiyah Docrat is a master's student at the University of 
Cape Town, South Africa. Susan Cleary is an Associate 
Professor of Health Economics at the University of Cape Town, 
and the Director of the Health Economics Unit, University of 
Cape Town, South Africa. 
Funding 
During the time of the research, Sumaiyah Docrat was a 
recipient of the National Research Foundation (NRF) Masters 
Equity Scholarship to complete a master's degree in public 
health. The funders had no role in the design, conduct, analyses 
or writing of this study. 
References 
[I] WHO, "Global Tuberculosis Control," Geneva, 2011. 
[2] WHO, "Tuberculosis: Fact Sheet WI04," November, 2010. 
[Online]. Available: 
http://www.who.intlmediacentre/factsheets/fsl04/enlindex.html. 
[3] S. Lawn and A. Zumla, "Tuberculosis.," Lancet, Mar. 20 II. 
[4] R. Wood, S. Lawn, J. Caldwell, R. Kaplan, K. Middellcoop, and L.-
G. Bekker, "Burden of New and Recurrent Tuberculosis in a Major 
South African City Stratified by Age and AN-Status," PLoS ONE, 
vol. 6, no. 10, p. e2S098, Oct. 2011. 
[S] F. K. Mukinda et al., "Rise in rifampicin-monoresistant tuberculosis 
in Western Cape, South Africa," The intemationaljoumal of 
tuberculosis and lung disease: the officialjoumal of the 
International Union against Tuberculosis and Lung Disease, vol. 
16,no.2,pp.196-202,Feb.2012. 
[6] B. Fourie, "The burden of tuberculosis in South Africa," MRC 
National Tuberculosis Research Programme, 20 II. [Online]. 
Available: http://www.sahealthinfo.org/tbitbburden.htm. [Accessed: 
01-Mar-2012j. 
[7] M. Thiede, D. Mcintyre, and P. Akweongo, "Exploring the 
Dimensions of Access," in The Economics of Health Equity, M. 
Thiede and D. Mcintyre, Eds. Cambridge University Press, 2007. 
[8] D. Mcintyre, M. Thiede, and S. Birch, "Access as a policy-relevant 
concept in low- and middle-income countries," Health economics. 
policy. and law, vol. 4, no. 2, pp. 179-193, Apr. 2009. 
[9] Western Cape Department of Health, "National Tuberculosis 
Control Programme Guidelines Pretoria.," Pretoria, 2004. 
[10] J. Van den Boogaard, M. 1. Boeree, G. S. Kibiki, and R. E. 
Aarnoutse, "The complexity of the adherence-response relationship 
in tuberculosis treatment: why are we still in the dark and how can 
we get out?," Tropical medicine & international health: TM & IH, 
vol. 16, no. 6, pp. 693-8, Jun. 20 II. 
[II] D. Mcintyre, L. Gilson, H. Wadee, M. Thiede, and O. Okarafor, 































challenges in South Africa," Journal of International Development, 
vol. 18, no. 3, pp. 435-446, Apr. 2006. 
K. S. Chetty, "Equity promoting health care policies in South 
Africa.," Paper preparedjor the Health Systems Knowledge 
Network of the World Health Organization's Commission on Social 
Determinants of Health., 2007. 
A. Oliver and E. Mossialos, "Equity of access to health care: 
outlining the foundations for action," Journal of epidemiology and 
community health, vol. 58, no. 8, pp. 655-658, Aug. 2004. 
M. Gulliford, "Modernizing concepts of access and equity.," Health 
economics. policy. and law, vol. 4, no. 2, pp. 223-30, Apr. 2009. 
L Aday and R. Andersen, "A framework for the Study of Access to 
Medical Care," Health Services Research, vol. 9, no. 3, pp. 208-
220,1974. 
G. Mooney, "Is it not time for health economists to rethink equity 
and access?," Health economics. policy. and law, vol. 4, no. 2, pp. 
209-221, Apr. 2009. 
A. Donabedian, "Models for organizing the delivery of health 
services and criteria for evaluating them," Milbank Memorial Fund 
Quarterly, vol. SO, no. 4, pp. 103-154, 1972. 
R. M. Andersen, "Revisiting the behavioral model and access to 
medical care: does it matter? ," Journal of health and social 
behavior, vol. 36, no. I, pp. 1-10, Mar. 1995. 
T. C. Ricketts and L. J. Goldsmith, "Access in health services 
research: the battle of the frameworks.," Nursing outlook, vol. 53, 
no.6,pp.274-80,2005. 
R. Penchansky and J. W. Thomas, "The concept of access: 
definition and relationship to consumer satisfaction.," Medical care, 
vol. 19, no. 2, pp. 127-40, Feb. 1981. 
WHO, "Social justice and equity in health: report on a WHO 
Meeting, Leeds, 22-26 July, 1985," Copenhagen, 1986. 
M. Whitehead, "The concepts and principles of equity and health.," 
Internationaljournal of health services: planning. administration. 
evaluation, vol. 22, no. 3, pp. 429-45, Jan. 1992. 
P. Braveman and S. Gruskin, "Defming equity in health," Journal 
of Epidemiology & Community Health, vol. 57, no. 4, pp. 254-258, 
Apr. 2003. 
A. Krasnik, "The concept of equity in health services research," 
Scandinavian journal of social medicine, vol. 24, no. I, pp. 2-7, 
Mar. 1996. 
WHO, World Health Statistics-201l. WHO Press, 2011. 
O. O'Donnell, E. Van Doorslaer, A. Wagstaff, and M. Lindelow, 
Analyzing Health Equity Using Household Survey Data: A Guide to 
Techniques and Their Implementation. Washington, DC: The 
World Bank, 2008. 
WHO, "Adherence to Long-Term Therapies: Evidence for Action," 
WHO Library Cataloguing-in-Publication Data, Geneva, 2003. 
S. A Munro, S.A Lewin, H. 1. Smith, M. E. Engel, A. Fretheim, and 
1. Volmink, "Patient adherence to tuberculosis treatment: a 
systematic review of qualitative research.," PLoS medicine, vol. 4, 
no. 7, p. e238, Jul. 2007. 
M. K. Gebremariam, G. a Bjune, and J. C. Frich, "Barriers and 
facilitators of adherence to TB treatment in patients on concomitant 
TB and HIV treatment: a qualitative study.," BMC public health, 
vol. 10, no. I, p. 651, Jan. 2010 .. 
H. Schneider, D. Mcintyre, S. Birch, and J. Eyles, "Researching 

















Results: Access challenges in TB, ART and maternal health 
services," Cape Town, 2009. 
MDHS Planning Task Team, "Department of Health Western Cape 
Metropole District Health Services Cape Town 2003-2004: Annual 
Report," Cape Town, 2004. 
B. Draper, D. Pienaar, W. Parker, and T. Rehle, "Recommendations 
for Policy in the Western Cape Province for the prevention of 
Major Infectious Diseases, including HIV/AIDS and Tuberculosis," 
in Western Cape Burden of Disease Reduction Project: Final 
Report, Cape Town: ,2007. 
Western Cape Department of Health, "Annual Performance Plan-
2011112," 2011. 
K. C. Farmer, "Methods for measuring and monitoring medication 
regimen adherence in clinical trials and clinical practice.," Clinical 
therapeutics, vol. 21, no. 6, pp. 1074-90; discussion 1073, Jun. 
1999. 
Western Cape Department of Health, "Mobilizing Against 
Tuberculosis. South African plan for TB control: 2002- 2005," 
Pretoria, 2002. 
T. Bam et al., "Factors affecting patient adherence to DOTS in 
urban Kathmandu, Nepal.," The International Journal of 
Tuberculosis and Lung Disease, vol. 10, no. 3, pp. 270-6, Mar. 
2006. 
E. Shargie and B. Lindgorn, "Determinants of Treatment 
Adherence Among Smear-Positive Pulmonary Tuberculosis 
Patients in Southern Ethiopia," PLoS Med, vol. 4, no. 2, Feb. 2007. 
M. Sagbakken, J. C. Frich, and G. Bjune, "Barriers and enablers in 
the management of tuberculosis treatment in Addis Ababa, 
Ethiopia: a qualitative study.," BMC public health, vol. 8, p. II, 
Jan. 2008. 
J. M. Cramm, H. 1. M. Finkenf1iigel, V. Meller, and A. P. Nieboer, 
"TB treatment initiation and adherence in a South African 
community influenced more by perceptions than by knowledge of 
tuberculosis.," BMC public health, vol. 10, p. 72, Jan. 20 I O. 
Z. F. Udwadia and L. M. Pinto, "Review series: the politics ofTB: 
the politics, economics and impact of directly observed treatment 
(DOT) in India," Chronic respiratory disease, vol. 4, no. 2, pp. 
10 1-6, Jan. 2007. 
M. K. Ranson, "Reduction of catastrophic health care expenditures 
by a community-based health insurance scheme in Gujarat, India: 
current experiences and challenges.," Bulletin of the World Health 
Organization, vol. 80, no. 8, pp. 613-21, Jan. 2002. 
N. Prescott, "Coping with catastrophic health shocks.," in 
Conference on social protection and poverty, 1999. 
D. Mcintyre, M. Thiede, G. Dahlgren, and M. Whitehead, "What 
are the economic consequences for households of illness and of 
paying for health care in low- and middle-income country 
contexts?," Social science & medicine (1982), vol. 62, no. 4, pp. 
858-65, Feb. 2006. 
1. Volmink and P. Gamer, "Directly observed therapy for treating 
tuberculosis.," Cochrane database of systematic reviews (Online), 
no. 4, p. CDOO3343, Jan. 2007. 
M. Zwarenstein, 1. H. Schoeman, C. Vundule, C. 1. Lombard, and 
M. Tatley, "Randomised controlled trial of self-supervised and 
directly observed treatment of tuberculosis.," Loncet, vol. 352, no. 
9137, pp. 1340-3, Oct. 1998. 
Western Cape Department of Health, National Health Act [Act 61 













[1] WHO, "Global Tuberculosis Control," Geneva, 2011. 
[2] WHO, ''Tuberculosis: Fact Sheet N°I04," November, 2010. [Online]. Available: 
http://www.who.int/mediacentre/factsheets/fsl04/en/index.html. 
[3] S. Lawn and A. Zumla, ''Tuberculosis.,'' Lancet, Mar. 2011. 
[4] R. Wood, S. Lawn, J. Caldwell, R. Kaplan, K. Middelkoop, and L.-G. Bekker, "Burden of New and Recurrent 
Tuberculosis in a Major South African City Stratified by Age and HIV-Status," PLoS ONE, vol. 6, no. 10, p. 
e25098, Oct. 2011. 
[5] F. K. Mukinda et aI., "Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa.," The 
international journal of tuberculosis and lung disease: the official journal of the International Union against 
Tuberculosis and Lung Disease, vol. 16, no. 2, pp. 196-202, Feb. 2012. 
[6] B. Fourie, "The burden of tuberculosis in South Africa," MRC National Tuberculosis Research Programme, 
2011. [Online]. Available: http://www.sahealthinfo.org/tb/tbburden.htm. [Accessed: 01-Mar-2012]. 
[7] M. Thiede, D. Mcintyre, and P. Akweongo, "Exploring the Dimensions of Access," in The Economics of Health 
Equity, M. Thiede and D. Mcintyre, Eds. Cambridge University Press, 2007. 
[8] D. MCintyre, M. Thiede, and S. Birch, "Access as a policy-relevant concept in low- and middle-income 
countries," Health economics, policy, and law, vol. 4, no. 2, pp. 179-193, Apr. 2009. 
[9] Western Cape Department of Health, "National Tuberculosis Control Programme Guidelines Pretoria.," 
Pretoria, 2004. 
[10] J. Van den Boogaard, M. J. Boeree, G. S. Kibiki, and R. E. Aarnoutse, ''The complexity of the adherence-
response relationship in tuberculosis treatment: why are we still in the dark and how can we get out?," 
Tropical medicine & international health: TM & IH, vol. 16, no. 6, pp. 693-8, Jun. 2011. 
[11] D. Mcintyre, L. Gilson, H. Wadee, M. Thiede, and O. Okarafor, "Commercialisation and extreme inequality in 
health: the policy challenges in South Africa," Journal of International Development, vol. 18, no. 3, pp. 435-
446, Apr. 2006. 
[12] K. S. Chetty, "Equity promoting health care policies in South Africa.," Paper prepared for the Health Systems 
Knowledge Network of the World Health Organization's Commission on Social Determinants of Health., 2007. 
[13] A. Oliver and E. Mossialos, "Equity of access to health care: outlining the foundations for action," Journal of 
epidemiology and community health, vol. 58, no. 8, pp. 655-658, Aug. 2004. 
[14] M. Gulliford, "Modernizing concepts of access and equity.," Health economics, policy, and law, vol. 4, no. 2, 
pp. 223-30, Apr. 2009. 
[15] L. Aday and R. Andersen, "A framework for the Study of Access to Medical Care," Health Services Research, 
vol. 9, no. 3, pp. 208-220, 1974. 
[16] G. Mooney, "Is it not time for health economists to rethink equity and access?," Health economics, policy, 












[17J A. Donabedian, "Models for organizing the delivery of health services and criteria for evaluating them," 
Milbank Memorial Fund Quarterly, vol. 50, no. 4, pp. 103-154, 1972. 
[18J R. M. Andersen, "Revisiting the behavioral model and access to medical care: does it matter?," Journal of 
health and social behavior, vol. 36, no. 1, pp. 1-10, Mar. 1995. 
[19J T. C. Ricketts and L. J. Goldsmith, "Access in health services research: the battle of the frameworks.," Nursing 
outlook, vol. 53, no. 6, pp. 274-80, 2005. 
[20J R. Penchansky and J. W. Thomas, "The concept of access: definition and relationship to consumer 
satisfaction.," Medical care, vol. 19, no. 2, pp. 127-40, Feb. 1981. 
[21J WHO, "Social justice and equity in health: report on a WHO Meeting, Leeds, 22-26 July, 1985," Copenhagen, 
1986. 
[22J M. Whitehead, "The concepts and principles of equity and health.," International journal of health services: 
planning, administration, evaluation, vol. 22, no. 3, pp. 429-45, Jan. 1992. 
[23J P. Braveman and S. Gruskin, "Defining equity in health," Journal of Epidemiology & Community Health, vol. 
57, no. 4, pp. 254-258, Apr. 2003. 
[24J A. Krasnik, "The concept of equity in health services research," Scandinavian journal of social medicine, vol. 
24, no. 1, pp. 2-7, Mar. 1996. 
[25J WHO, World Health Statistics-2011. WHO Press, 2011. 
[26J O. O'Donnell, E. Van Doorslaer, A. Wagstaff, and M. Lindelow, Analyzing Health Equity Using Household 
Survey Data: A Guide to Techniques and Their Implementation. Washington, DC: The World Bank, 2008. 
[27J WHO, "Adherence to Long-Term Therapies: Evidence for Action," WHO Library Cataloguing-in-Publication 
Data, Geneva, 2003. 
[28J S. A Munro, S. A Lewin, H. J. Smith, M. E. Engel, A. Fretheim, and J. Volmink, "Patient adherence to 
tuberculosis treatment: a systematic review of qualitative research.," PLoS mediCine, vol. 4, no. 7, p. e238, 
Jul. 2007. 
[29J M. K. Gebremariam, G. a Bjune, and J. C. Frich, "Barriers and facilitators of adherence to TB treatment in 
patients on concomitant TB and HIV treatment: a qualitative study.," BMC public health, vol. 10, no. 1, p. 
651, Jan. 2010. 
[30J H. Schneider, D. Mcintyre, S. Birch, and J. Eyles, "Researching Equitable Access to Health Care to Health Care 
Project: Phase 1 Results: Access challenges in TB, ART and maternal health services," Cape Town, 2009. 
[31J MDHS Planning Task Team, "Department of Health Western Cape Metropole District Health Services Cape 
Town 2003-2004: Annual Report," Cape Town, 2004. 
[32J B. Draper, D. Pienaar, W. Parker, and T. Rehle, "Recommendations for Policy in the Western Cape Province 
for the prevention of Major Infectious Diseases, including HIV/AIDS and Tuberculosis," in Western Cape 
Burden of Disease Reduction Project: Final Report, Cape Town: , 2007. 












[34] K. C. Farmer, "Methods for measuring and monitoring medication regimen adherence in clinical trials and 
clinical practice.," Clinical therapeutics, vol. 21, no. 6, pp. 1074-90; discussion 1073, Jun. 1999. 
[35] Western Cape Department of Health, "Mobilizing Against Tuberculosis. South African plan for TB control: 
2002- 2005," Pretoria, 2002. 
[36] T. Bam et aI., "Factors affecting patient adherence to DOTS in urban Kathmandu, NepaL," The International 
Journal of Tuberculosis and Lung Disease, vol. 10, no. 3, pp. 270-6, Mar. 2006. 
[37] E. Shargie and B. Lindtjorn, "Determinants of Treatment Adherence Among Smear-Positive Pulmonary 
Tuberculosis Patients in Southern Ethiopia," PLoS Med, vol. 4, no. 2, Feb. 2007. 
[38] M. Sagbakken, J. C. Frich, and G. Bjune, "Barriers and enablers in the management of tuberculosis treatment 
in Addis Ababa, Ethiopia: a qualitative study.," BMC public health, vol. 8, p. 11, Jan. 2008. 
[39] J. M. Cramm, H. J. M. Finkenflugel, V. M0l1er, and A. P. Nieboer, "TB treatment initiation and adherence in a 
South African community influenced more by perceptions than by knowledge of tuberculosis.," BMC public 
health, vol. 10, p. 72, Jan. 2010. 
[40] Z. F. Udwadia and L. M. Pinto, "Review series: the politics ofTB: the politics, economics and impact of 
directly observed treatment (DOT) in India.," Chronic respiratory disease, vol. 4, no. 2, pp. 101-6, Jan. 2007. 
[41] M. K. Ranson, "Reduction of catastrophic health care expenditures by a community-based health insurance 
scheme in Gujarat, India: current experiences and challenges.," Bulletin of the World Health Organization, 
vol. 80, no. 8, pp. 613-21, Jan. 2002. 
[42] N. Prescott, "Coping with catastrophic health shocks.," in Conference on social protection and poverty, 1999. 
[43] D. Mcintyre, M. Thiede, G. Dahlgren, and M. Whitehead, "What are the economic consequences for 
households of illness and of paying for health care in low- and middle-income country contexts?," Social 
science & medicine (1982), vol. 62, no. 4, pp. 858-65, Feb. 2006. 
[44] J. Volmink and P. Garner, "Directly observed therapy for treating tuberculosis.," Cochrane database of 
systematic reviews (Online), no. 4, p. CD003343, Jan. 2007. 
[45] M. Zwarenstein, J. H. Schoeman, C. Vundule, C. J. Lombard, and M. Tatley, "Randomised controlled trial of 
self-supervised and directly observed treatment of tuberculosis.," Lancet, vol. 352, no. 9137, pp. 1340-3, 
Oct. 1998. 



































ACCESS BARRIERS & TB-TREATMENT 
EXPLORING EQUITY IN ACCESS TO TB-TREATMENT & THE I 0' 
""CCESS BARRIERS ON TB-TREATMENT ADHERENCE IN MITCHELl'S PtAtN. 
SOUTH AFRICA 
• N0T AJ~"'NG TO TB T~[ATMH,T s '-0T AS'/ X 'IATD 
IV'TII '~C[SS EAP, "[~S 
• r -<, ~,'TRI"JT;c.'j Of TB-SlHV e[s ,N MITCIIHl'S 
PI ~I~, S.(XJ" H M k U. M F __ .R.' "Co "[ EQUIT A"" 
SOURCE 
Thi , policy brief is based on a journ al article 
t it led "An Analysis of Adherence & Equity in 
Access to TB-DOTS Services in Mi l chell' s 
Plain, South Africa" 
AUTHORS 
Sumaiyah Dacrat' , Susan Cleary' 
, Health Economics Unit, University of Cape 
Town, Observatory 7915, Western Cape, 
South Africo 
CORRESPONDENCE 
For more informat ion about thi ~ policy brief 
please email: 




Sout h Alrico fMes one 01 t he wor.lt Tuberculosis iTS) 
epidem;c, 'n th e world 01 every 100,000 
M(c~n" 904 ~re expected to develop T~. 
ratiorol method 01 treotirg Tuberculosis, ;'::,:~: I 
Observed Tr e~ t ment-Short Cour.le mOTS), ho~ 
supported by the ,Vorld He~l t h Ore~n:'~tior' 
.nd is used globa:ly to comb. ! the disease. When 
patient i, treoted UI;ng the DOTS strotegy, they' 
typic~lIy required to t~ke medic~tion dJily, over 0 
period of ,ix to eieht month" The DOTS ","",,1 
rt'quires thot f'Jeh potif'nt oc sUpt'rvised, thereforf', 
e~ch p~tient is required to either: vi,it a heJlth 
f.ci:ity on a daily basis OVH the treatment pHiod 
be visited by ~ desi~nated commllrity-member 
administers ard supervisu the p. tier". ':;,';~~~';; I 
thf'medicatior Despite the odoption of the 
st"tegy ir 1')% ~nd IMge fir~nci~1 inve'tn-ent, in 
cor t rol, South Alric. h.s nOl met thf' TB'r :. , 
t ",gets which have beer ,et by ,he WHO. At 
trends, 35 million people wi!1 develop TR ~nd 
approx;malf'ly 90,000 people will die a, • resu'l 











BARRIERS & TB-TREATMENT 
EQUITY IN ACCESS TO TB-TREATMENT & THE INFLueNCE or 
BARRIERS ON TB-TREATMENT AOHERENCE IN MITCHELL's -PLAIN, 
I SC'UT!< AFRICA 
I ~,~:::::: th~ policy goal of identi fy ing 71})1, of ~II new TB ca'~' and .,ucc~.>Sfully curing 85% ~:::':~ II. in t r~Jtment in South Afric ~ requires ~n undef\ t~ nding Df th ~ sp ~ cific ba"i~rs b~ing fac~d by t 
TB, pJrticulJfly in light of the ~v~ ilabili t y Df ~ff~ct iv ~ tr~atm~nt, It is al,;o impDItJnt that acccs> to TB·serviccs 
cquit d bl~ i,e. di,;tfibutcd in ~ way tha t en.\ur~s that all in n ~~d hav<' an ~qua l opport unity ID us~ TB ,-'""'-, I 
regardless Df sociJI stJtus, geo g raphic ~ llocatiDn Dr Dth ~ r p~rson~1 characteristics, 
While TB sen'icc!'> in the public ~l'ctl)rarc free ;Itthl' pnint of usc, little is known 
about overall ;I((CSS barriers and their implicatioll'i for treatment adhl'rcnct'. 
This brief ~umm;lI'i'lt'~ Ihe'it' hal ril'r<; 11'0111 thc pt'rspl'rtin' of T8 path'tlh l'nrollcd 
in Oiredl\" Obst'n'cd Trealml'n t, Short ·(lIl1rs~ (DO rS) ill Mih'hcll's 1'1.1 i II, Sutlth 
Mril'.l. 
RESEARCH OBJECTIVES 
1. To describe the characteristics of adherent and non·adherent DOTS patients 
Who is adhering and who isn't? 
2. Explore the relationship between access to DOTS services and patient adherence 
Do non-adherent patients face more ac~ess ba rrie" tha n adh~rent patients? 
3. Explore the relationship between access and socioeconomic status 
Do the poor face more barriers to accessing DOTS selllk~s that the rich? 
METHODS 
During 2008 and 2009, exit interviews were conducted with 334 users ofTB-service',~;:'~' ~:~::i::I';·; ! 
Plain across five health facilities. Use rs were asked to report socioeconomic and 
information as well as information regarding key barriers to DOTS TB-treatment Ii 
Users were deemed 'adherent' if they reported havin g never missed a dose of TB-medication 
were deemed 'non-adherent' if they reported havi ng missed one or more doses of 
medication. In addition, users were grouped as 'rich' or 'poor' based on their "cI""",;om;, 
status. Their experiences in accessing TB-services were compared by both adherence group 
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EQUITY IN ACCESS TO TB·TREATMENT & THE OF 
BARRIERS ON TB'TREATMENT ADHERENCE IN MITCHELL'S PLAIN ..... 
non-adherence. 
'_' The median (interquartile range) age ofthe par t icipanb wa,; 34 year,; (42·27) and 
years (38-23.5) for the adherent and non-adherent groups_ 
• Age, Marital Status and the Province of the Respondent's birth were associated 
adherence. 











fi~ u .. 1 
Users in older age groups were more likely to be adherent. 
Users that were married were more likely to be adherent than those that were 
single. 
Respondents who were born in the Eastern Cape Province were more likely to 
adherent. 
1 7 ~. 
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BARRIERS & TB-TREATMENT 
EXPLORING EQUITY IN ACCESS TO TB'TREATMENT & ~~:~~~O~':-~ I A.WESS BAIiRIERS ON TS-TREATMENT ADHERENCE IN fI 
I SOUTH AFRICA 
• Adherent patients incurred higher costs, but these costs were mainly ;"'""" ;~:~1 
using other providers (private general practitioners, traditional healers) and 5 
money on self care (special foods, traditional medicines, vitamins), 
• Costs were catastrophic (i.e, represented over 10% of household expenditure) for 32% 
respondents, of these user'), a larger proportion were poor than rich. In total, the pp'''1 
spent 17% of their household expenditure on TB-related care. 
• Direct costs of transportation represented the largest burden of costs for all users. 
Ta ken together, these findings do not provide sufficient evidence of systematic ineq ualities 
access to DOTS TS-services in Mitchell's Plain, South Africa Despite the fact that the pom j 
were found to experience increased barriers to accessing treatment, by the high cost 
seeking treatment, these associations were not found to be ')ignificant. 
POLICY IMPLICATIONS 
This ')tudy reflects that the TB-service in Mitchell's Plain appears to be distributed in a way that 
reflects the equity goals of the government. Nonetheless, thi') study elicits concerns about the 
high co')t') of using TS-services and the impact on households of catastrophic payments. This 
j ~''''o,;t, a need to further explore the issue of transport costs - the main constituent of the 
I monthly cost. South Africa faces many challenges in successfully controlling the T8-
epidemic over the next deCade. We hope that our findings illustrate the potential of the T8-
service, and the health system more widely, in reaching and treating all tho')e in need. 
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APPENDIX A: EXIT INTERVIEW QUESTIONNAIRE 
CONSENT TO PARTICIPATE IN THE INTERVIEW 
Facility: {enter nalTle OF faci1d;J_ 
I HAVE BEEN INFORMED ABOUT THE PROJECT 
RESEARCHING EQUITY IN ACCESS TO HEAL TH CARE, AND I 
UNDERSTAND THAT IT IS UP TO ME WHETHER OR NOT TO 
BE INTERVIEWED. 
I understand that there will be no consequences of any kind through my 
responding to this questionnaire. in particular, there ,;ill be no impact on the 
care that I receive in this hospital. 
I understand that I can ask the rel~on interviewing me to stop the interview at 
any time. 
I understand that the information that I give will be treated in the strictest 
confidence and that my name will not be used when the interviews are 
analysed. 
Yes, I give my permission for the interview 
Interviewee's signature Date 
Interviewer's name (please print) 
Interviewer's signature Date 
o 
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APPENDIX A: EXIT INTERVIEW QUESTIONNAIRE 
SEGTIO~ I ' SOCIOECO"'O~IG AND D~MOGRAPHIC BACKCROU'ID QUESTIONS ABOUT THE 
RESPO'lOEOH HIS/HER HOUSEHOLD AND HOUSEHOLD HEAD 
READ OUT 
I am going to ,too hI' "' king yw ~ f~w ,"ueolio." a/>(:Jyt VOU '''" your h""ehoId . When II'" 00001 y(>l.( 
"O,,,,,,,,,d, I om "clue ing .. I th~ people who Ive in I'm" ho<J,~ "'0 who ,h,,'lre ' he . arne food v.;th voo 







Whot "",s y<:;J' age ~t)'OL.O" ~st Il rtM,y? 
F II in o.1e bk>ck W ly 
, .• 
We.:, is the heoc of yo ,," ho<Jse/1o~~? 8y this, I me",", wflo is 
the pa;80/1 ~ u_'_"",I ~ '1.li!II.e., th ~.i.IJ1~.nl cI<oci.p.o , " th<t 
F~d, l ~kO<'te relot>o." hi~9_ totho -, mother not 
"~ 
li 
Co:le ,ex uf HHH I' no: cl .", ask: W"' l ;,; th" s e, 01 y"'-" ./::' 
, .• 
Cc:<J e posi~on " HH (j respo.'1dMi. ~f unc lear. 
~s<: -
Who! i, your pooit'un " the huu,ehuk:!, r.,;:~ 
,,,,.tiun Iu th e r.ou,eh:Jjd heM ,l>Oh 00 ' eifl 
001. few ceiev",,1 0;>(:""" . 
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H US b"" d.'M rei""", er 
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, ' , 
, 
, 
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Other ''''''.Ive (~ .~ . I~ T""", 01 ""rl/uncle) S 
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APPENDIX A: EXIT INTERVIEW QUESTIONNAIRE 
RE AD OUT: So"" peOI' " I,ne ' '1 '' 16 C",C 10 ", c~ IJ tce - TC tr"at"",,1 ac d ITiD N not ,I" 'i' 11 " " "I" 
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" Ih ",,~ ,u ris 01 ofOb "," , ",1(; '.'.11.etl f\e 'e,,",,, , rri M 110 
va 
Die j'OU rre;, l'-.kirg " oy 0< ymx T~ tn olet, Y ~ S I ~RDA y? 
2,11 
Did ;'w .... " -aking a.'y TB 1001« 8 th e c'-"f W ore Y~STE~Dlln 
2,12 
DKJ , 00 ~;" I. ki [\; . n), TO tai>e(, 3 DAYS AGU"~~~~. 
Spoee I)' :h e calw,da r (lay i' r~at""~ 10 t",e cai of ;~6 'Ief '" j"..,. 
2,13 
llport fro" -r", "",', th:"" tko", h . ','~ j'UU e',',,- ""sed lakinq a.')' "ble l,? 
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"' Wn"'" the ,","''' ",:"" .1 ot you' hc<,,~', m"fO 
"' 
Ti", 




f~-'w Ol ~l1y room" il>ClJ ~"'g Kit<or.c"" doe" your hoc'" "'.,.~? 
Ir.j,,,,,i<owo ·, prevo. rid o,{OI,& b~'l1,'oo""" s!1.,ci;. 9"""'"'. 
,t~bb, w_e (rom [he let,1 L>"ies, poo~'e "'" li;;% in ""'" 
"" 'f..".! j, 110 " .. in "ourc~ 01 drinking w.ter fey 
me'-..Wf' of i01Jr hoo""CoId? 
0.' 
' .... 'tklt t~pe 0' :oil<><: (0._' yOLX 'ou,m(>I;: "",0 
Pi;>c~ (t"" i wat<lf In c_I.r~ 
Piped C." I W ... '" ' )f1 Slie '" in y.e<J 
Bo",co'~ on "t~ 
~,"r ",. Ie' t...-k 1M sj'_o 
Neicj1bou(; la~ 
P'J: ieiwol"'u"," '-"!l (";'_he, rr"~ o r p;.;d) 
Waler Ulroer,\a",e, 
Bor..,,w, 0' s<1",'mcln\uO" 






r"" " lOci (mnooc lod '" ''' ..... ''90) 
~ kJ ,c tol e! (,,;th ""I'fic_~,!,_; ) 
C~~I'_"' le'_ 
Pil 'do"" ',.,;th '",n;r",,,,,, ;>1"" " 
Pit '~tcj"" ,,,;thoot vOC(iI.t"", pi?<:: 
flu<,ket loilo! 



























APPENDIX A: EXIT INTERVIEW QUESTIONNAIRE 
~,10 '" 
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APPENDIX B: RECORD REVIEW QUESTIONNAIRE 
RESEARCHING EQUITY IN ACCESS TO HEALTH CARE l 
RECORD REVIEW OF TUBERCULOSIS SERVICES; 
_~O_NSENT F(}_RM _________ ~ 
Facility: [enter name of facilityl ______________ _ 
I have been informed about tho projnct Reseerching equity in eccess t() heelth care, and 
I understand that it is up to mo whothor or not to allow my medical record to be 
ro~iowod 
I understand that the'e ,,,,.ill bo no consoquorlcos of any kind through my agmernent to 
this rflquosl; irl particular. tllere will be 110 impact 011 the ca'e that I receive irl this 
clinic/hospital. 
I ullderstand that the illfo'malion obtained from Illy patient medical record Will be treated 
in the strictest confidenco and that Illy namo ,,,,.ill not bo usfld whorl tho information is 
analysed. 
Yos, I givo my pormission to review my record n 
-
Intorviowoo's signatLJrfl Dale 
Inter~iewer's nalllO (ploaso print) 











APPENDIX B: RECORD REVIEW QUESTIONNAIRE 
Record Review 
INSTRUCTIONS 
o Make sure that the patient's study sticker is attached below. 
o Complete the information overleaf using the patient's blue card. 
o The completed questionnaire must be attached to the patient's exit interview. 
o Once quality control has been completed the front page will be detached and kept 




dd mm yyyy 
Date completed: I I III I III I I I I 
Blue card found? Yes No 












APPENDIX B: RECORD REVIEW QUESTIONNAIRE 
A. RECORDING & REPORTING 
The section is concerned with the general level of completeness of the blue card, that is whether or not all the 
required information has been filled in. Circle Yes or No to indicate if the following information is filled in on the card. 
Only circle Yes if ALL the required information is completed. Circle No if there is no information filled in or the 
information is incomplete or the information is not available on your version of the carel. 
Page 1: 
1. Registration number Yes No 
2. Registration date Yes No 
3. Patient origin (N, M or T ticked in upper right hand corner) Yes No 
4. Full names of patient Yes No 
5. Patient 10 number Yes No 
6. Patient date of birth Yes No 
7. Patient age Yes No 
8. Patient gender Yes No 
9. Patient home and work addresses Yes No 
10. Address in sufficient detail to trace patient (Clear description if no formal address) Yes No 
11. Name and addresses of next of kin Yes No 
12. Patient category Yes No 
13. Disease classification Yes No 
14. Notification date Yes No 
Page 2 : 
15. Pre-treatment sputum results Yes No 
16. Intensive phase regimen and dosage Yes No 
17. Continuation phase regimen and dosage Yes No 
18. Adherence section up to date (To 1 week ago if weekly Rx I To 1 month ago if monthly Rx) Yes No 
19. Name and contact details of treatment supervisor (For both phases on new form) Yes No 
Page 3: 
20. HIV status Yes No 
21. Clinical notes on patient progress Yes No 
22. Patient's weight recorded at each visit Yes No 
Page4: 
23. Patient contact section filled in (No Contacts should be written if there were no contacts) Yes No 
24. Treatment outcome recorded Yes No 












APPENDIX B: RECORD REVIEW QUESTIONNAIRE 
B. CLINICAL MANAGEMENT 
The section is concemed with whether or not the completed information is correct and the patient has been managed 
correctly. For each question below simply copy the required information directly from the card. Note that not all 
answers may be appropriate or completed for your patient. If the information is not available please write NJA in the 
box or next to the question. 
1. Version of the card (Date in top right comer Eg: Sep 2002 or Nov 2006) 
d d m m Y Y Y Y 
2. Patient's registration date I I 1'1 1'1 I I I I 
d d m m Y Y Y Y 
3. Patient's birth date I I 1'1 I 1'1 I I I I 
4. Patient category N RC RAC RF RD OR 
5. Classification of disease 
Pulmonary TB TB Primary Extra PTBI Any otherTB 
6. Patient has been notified? (Y ticked AND date recorded) Yes No 
7. Record all the sputum test dates and results listed for the patient on the form: 
Smear Date Smear Result 
d d m m Y Y Y Y 
Pre-Treatment L , , 
iL , , 
End of intensive phase L , , 
ii. , , 
iii. , , 
iv. , , 
Discharge I End of treatment i. , , 
iL , , 
8. Record all the culture test dates and results listed for the patient on the form: 
Culture Date Culture Result 












APPENDIX B: RECORD REVIEW QUESTIONNAIRE 
9. Drug Regimen 1 2 3 
dd mm yyyy 
10. Treatment start date I I III I III I I I I 
11. Patient's weight at diagnosis kg 
12. Drug dosage in INTENSIVE phase 
RHZE RHZ S E 
Number of tablets I dose 
13. Drug dosage in CONTINUATION phase 
RH (150n5) RH (300/150) RH (60/30) E 
Number of tablets I dose 
14. Number of visits missed. (Count the total number of Xs in calendar section on page 2 for each phase) 
Intensive phase 
Continuation phase 
15. Any patient contacts? Yes 
If YES, check contact tracing done correctly? 
No 
All children « 5 years) had X-Ray AND Mantoux/tuberculin test 
All adults (> 13 years) had sputum test 
16. Treatment outcome 
Not Recorded 
Patient transferred I Moved 
Cured 
Treatment completed 
Treatment defaulted I interrupted 
Treatment failure 
Died 
dd mm yyyy 














APPENDIX C: ETHICS CLEARANCE 
U~IVE1l:SITY Of C.'.C'E j 1JW~ , 
RE C R.E F, 4M / 20{l6 
!\.iPwfD MeI" ty'" 
HuI," 1::0",,",""''' 1-' "" 
".0. "" ·,1 ru~, j 'bIth 
He~1th Sci ~ nc~. FacuIt\· 
R ",,~,cI, E,h k . Com",;".", 
R,,,,,, E>'_" Groot< Soh"", II.,.,.;.. ' Old M.;" II"",",. 
Ob" "'-""", 'iW. ' 
I'."_ ,q ><"y" . ,~_ " ",' _ ' " 
. _~.~ ~"M,","""" _,. ' " 
1'~OJ£CTTITLE, RESEARCmNG EQUITY IN ACCESS TO HEALTH CARE (REACH) 
It;' , ph",,, to ,n[n= wu ti", ,h, E,hi" CoC' mi"", h" g-<antod «hk il oW",,,,,l to "" tho '" ," d,·, 
p,h.,ring tool. 'ml intDm",oon ,I""" .nd inf""""d ,,,,,,,,n, to"", demibd in . pp<nJic<> 1_1S, 
• \'x'ill r""""'-pu!i<>p.m, "eel'-,' ,,-,- " '''''p'',,","nn to" "";,,. I"'''' ' _" t10 ",_d, : ~h in""..,,,,, (<<mi_ 
",,,,,,uted . nJ ",,-mti"e.)' Th.,,, ,"" "~~ ,,><\ ""'f b< ",,,J<nMne to, 5<0,,,, p"~""l> 
• Do Ym' i,}<""d '" .. ," "")' .ci," ,hodd you ob,er". h",,,>o; ... rt- " ";",,, ;nee"" ",,,"-' Y,,,, ,od""" 
,h ... U "",e<v' ''''''' ' ~ill b, . trictly eo~fi<ko",1 w""" migh' 1"'" .0 "h,d ,f.!",r,n» ,h<."W ·p.Uent_ 
.bu.,,' b< "1",,,'«1 by ",.om b«" 
Ph" woold 1''''' c_oolj- j), T""'7 K.Jcdi j~ the \1/,,,<," C. p" D<p..-ttn"n' nf lk,hh d"" \'U" '" 
llnde"';;'<1g !hi. ,rudy, You U>dr.H< ,11t roc< .1",";' h.", ?"nvi ... ,iol 1"'''''''''''''' to do tl'" "".,,1 . ~, j[ ,;\. ~' 
"'. "J._",J"" "'''''' till oll-"jl ro" h." I. t<"" """"" ""'tn",> 
I'k"o fl"" <to" ,1, OOj1;O<og ,,1.,,1 '0"""'" of ,h, ",.cl)' <en .. in. ,h< '''I'W"bilily or ,h,c ?riocip.l 
"" -'" ":ii'"'''' 
Pl<o'c quote th (' RFC ItE l' in , U your co,,<spond~hcc_ 
PROF M BLOnN_ov:J 











APPENDIX D: JOURNAL INSTRUCTIONS FOR AUTHORS 
Mi1l1u, cnpL .,hould be " "itle n in F n~li,h Th~, sl"mld b ~ deM, r:n n'i' ~ ;, nd lo~ical 
Mdn u,uipls s hou Id be' ,tructu red 0.' lallo,,"o: 
• Iltll' Pi1e,e 
• ,\b,t r.ct 
• Il1tmduction 




• Ackno ..... ll'dgemenb {l'.~ to -'Pon,,,,,) 




COl1cbe ond Inlorm~livc 11t h ore atten LJ, ~d in in lormalion-r~lri ~, ; ' 1 "sle",,- A,,,id 
~bb,evlolia It> ;' nd 10rmLJ la ~ wher~ pm,i bl ~ 
• A"thaf nom~5 ond affiliations 
Wller~ 1 h~ la m ily 11 . "", m.y be i1mbie,uous {e.,;., d dou bl e n~m<.'), p leo,e In d Icotl' th" ek.'o"y 
P reS~n l the auth ors' .ff1 1 i.tio n . dd re,,,,, ( ..... he'e the i1ctui11 wor' 1'0' 0' done) be'la ..... the 
," m~' Illd icate ;,1 1 . ff11 i.tion, with d lo ..... e' -e.,e super5Cf1pt Il'tte r imn1l'd'~tcly i1tte, the 
author', l1 . me dnd in f ront of the ~ppropri~te i1ddrl''' 
• Corr~sponding authar 
CIt'Mly i Ixlir:;'t ~ "" ho ..... ill h.ndle cOffespondenee ~t oil 't~r,e., 01 rderl'ei n,; i1l1d publiCi1lion, 
, ISf' p<lSt -p~bli CijlJon [n,ure thi1t telq*' one i1 nd f~, num ber., (with (a IJ nl ry ;, nd ar~, (ode) 
are pmvi ded '" ~dd'li on to th l' l'-m' il ad d(~." dnd t h~ com pl~te po'tdl dodd re» ContMt 
dl't~rI, Hllh\ be' ,~ pt IJp to date by the cnrrespondil1g . uth o( 
• Classification and keywords 
Autho" i1 re o,ked to cI;,,,ify tllei r 'lJbmi'.,ion usin g th ~ provided c",,, ift CijlJon ,y,te m. They 
are i1l>a a, ked ta i ncllJde 3 to 6 k~yw ords, p(d~r dbr, fmm the M edie. 1 Su bject He.di n,;' 
Irom In dex M l',!icu.\ 
ABSTRACT 
,\n ,bstra ct of up to lC'O wa,d., mu,t be' inclLJd ~d in lh~ .'LJbmitt~d m;, "uscripl. ,\s th e ab st rdct is 
ofl ~ n viewed ,ep.r.tely from th e ~rlicll', it mLJ,1 b ~ atM to stand alon ~ . It ,ho~ld ,t.te bri efiy dnd 
cle d[~' the purpose ond , cHing, th ~ prinr:ipal hndin gs ,nd m. jo, eOl1clu,"ol1" Mtd the pi1 per"., 
co ntn bulJon to 'now ledge. I 1 ~pp lir:;'bl~, th~ c()u I1try!COU I1t ri e,/locati Oil, sh ould bl' cleo,ly .,ti1 ted, ~, 











Please note that excessive statis:;cal details shoold be avoided, abbreviation,/acronyms u,ed only if 
essential or firmly established, and the abstract shoold not contain reference, to other j>Ubli'hed 
work. 
FIGURES, TABLES & EQUATIONS 
Figure , ,nd t,bles, and esped,11y equation, or other formulae should be kept to a minimum. Onl y 
those figure" table, and equation, that are essential to clorify arguments in the manu,cript ,hoold 
be include d. Exeept in exceptional circum,t,ne"",, the ,dmi"i~e number 01 figure, and table, 
toget her is 2 lor short article" 4 lo r full-length artides and 6 for review-type , rtide" Additional 
figure, and tables m,y be , uppli~d as , upplementary dat' 
LITERATURE REFERENCES 
Citation of lit erature references in the te,t should be done as numbers in square brackets All 
refefena. s , hould be li'ted at the end of the paper on a separate p'ge, aH,nged in num e ric, I order 
of their appe,,,nce in the te,t. not in alph,betical order. 
The Authors should en,ure that there is a , trict one-to-one correspondence between the names and 
years in the te,t and thos e on ~ he relerenc~ lis~. 
CONFLICT OF INn:m",'' '--
All authors ore requested to .Jisdose ,ny actu,' or potential confiict 01 int~rest including ,ny 
financi al, personal or oIher relationships with other people or organirations within tllree years of 
begirlning tile submitted work tllat coold inappropriatelv inHu e rlce, or be perceived to in/lu ~ nce, 
th eir work. 
FUNDING 
Vou are request~d to identify who provided fin, nci,,1 support for the conduct of the re",arch ,nd/or 
preparation of th e ar~cle and to briefiy describe the mle of the spomor(,), il any, in study de sign; in 
the collectio n, a naIV, i, arid irlterp<eta~on 0/ data; in t he writirlg o/the r~port; arid irl the decision ~o 













APPENDIX E: PLAGIARISM DECLARATION 
PlAGIARISM DEClARATION 
1. I know thot plagiarism is wrong. fJlagiarism is to use another's wark and pretend that it is one's awn. 
2. I have used the UCF-Ham:lrd COIIWIItion for citation and referendn, of PrItts A, B# & D. I have used the 
BIoMed Cent"" convention for dttnion lind te/erendn, of Prlrt C. Each contribution to, and quotation In, this 
report, /tom the work(s} 0/ other people has been attributed, and has been cited and referenced. 
3. This NllnJ-DisHrtIltion is my own work. 
4. I have not allowed. and will not allaw, onyone to copy my work with the .intention 0/ passing it off as his or her 
awn work. 
S. I acknowledge thot copying someone else's assignment or essoy, or part of it, is wrong, and declare that this is 
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